<SEC-DOCUMENT>0001493152-24-044154.txt : 20241108
<SEC-HEADER>0001493152-24-044154.hdr.sgml : 20241108
<ACCEPTANCE-DATETIME>20241108072910
ACCESSION NUMBER:		0001493152-24-044154
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		23
CONFORMED PERIOD OF REPORT:	20241104
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241108
DATE AS OF CHANGE:		20241108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apyx Medical Corp
		CENTRAL INDEX KEY:			0000719135
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				112644611
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31885
		FILM NUMBER:		241438009

	BUSINESS ADDRESS:	
		STREET 1:		5115 ULMERTON ROAD
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33760
		BUSINESS PHONE:		7273842323

	MAIL ADDRESS:	
		STREET 1:		5115 ULMERTON ROAD
		CITY:			CLEARWATER
		STATE:			FL
		ZIP:			33760

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BOVIE MEDICAL Corp
		DATE OF NAME CHANGE:	20150319

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BOVIE MEDICAL CORP
		DATE OF NAME CHANGE:	19990216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AN CON GENETICS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:APYX="http://apyxmedical.com/20241104">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_APYX_apyxmedical.com_20241104 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20241104_20241104 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0000719135 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000004" name="dei:EntityCentralIndexKey">0000719135</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="apyx-20241104.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-11-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000719135</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-11-04</xbrli:startDate>
        <xbrli:endDate>2024-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90F_edei--DocumentType_c20241104__20241104_zR8MXw0vuxI1"><ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--DocumentPeriodEndDate_c20241104__20241104_zUSR604GAn6e"><ix:nonNumeric contextRef="AsOf2024-11-04" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">November
4, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (date of earliest event reported)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<img src="form8-k_001.jpg" alt=""/></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span><span id="xdx_908_edei--EntityRegistrantName_c20241104__20241104_zTPZOt2BUMib"><ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000011" name="dei:EntityRegistrantName">APYX
MEDICAL CORPORATION</ix:nonNumeric></span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20241104__20241104_zUPM7hfI7I55"><ix:nonNumeric contextRef="AsOf2024-11-04" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></p></td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityFileNumber_c20241104__20241104_zfe3Ip9wPyDe"><ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000013" name="dei:EntityFileNumber">001-31885</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20241104__20241104_zcQyV6yg6Bq1"><ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000014" name="dei:EntityTaxIdentificationNumber">11-2644611</ix:nonNumeric></span></b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
or other jurisdiction of<br/>
 incorporation or organization)</span></p></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
                                                                                 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></p></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</span></p>
                                                                              <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; border-right-width: 0in; border-right-color: Black; border-left-width: 0in; border-left-color: Black"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityAddressAddressLine1_c20241104__20241104_zYkNHbgTJd73"><ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000015" name="dei:EntityAddressAddressLine1">5115
Ulmerton Road</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressCityOrTown_c20241104__20241104_zbzkml3GB6Ra"><ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000016" name="dei:EntityAddressCityOrTown">Clearwater</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20241104__20241104_zPKII7tV0wZ7"><ix:nonNumeric contextRef="AsOf2024-11-04" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">Florida</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20241104__20241104_z8q2Cln1KKv3"><ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000018" name="dei:EntityAddressPostalZipCode">33760</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices, zip code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--CityAreaCode_c20241104__20241104_zKJ21MorE6nc"><ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000019" name="dei:CityAreaCode">(727)</ix:nonNumeric></span>
<span id="xdx_903_edei--LocalPhoneNumber_c20241104__20241104_zvkTjkUwyWs3"><ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000020" name="dei:LocalPhoneNumber">384-2323</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 50%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report.)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--WrittenCommunications_c20241104__20241104_zu2teuWkEuAe"><ix:nonNumeric contextRef="AsOf2024-11-04" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)</span></td></tr>

<tr style="vertical-align: top">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--SolicitingMaterial_c20241104__20241104_zLywQJCMSJB4"><ix:nonNumeric contextRef="AsOf2024-11-04" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)</span></td></tr>

<tr style="vertical-align: top">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20241104__20241104_zOfQ9FUoTxR4"><ix:nonNumeric contextRef="AsOf2024-11-04" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>

<tr style="vertical-align: top">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20241104__20241104_z8T5n9PhYn5j"><ix:nonNumeric contextRef="AsOf2024-11-04" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20241104__20241104_zXTaRf56tVAj"><ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000025" name="dei:Security12bTitle">Class
    A common stock</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--TradingSymbol_c20241104__20241104_zvU9Fqfu5Yxg"><ix:nonNumeric contextRef="AsOf2024-11-04" id="Fact000026" name="dei:TradingSymbol">APYX</ix:nonNumeric></span></span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SecurityExchangeName_c20241104__20241104_z31sMU9stH04"><ix:nonNumeric contextRef="AsOf2024-11-04" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq
    Global Select Market</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_902_edei--EntityEmergingGrowthCompany_c20241104__20241104_zl8kD2w3ppUh"><ix:nonNumeric contextRef="AsOf2024-11-04" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                                            1.01.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entry
                                            into a Material Definitive Agreement.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Amendment
to the Credit and Guaranty Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2024, Apyx Medical Corporation (the &#8220;Company&#8221;) entered into Amendment No. 1 (the &#8220;Amendment&#8221;) to
the Credit Agreement and Guaranty (the &#8220;Credit Agreement&#8221;), by and among the Company (as borrower), Apyx China Holding Corp.
and Apyx Bulgaria EOOD, the Company&#8217;s wholly-owned subsidiaries (as subsidiary guarantors), and Perceptive Credit Holdings IV,
LP (&#8220;Perceptive&#8221;) (as initial lender and administrative agent).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms and conditions of the Amendment:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company shall not permit or allow its Operating Expenses (as defined in the Amendment) to
                                            exceed: (a) $40,000,000 for the fiscal year ended December 31, 2025; or (b) $45,000,000 for
                                            the fiscal year ended December 31, 2026.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Minimum Advanced Energy Net Revenue Targets, as previously set forth in Section 10.02 of
                                            the Credit Agreement, have been reduced for the quarterly periods beginning on September
                                            30, 2024 and continuing until September 30, 2028.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Amendment also included and modified certain other covenants within the Credit Agreement and made certain other conforming changes to
the Credit Agreement to effect the foregoing. The Amendment was subject to several conditions precedent set forth therein, including,
but not limited to, the Company&#8217;s receipt of $5,000,000 of net cash proceeds from the issuance of its common Equity Interests (as
defined in the Credit Agreement) and the Company&#8217;s issuance of 150,000 shares of the Company&#8217;s common stock, par value $0.001
per share (the &#8220;Common Stock&#8221;) to Perceptive (the &#8220;Perceptive Shares&#8221;). The Perceptive Shares were issued in
a transaction exempt from registration pursuant to Section 4(a)(2) of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Amendment is not complete and is subject to, and qualified in its entirety by reference to the full text
of the Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Purchase Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 7, 2024, the Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with several
institutional investors named therein (the &#8220;Purchasers&#8221;), pursuant to which the Company agreed to issue and sell, in a
registered direct offering (the &#8220;Registered Offering&#8221;), an aggregate of: (i) 3,000,000 shares (the &#8220;Shares&#8221;)
of Common Stock, at an offering price of $1.18 per share, and (ii) <span style="background-color: white">pre-funded warrants (the
&#8220;Pre-Funded Warrants&#8221;) to purchase up to an aggregate of 2,934,690 shares of Common Stock (the &#8220;Warrant
Shares&#8221;) <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at an offering price of $1.179 per
Pre-Funded Warrant (which represents the per share offering price for Common Stock, less the exercise price per share for each
Pre-Funded Warrant of $0.001)</span>.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">aggregate gross proceeds of the Registered Offering,
before deducting related expenses, is approximately $7 million. The Company did not use a placement agent in connection with the Registered
Offering. <span style="background-color: white">The Company intends to use the net proceeds from the Registered Offering for working
capital and general corporate purposes. The Registered Offering closed on November 8, 2024.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement contains customary representations and warranties and agreements of the Company and the Purchasers and customary indemnification
rights and obligations of the parties. <span style="background-color: white">Subject to certain ownership limitations described in the
Purchase Agreement and Pre-Funded Warrants, the Pre-Funded Warrants are immediately exercisable and may be exercised at a nominal consideration
of $0.001 per share of Common Stock at any time until all of the Pre-Funded Warrants are exercised in full. A holder will not have the
right to exercise any portion of the Pre-Funded Warrants if the holder (together with its affiliates) would beneficially own in excess
of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership
is determined in accordance with the terms of the Pre-Funded Warrants.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of the Shares and Warrant Shares were made pursuant to a prospectus supplement to a Registration Statement on Form S-3 (File
No. 333-268532), which was filed with the Securities and Exchange Commission on November 22, 2022 and declared effective by the SEC on
December 2, 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing is a summary of the material terms of the Purchase Agreement and transactions contemplated therein and is not complete and is
subject to, and qualified in its entirety by reference to the full text of the Purchase Agreement and the form of Pre-Funded Warrant,
copies of which are filed as Exhibits 10.2 and 4.1, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
copy of the legal opinion, including the related consent, of Ruskin Moscou Faltischek, P.C. relating to the legality of the issuance
and sale of Shares, and the Pre-Funded Warrants, in the Registered Offering is filed as Exhibit 5.1 to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                                            2.02.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
                                            of Operations and Financial Condition</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2024, the Company issued a press release reporting on its results of operations for the third quarter ended September 30,
2024. A copy of that press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
information is intended to be furnished under Item 2.02 of Form 8-K and shall not be deemed &#8220;filed&#8221; for purposes of Section
18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                                            2.03.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Creation
                                            of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
                                            of a Registrant.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                                            3.02.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered
                                            Sales of Equity Securities.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                                            5.02.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure
                                            of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
                                            Compensatory Arrangements of Certain Officers</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&#8217;s cost saving and restructuring program, the Company implemented several personnel changes to optimize
and streamline its operations, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Resignation
of Directors</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective
immediately. In connection with the aforementioned resignations, the Board approved
a decrease in the size of the Board from eight to five directors. The decision of each of Messrs. Andres, Geraghty, and Swandal to resign
did not result from any disagreement with the Company on any matters relating to the Company&#8217;s operations, policies, or practices.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Appointment
of Shawn Roman as Chief Operating Officer</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 6, 2024, the Board appointed Shawn D. Roman as the Chief Operating Officer of the Company, effective immediately. Mr. Roman previously served as the Company&#8217;s Vice President of Research and Development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with his appointment to COO, Mr. Roman&#8217;s annual base salary will be $305,761. The Company has not entered into a formal
employment agreement with Mr. Roman.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Roman, age 53, joined the Company in October 2014 and has served as Vice President of Research and Development since June 2015. In this
role, he has been responsible for new product and technology development as well as the clinical research supporting the safety and efficacy
of the Company&#8217;s Renuvion product portfolio. Prior to joining the Company, Mr. Roman served as Engineering Manager and then General
Manager of the Co-Innovation Florida location of Coorstek Medical, a privately held company specializing in providing product development
and manufacturing services to orthopedic medical device companies. Prior to joining Coorstek, Mr. Roman spent more than 14 years with
the craniomaxillofacial division of what is now Zimmer Biomet in a variety of product development roles of increasing responsibility
including Vice President of Research and Development. Mr. Roman holds a Bachelor of Science in Mechanical Engineering from the University
of Florida and a Bachelor of Physics from Jacksonville University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no arrangements or understandings between Mr. Roman and any other persons pursuant to which Mr. Roman was appointed as COO of the
Company. There are no family relationships between Mr. Roman and any director or executive officer of the Company and Mr. Roman has no
direct or indirect interest in any transaction or proposed transaction required to be disclosed pursuant to Item 404(a) of Regulation
S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Termination
of Todd Hornsby</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 4, 2024, the Company terminated Todd Hornsby, Executive Vice President of Sales and Marketing, effective immediately.
The Company treated Mr. Hornsby&#8217;s departure from the Company as a termination without &#8220;cause&#8221; pursuant to his employment
agreement with the Company, dated as of September 17, 2020 (the &#8220;Employment Agreement&#8221;). Subject to the execution, delivery
and non-revocation of a general release and waiver of claims against the Company and Mr. Hornsby&#8217;s compliance with certain covenants
contained therein, Mr. Hornsby will receive the previously negotiated severance payments and benefits set forth in the Employment Agreement
as detailed in the Company&#8217;s most recent proxy statement filed with the Securities and Exchange Commission on June 25, 2024. Mr.
Hornsby&#8217;s role and responsibilities will be assumed by Charlie Goodwin, President and Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                                            8.01.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
                                            Events</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 8, 2024, the Company issued a press release announcing the Registered Offering, a copy of which is attached hereto as Exhibit 99.2 and is incorporated by reference into this Item 8.01 of this Current
Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
                                            9.01.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
                                            Statements and Exhibits.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><a href="ex4-1.htm">Form of Pre-Funded Warrant.</a></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><a href="ex5-1.htm">Opinion of Ruskin Moscou Faltischek, P.C.</a> </span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><a href="ex10-1.htm">Amendment No.1 to Credit Agreement and Guaranty, dated November 7, 2024</a>.</span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Securities <span>Purchase Agreement, dated November 7, 2024.</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><a href="ex5-1.htm">Consent of Ruskin Moscou Faltischek, P.C. (included in Exhibit 5.1).</a></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><a href="ex99-1.htm">Earnings Press Release, dated November 8, 2024.</a></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><a href="ex99-2.htm">Press Release, dated November 8, 2024.</a></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File embedded within the Inline XBRL document</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: justify">Date: November 8, 2024</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Apyx Medical Corporation</b></span></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify; width: 50%">&#160;</td>
    <td style="width: 3%">&#160;</td>
  <td style="text-align: justify; width: 47%">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="padding-bottom: 1pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1pt">By:&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: justify"><i>/s/ Matthew Hill</i></td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
  <td style="text-align: justify">Matthew Hill</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
  <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer, Secretary and Treasurer</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160; </p>


<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2Osq1IvAysYgsRCK63XKMJd2R2e3HR+ot25RoGBiGc75zhBiJNa10jQynZZHBAZu2Vg6hwAoZzQW9I9lsY/C3wKu2jpVx/fsDE/IMemY+jmZnL/TWh7ZYxiDlJFxMohmE01hKyHci+OoJmUqXaJxWNShTQs7UskanuBsSDupFhpqurzoiW03Gx43DQX5DFMoI9vRQT+KbhSxLRDDqJxBrpnvrXenLofmSkNbY+Do70P8NPgTBSok= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRE-FUNDED
COMMON STOCK PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>APYX
MEDICAL CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant Shares: _______</FONT></TD>
  <TD STYLE="text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issue Date: November [&#9679;],
  2024</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise Date: November
  [&#9679;], 2024</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____________ or its
assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date set forth above (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and until this Warrant is
exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Apyx Medical Corporation,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ______ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of the Company&rsquo;s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal
to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated November 7, 2024, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following
the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.001 per Warrant Share,
was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the
nominal exercise price of $0.001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise of
this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price
under any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination
Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment hereunder
(such remaining unpaid exercise price, the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable
                                            Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant
                                            to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered
                                            pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
                                            hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
                                            laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
                                            Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price
                                            of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the
                                            time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice
                                            of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is
                                            delivered within two (2) hours thereafter (including until two (2) hours after the close
                                            of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof
                                            or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
                                            of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant
                                            to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading
                                            Day;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">=</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>&ldquo;Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">L.P.
<FONT STYLE="background-color: white">(based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)),
(b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share
of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities
then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&ldquo;<U>VWAP</U>&rdquo;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">means, for any date, the price determined by the first
of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then
listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City
time)), (b) if the OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or the OTCQX Best Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable,
(c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported
on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by the OTC Markets, Inc. (or a similar organization or agency succeeding
to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases,
the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a
majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall
be paid by the Company<FONT STYLE="background-color: white">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received by the Warrant Share Delivery Date. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per
Trading Day on the third (3<SUP>rd</SUP>) Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant
Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer
agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard
Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on
the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed
with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by
the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of
a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo;
shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61<SUP>st</SUP> day after such notice is delivered to the Company. The provisions of this
paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct
this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained
in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or reclassification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for
the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares
of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the
extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership
Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such
shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance
for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company or (any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of the Company&rsquo;s assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer
or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to
sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the
outstanding shares of Common Stock or 50% or more of the voting power of the common equity of the Company, (iv) the Company, directly
or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities,
cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase
agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme
of arrangement) with another Person or group of Persons whereby such other Person or group acquires 50% or more of the outstanding shares
of Common Stock or 50% or more of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have
been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without
regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring
corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;<U>Alternate Consideration</U>&rdquo;)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;Successor Entity&rdquo;) to assume in writing
all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this
Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without
unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for
this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent
to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise
of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such
shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction
and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of
protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably
satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall
be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental
Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall
refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity
or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the
Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other
Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to
the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant
and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, at all times during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common
Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under
this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are
charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without
violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.
The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant
will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be
duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect
of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant, if the Company
willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the
Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable
attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto
or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder of this Warrant, on the other hand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>APYX
    Medical corporation</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>APYX
                                            MEDICAL CORPORATION</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature: ___________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address: ____________________________</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex5-1_001.jpg" ALT=""style="width:400px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Writer&rsquo;s
Direct Dial: 516-663-6600</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Writer&rsquo;s
Direct Fax: 516-663-6601</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3.5in; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
8, 2024</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apyx
Medical Corporation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5115
Ulmerton Road</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clearwater,
Florida 33760</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Apyx Medical Corporation, a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the
preparation and filing with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) of a Prospectus Supplement,
dated November 8, 2024 (the &ldquo;<U>Prospectus Supplement</U>&rdquo;), to a Prospectus, dated December 2, 2022 (the &ldquo;<U>Prospectus</U>&rdquo;),
filed pursuant to a Registration Statement on Form S-3, Registration No. 333-268532 (the &ldquo;<U>Registration Statement</U>&rdquo;)
and filed by the Company with the Commission under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;).
The Prospectus Supplement relates to the issuance of: (a) 3,000,000 shares (the &ldquo;<U>Shares</U>&rdquo;) of the Company&rsquo;s common
stock, $0.001 par value per share (the &ldquo;<U>Common Stock</U>&rdquo;), (b) pre-funded warrants (the &ldquo;<U>Pre-Funded Warrants</U>&rdquo;)
to purchase up to 2,934,690 shares of Common Stock (the &ldquo;<U>Warrant Shares</U>&rdquo; and together with the Shares and the
Pre-Funded Warrants, the &ldquo;<U>Securities</U>&rdquo;), and (c) the Warrant Shares, pursuant to a Securities Purchase Agreement, dated
November 7, 2024, between the Company and the purchasers named therein (the &ldquo;<U>Purchase Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement will be filed as an exhibit to a Current Report on Form 8-K and incorporated by reference into the Registration Statement.
This opinion is being rendered in connection with the filing of the Prospectus Supplement with the Commission. All capitalized terms
used herein and not otherwise defined herein shall have the respective meanings given to them in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this opinion, we have (i) examined and relied upon: (A) the Registration Statement, the Prospectus, and the Prospectus
Supplement, (B) the form of Pre-Funded Warrant which will be filed as an exhibit to a Current Report on Form 8-K and incorporated by
reference into the Registration Statement, (C) the Company&rsquo;s Certificate of Incorporation and Bylaws, as currently in effect, (D)
the Purchase Agreement, and (E) the originals or copies of such records, documents, certificates, memoranda and other instruments and
undertaken such further inquiry as in our judgment are necessary or appropriate to enable us to render the opinions expressed below;
and (ii) assumed that the Securities to be sold by the Company will be sold at a price and on terms established by the Board of Directors
of the Company or a duly constituted pricing committee thereof in accordance with Section 153 of the Delaware General Corporation Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
to certain factual matters, we have relied upon information from officers and representatives of the Company and have not independently
verified such matters. In rendering this opinion, we have assumed the genuineness and authenticity of all signatures on signed records,
instruments, certificates and documents; the authenticity and completeness of all documents submitted to us as originals; the conformity
to originals of all documents submitted to us as copies; the accuracy, completeness and authenticity of certificates of public officials;
the legal capacity of all natural persons; the truth, accuracy and completeness of the information, representations and warranties contained
in the records, documents, instruments and certificates we have reviewed; and the due authorization, execution and delivery of all documents
where due authorization, execution and delivery are a prerequisite to the effectiveness thereof (except we have not made such assumption
with respect to the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Apyx Medical Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">November 8, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are members of the Bar of the State of New York. Our opinion is limited to the General Corporation Law of the State of Delaware and,
as to the Pre-Funded Warrants constituting valid and binding obligations of the Company, the laws of the State of New York, and we express
no opinion with respect to the laws of any other jurisdiction. In addition, no opinion is expressed herein with respect to the qualification
of the Securities under the securities or blue sky laws of any state or any foreign jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
regard to our opinion concerning the Pre-Funded Warrants constituting valid and binding obligations of the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            opinion is subject to, and is limited by, (a) applicable bankruptcy, reorganization, insolvency,
                                            moratorium, fraudulent conveyance, debtor and creditor, and similar laws which relate to
                                            or affect creditors&rsquo; rights generally, and (b) general principles of equity (including,
                                            without limitation, concepts of materiality, reasonableness, good faith and fair dealing)
                                            regardless of whether considered in a proceeding in equity or at law.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
                                            opinion is subject to the qualification that the availability of specific performance, injunctive
                                            relief or other equitable remedies is subject to the discretion of the court before which
                                            the request is brought.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            express no opinion as to any provision of the Pre-Funded Warrants that: (a) provides for
                                            liquidated damages, buy-in damages, monetary penalties, or other economic remedies to the
                                            extent such provisions may constitute unlawful penalties, (b) relates to advance waivers
                                            of claims, defenses, rights granted by law, or notice, opportunity for hearing, evidentiary
                                            requirements, statutes of limitations, trial by jury, or procedural rights, (c) restricts
                                            non-written modifications and waivers, (d) provides for the payment of legal and other professional
                                            fees where such payment is contrary to law or public policy, (e) relates to exclusivity,
                                            election or accumulation of rights or remedies, or (f) provides that provisions of the Pre-Funded
                                            Warrants are severable to the extent an essential part of the agreed exchange is determined
                                            to be invalid and unenforceable.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            express no opinion as to whether a state court outside of New York or a federal court of
                                            the United States would give effect to the choice of New York law governing the Pre-Funded
                                            Warrants.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to the Warrant Shares, we express no opinion to the extent that, notwithstanding its current reservation of shares of Common
Stock, future issuances of Company securities, including the Warrant Shares, and/or adjustments to outstanding Company securities, including
the Pre-Funded Warrants, may cause the Pre-Funded Warrants to be exercisable for more shares of Common Stock than the number that remain
authorized but unissued. Further, we have assumed the Exercise Price (as defined in the Pre-Funded Warrants) will not be adjusted to
an amount below the par value per share of the Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the basis of the foregoing, and in reliance thereon, we are of the opinion that (i) the Shares, when sold and issued in accordance with
the Purchase Agreement, the Registration Statement, the Prospectus and the Prospectus Supplement, will be validly issued, fully paid
and nonassessable, (ii) provided that the Pre-Funded Warrants have been duly executed and delivered by the Company and duly delivered
to the purchasers thereof against payment therefor, the Pre-Funded Warrants, when sold and issued as contemplated in the Purchase Agreement,
the Registration Statement, the Prospectus and the Prospectus Supplement, will be valid and binding obligations of the Company, and (iii)
the Warrant Shares, when issued and paid for in accordance with the terms of the Pre-Funded Warrants, will be validly issued, fully paid
and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth herein is as of the date hereof. We assume no obligation to advise you of changes that may hereafter be brought
to our attention. Our opinions herein are based on statutory laws and judicial decisions that are in effect on the date hereof, and we
do not opine with respect to any law, regulation, rule or government policy that may be enacted or adopted after the date hereof. We
do not express an opinion on any matters other than those expressly set forth in this letter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the filing of this opinion as an exhibit to a Current Report on Form 8-K in accordance with the requirements of Item
601(b)(5) of Regulation S-K under the Securities Act and to the use of this Firm&rsquo;s name therein and in the Prospectus Supplement
under the caption &ldquo;Legal Matters.&rdquo; In giving such consent, we do not hereby admit that we are in the category of persons
whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very
    truly yours,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ruskin Moscou Faltischek, P.C.</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RUSKIN
    MOSCOU FALTISCHEK, P.C. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Execution
Version</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AMENDMENT
NO. 1 TO CREDIT AGREEMENT AND GUARANTY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<B>AMENDMENT NO. 1 TO CREDIT AGREEMENT AND GUARANTY</B>, dated as of November 7, 2024 (this &ldquo;<B><I>Amendment</I></B>&rdquo;), is
among Apyx Medical Corporation, a Delaware corporation (the &ldquo;<B><I>Borrower</I></B>&rdquo;), the Subsidiary Guarantors party hereto,
the Lenders party hereto and Perceptive Credit Holdings IV, LP, as administrative agent for the Lenders (in such capacity, together with
its successors and assigns, the &ldquo;<B><I>Administrative Agent</I></B>&rdquo;). Reference is made to the Credit Agreement and Guaranty,
dated as of November 8, 2023 (as amended, supplemented or otherwise modified from time to time, the &ldquo;<B><I>Credit Agreement</I></B>&rdquo;),
among the Borrower, the Subsidiary Guarantors party thereto, the Lenders party thereto and the Administrative Agent. Capitalized terms
used herein without definition shall have the same meanings as set forth in the Credit Agreement, as amended hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECITALS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Borrower has requested that the Required Lenders agree to amend certain Sections of the Credit Agreement, subject to the terms and
conditions set forth herein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
subject to the terms and conditions hereof, the Lender party hereto and the Administrative Agent are willing to agree to such amendments
and other modifications; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Lender party hereto constitutes the Required Lenders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the premises and the agreements, provisions and covenants herein contained, the parties hereto agree
as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SECTION
1. AMENDMENTS TO THE CREDIT AGREEMENT.</B> As of, and subject to the occurrence of, the Amendment No. 1 Effective Date (as defined below),
the Credit Agreement is hereby amended as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.
</B>Section 1.01 of the Credit Agreement is hereby amended by inserting the following new </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">definitions
in their alphabetically correct place:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Amendment
No. 1</I></B>&rdquo; means that certain Amendment No. 1 to Credit Agreement and Guaranty, dated as of the Amendment No. 1 Effective Date,
by and among the Obligors, the Lenders party thereto and the Administrative Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Amendment
No. 1 Effective Date</I></B>&rdquo; means November 7, 2024.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Common
Stock</I></B>&rdquo; means the Borrower&rsquo;s common stock, par value $0.001 per share, having ordinary voting rights, as provided
in the Borrower Certificate of Incorporation, as in effect on the Amendment No. 1 Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Holder</I></B>&rdquo;
has the meaning set forth in the definition of &ldquo;Specified Shares&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Operating
Expenses</I></B>&rdquo; means the sum of the following expenses of the Borrower and its Subsidiaries: (i) research and development expenses,
(ii) professional services expenses, (iii) customary salary, bonus, severance, indemnification obligations and other benefits payable
to officers and employees of the Borrower and its Subsidiaries, (iv) sales and marketing expenses, (v) general and administrative expenses
and (vi) commissions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Rule
144</I></B>&rdquo; means Rule 144 promulgated under the Securities Act.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Specified
Shares</I></B>&rdquo; means the shares of Common Stock issued by the Borrower to the Administrative Agent (or its designated Affiliate)
(together with its successors and assigns, the &ldquo;<B><I>Holder</I></B>&rdquo;) pursuant to Section 3(C) of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.
</B>Section 8 of the Credit Agreement is hereby amended by adding the following new Section 8.19 immediately after Section 8.18 thereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8.19
Rule 144; Specified Shares</B>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
At all times, and with a view to making available to the Holder the benefits of Rule 144 and any other rule or regulation of the United
States Securities and Exchange Commission that may at any time permit a holder to sell securities of the Borrower to the public without
registration, the Borrower shall: (i) use reasonable commercial efforts to make and keep adequate public information available, as required
by clause (c) of Rule 144; (ii) use reasonable commercial efforts to file with the United States Securities and Exchange Commission in
a timely manner all reports and other documents required of the Borrower under the Securities Act and the Exchange Act; and (iii) furnish,
or otherwise make available to the Holder so long as the Holder owns the Specified Shares, promptly upon request, a written statement
by the Borrower as to its compliance with the reporting requirements of Rule 144 and the Exchange Act, a copy of the most recent annual
or quarterly report of the Borrower, and such other reports and documents so filed or furnished by the Borrower as the Holder may reasonably
request in connection with the sale of the Specified Shares without registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In no event shall the Specified Shares contain or include any legend restricting the transfer thereof in any of the following circumstances:
(i) following any sale of the Specified Shares under or in connection herewith pursuant to Rule 144, (ii) if the Specified Shares are
eligible for sale under clause (b)(1) of Rule 144, or (iii) if such legend is not required under applicable requirements of the Securities
Act (including judicial interpretations and pronouncements issued by the staff of the United States Securities and Exchange Commission)
(the &ldquo;<B><I>Unrestricted Conditions</I></B>&rdquo;), and the Borrower shall take all commercially reasonable efforts to cause the
removal of any such restrictive legends in respect of the Specified Shares at any time any Unrestricted Condition is met.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
In connection with any sale by the Holder of the Specified Shares pursuant to Rule 144, the Borrower shall not require a &ldquo;no registration&rdquo;
or &ldquo;legend removal&rdquo; or other similar securities opinion from counsel to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.
</B>Section 9.12(a)(i) of the Credit Agreement is hereby amended by adding the text &ldquo;or fail to comply with&rdquo; immediately
after the text &ldquo;modify&rdquo; appearing therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.
</B>Section 9.12(d) of the Credit Agreement is hereby amended and restated in its entirety to read as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="margin-left: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Borrower shall arrange for (and expressly provide for its affirmative recommendation in support of) a vote of its stockholders, to
amend the Borrower Certificate of Incorporation to delete &ldquo;Article EIGHTH&rdquo; therefrom in its entirety, such vote to occur
at the Borrower&rsquo;s 2025 annual meeting of stockholders, but in no event later than December 31, 2025, and shall take all commercially
reasonable efforts to obtain the approval of its stockholders therefor and to provide for such amendment to become effective no later
than December 31, 2025. Copies of all notices to stockholders in respect of such amendment shall be delivered simultaneously to the Administrative
Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E.
Section 10 of the Credit Agreement is hereby amended by adding the following new Section 10.03 immediately after Section 10.02 thereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.03
Operating Expenses</B>. With respect to each of the Borrower&rsquo;s fiscal years ending December 31, 2025 and December 31, 2026, the
Borrower shall not permit or allow Operating Expenses to exceed (i) $40,000,000 for the fiscal year ended December 31, 2025 or (ii) $45,000,000
for the fiscal year ended December 31, 2026. Within 90 days following each such fiscal year the Borrower shall deliver to the Administrative
Agent written evidence, prepared in reasonable detail, demonstrating compliance with this <B>Section 10.03</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F.
The table set forth in Section 10.02 of the Credit Agreement is hereby amended and restated in its entirety to read as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse; margin-right: 0.5in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 53%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
    Date</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TTM
    Advanced Energy Net Revenue</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$38,250,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2024</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$34,400,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    31, 2025</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$35,400,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2025</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$37,200,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2025</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$35,700,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2025</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$37,000,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    31, 2026</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$40,000,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2026</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$44,500,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2026</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$48,600,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2026</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$52,400,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    31, 2027</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$54,000,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2027</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$55,600,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2027</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$57,500,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2027</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$60,300,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    31, 2028</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$62,100,000</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    30, 2028</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$64,500,000</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse; margin-right: 0.5in">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 53%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Calculation
    Date</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TTM
    Advanced Energy Net Revenue</B></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2028</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$66,500,000</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
2. COVENANTS, REPRESENTATIONS AND WARRANTIES. </B>In order to induce the Administrative Agent and the Lenders to enter into this Amendment,
the Borrower and each other Obligor hereby acknowledges, consents, agrees, represents and warrants as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.
</B>Notwithstanding the effectiveness of this Amendment, the Obligations of each Obligor under each Loan Document to which such Obligor
is a party shall not be impaired, extinguished, novated, waived, canceled or otherwise satisfied, in whole or in part, as a result of
the transactions contemplated hereby and each such Loan Document to which such Obligor is a party is, and shall continue to be, in full
force and effect and is hereby confirmed and ratified in all respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.
</B>All Guaranteed Obligations include all Obligations under, and as defined in, the Credit Agreement, as amended by this Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.
</B>Notwithstanding the conditions to effectiveness set forth in this Amendment, no Subsidiary Guarantor is required by the terms of
the Credit Agreement or any other Loan Document to consent to the amendments to the Credit Agreement effected pursuant to this Amendment,
and nothing in the Credit Agreement, this Amendment or any other Loan Document shall be deemed to require the consent of any Subsidiary
Guarantor to any future amendments to the Credit Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.
</B>All representations and warranties made by the Borrower and the other Obligors in the Loan Documents are true and correct in all
material respects as if made on and as of the date hereof (or in the case of any representation or warranty qualified by materiality,
Material Adverse Effect or similar qualification, true and correct in all respects) unless stated to relate solely to an earlier date,
in which case such representations or warranties shall be true and correct in all material respects as of such earlier date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.
</B>Each Obligor has full power, authority and legal right to enter into this Amendment and perform its obligations under this Amendment
and each Loan Document, as amended hereby or thereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.
</B>The transactions contemplated by this Amendment are within each Obligor&rsquo;s corporate powers and have been duly authorized by
all necessary corporate or other organizational action and, if required, by all necessary holders of the Equity Interests of such Obligor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>G.
</B>This Amendment has been duly executed and delivered by each Obligor and constitutes the legal, valid and binding obligation of such
Obligor, enforceable against such Obligor in accordance with its terms, except as such enforceability may be limited by (x) bankruptcy,
insolvency, reorganization, moratorium or similar laws of general applicability affecting the enforcement of creditors&rsquo; rights
and (y) the application of general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity
or at law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>H.
</B>The transactions contemplated by this Amendment (1) do not require any Governmental Approval of, registration or filing with, or
any other action by, any Governmental Authority or any Person, except for such as have been obtained or made and are in full force and
effect, (2) will not violate (x) any Law or any order of any Governmental Authority, other than any such violations that, individually
or in the aggregate, could not reasonably be expected to have a Material Adverse Effect, or (y) the Organic Documents of each Obligor
or its Subsidiaries, (3) will not violate or result in a default under any indenture, agreement or other instrument binding upon such
Obligor or its Subsidiaries or assets, or give rise to a right thereunder to require any payment to be made by any such Person, and (4)
will not result in the creation or imposition of any Lien (other than Permitted Liens) on any asset of such Obligor or its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>I.
</B>Both immediately before and after giving effect to this Amendment, no Default or Event of Default has occurred and is continuing,
or could reasonably be expected to result from this Amendment or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
3. CONDITIONS TO EFFECTIVENESS. </B>This Amendment shall become effective only upon the satisfaction of the following conditions precedent
(the date of satisfaction of all such conditions being referred to as the &ldquo;<B><I>Amendment No. 1 Effective Date</I></B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.
</B>The Obligors, the Administrative Agent and the Required Lenders shall have each indicated their consent to this Amendment by the
execution and delivery of the signature pages hereto to the Administrative Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.
</B>The statements, representations and warranties set forth in <B>Section 2 </B>above shall each be true and correct, both immediately
before and after the effectiveness of this Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.
</B>The Administrative Agent shall have received evidence of the issuance by the Borrower to the Administrative Agent (or its designated
Affiliate) of 150,000 shares of the Borrower&rsquo;s common Equity Interests for no consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.
</B>The Administrative Agent shall have received evidence of receipt by the Borrower of $5,000,000 of net cash proceeds from the issuance
of its common Equity Interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.
</B>The Administrative Agent and the Lenders shall have received all reasonable and documented out of pocket expenses for which invoices
have been presented (including the reasonable fees and expenses of legal counsel for which the Borrower is responsible pursuant to Section
14.03 of the Credit Agreement) that are due and payable in connection with this Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.55in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
4. MISCELLANEOUS</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>A.
Reference to and Effect on the Loan Documents.</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
On and after the Amendment No. 1 Effective Date, each reference in any Loan Document to the Credit Agreement shall mean and be a reference
to the Credit Agreement as amended by this Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Except as expressly amended hereby, all of the representations, warranties, terms, covenants, conditions and other provisions of the
Loan Documents shall remain unchanged and shall continue to be, and shall remain, in full force and effect in accordance with their respective
terms. The amendments and modifications set forth herein shall be limited precisely as provided for herein to the provisions expressly
amended herein or otherwise modified or consented to hereby and shall not be deemed to be an amendment to, waiver of, consent to or modification
of any other term or provision of the Credit Agreement or any other Loan Document or of any transaction or further or future action on
the part of any Obligor which would require the consent of the Lenders or the Administrative Agent under the Credit Agreement or any
other Loan Document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The execution, delivery and performance of this Amendment shall not constitute a waiver of any provision of, or operate as a waiver of
any right, power or remedy of the Administrative Agent or any Lender under any Loan Document or applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
This Amendment shall constitute a Loan Document.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>B.
Captions</B>. The captions and section headings appearing herein are included solely for convenience of reference and are not intended
to affect the interpretation of any provision of this Amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>C.
Severability</B>. If any provision hereof is found by a court to be invalid or unenforceable, to the fullest extent permitted by any
Law, the parties agree that such invalidity or unenforceability shall not impair the validity or enforceability of any other provision
hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>D.
Integration</B>. This Amendment, together with the other Loan Documents, constitutes the entire agreement among the parties with respect
to the subject matter hereof and supersedes any and all previous agreements and understandings, oral or written, relating to the subject
matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>E.
Governing Law</B>. This Amendment and the rights and obligations of the parties hereunder shall be governed by, and construed in accordance
with, the law of the State of New York, without regard to principles of conflicts of laws that would result in the application of the
laws of any other jurisdiction; <U>provided</U> that Section 5-1401 of the New York General Obligations Law shall apply.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>F.
Counterparts; Electronic Signatures</B>. This Amendment may be executed in any number of counterparts, all of which taken together shall
constitute one and the same instrument and any of the parties hereto may execute this Amendment by signing any such counterpart. Any
signature (including, without limitation, (x) any electronic symbol or process attached to, or associated with, a contract or other record
and adopted by a Person with the intent to sign, authenticate or accept such contract or record and (y) any facsimile or .pdf signature)
hereto or to any other certificate, agreement or document related to this Amendment, and any contract formation or record-keeping, in
each case, through electronic means, shall have the same legal validity and enforceability as a manually executed signature or use of
a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in
Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any similar state law based on the Uniform
Electronic Transactions Act, and the parties hereto hereby waive any objection to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>[Signature
Pages Follow]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the parties hereto have caused this Amendment to be duly executed and delivered by their respective officers thereunto
duly authorized as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BORROWER:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APYX
    MEDICAL CORPORATION</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Matthew Hill</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Matthew Hill</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUBSIDIARY
    GUARANTORS:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>APYX
    CHINA HOLDING CORP.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Matthew Hill</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Matthew Hill</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APYX
    BULGARIA EOOD</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Matthew Hill</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Matthew Hill</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page &ndash; Amendment No. 1</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PERCEPTIVE
CREDIT HOLDINGS IV, LP,</B> as</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Administrative Agent and Lender</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>By:</B></FONT></TD>
  <TD STYLE="width: 97%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Perceptive Credit Opportunities
  GP, LLC,</B></FONT></TD></TR>

<TR STYLE="vertical-align: top">
  <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>its general partner</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Sandeep Dixit</I></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sandeep Dixit</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Credit Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>/s/
    Sam Chawla</I></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sam Chawla</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Portfolio Manager</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page &ndash; Amendment No. 1</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-transform: uppercase; text-align: right; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: none"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-transform: uppercase; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of November 7, 2024, between Apyx Medical Corporation,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including
its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo; and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities
Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires
to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.</B><BR>
DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.4.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <U>provided</U>, <U>however</U>, for clarification, commercial banks shall not be deemed to be authorized
or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo;
or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority
so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally
are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Shares pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Shares, in each case, have been satisfied or waived, but in no event later than the second (2<SUP>nd</SUP>)
Trading Day following the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Ruskin Moscou Faltischek, P.C., with offices located at 1425 RXR Plaza, East Tower, 15<SUP>th</SUP> Floor, Uniondale,
NY 11556.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading
Day, no later than 9:01 a.m. (New York City time) on the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Duane
Morris</U>&rdquo; means Duane Morris LLP, with offices located at 1540 Broadway, New York, NY 10036.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FDCA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GDPR</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(pp).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Health
Care Laws</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>HIPAA</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(oo).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>IT
Systems</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(oo).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $1.18, subject to adjustment for reverse and forward stock splits, stock dividends, stock
combinations and other similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase
price per Pre-Funded Warrant shall be the Per Share Purchase Price minus $0.001.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pharmaceutical
Product</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>PHI</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(oo).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrant</U>&rdquo; means, collectively, the pre-funded warrants delivered to the Purchasers at the Closing in accordance with Section
2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and shall expire when exercised in full, in the form of Exhibit
B attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Pre-Funded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Privacy
Laws</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(pp).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the
Commission and delivered by the Company to each Purchaser at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.7.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement with Commission file No. 333-268532 which registers the sale of the Shares
to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Regulatory
Agencies</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(hh).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Safety
Notices</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(ss).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares purchased hereunder as specified below such
Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United States
dollars and in immediately available funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth in the SEC Reports, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, OTCQB or OTCQX (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, all exhibits and schedules hereto and any other documents or agreements executed in connection
with the transactions contemplated hereunder, including the Pre-Funded Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Manhattan Transfer Registrar Co., the current transfer agent of the Company, with a mailing address of One Grand
Central Place, 60 East 42<SUP>nd</SUP> Street, Suite 1201, New York, NY 10165 and a telephone number of (631) 928-7655, and any successor
transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASE
AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the
execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly,
agree to purchase, up to an aggregate of $7,000,000 of Shares; <U>provided</U>, <U>however</U>, that, to the extent that a Purchaser
determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s Affiliates, and any Person acting as a
group together with such purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially own in excess of the Beneficial Ownership
Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Shares such Purchaser may elect to purchase Pre-Funded Warrants
in lieu of Shares in such manner to result in the same aggregate purchase price being paid by such Purchaser to the Company. The &ldquo;Beneficial
Ownership Limitation&rdquo; shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to
the issuance of the Shares on the Closing Date. Each Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto
executed by such Purchaser shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company or its designee.
On or before the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, via wire transfer of immediately
available funds pursuant to the wire instructions delivered to such Purchaser by the Company on or prior to the Closing Date, an amount
equal to the purchase price to be paid by the Purchaser for the Subscription Amount to be acquired by it. The Company shall deliver to
each Purchaser its respective Shares, and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable
at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices
of Duane Morris or such other location as the parties shall mutually agree. Settlement of the Shares shall occur via &ldquo;Delivery
Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers&rsquo;
names and addresses and released by the Transfer Agent directly to the account(s) identified by each Purchaser. If the Closing has not
occurred for any reason on or prior to the fifth (5<SUP>th</SUP>) Trading Day after the date hereof and the Agreement has been terminated
by the Purchaser pursuant to Section 5.1, the applicable purchase price shall be promptly returned to the applicable Purchaser. Notwithstanding
anything to the contrary herein and the Purchaser&rsquo;s Subscription Amount set forth on the signature pages attached hereto, the number
of Shares purchased by a Purchaser (and its Affiliates) hereunder shall not, when aggregated with all other shares of Common Stock owned
by such Purchaser (and its Affiliates) at such time, result in such Purchaser beneficially owning (as determined in accordance with Section
13(d) of the Exchange Act) in excess of 9.99% of the then issued and outstanding Common Stock outstanding at the Closing (the &ldquo;<U>Beneficial
Ownership Maximum</U>&rdquo;), and such Purchaser&rsquo;s Subscription Amount, to the extent it would otherwise exceed the Beneficial
Ownership Maximum immediately prior to the Closing, shall be conditioned upon the issuance of Shares at the Closing to the other Purchasers
signatory hereto. To the extent that a Purchaser&rsquo;s beneficial ownership of the Shares would otherwise be deemed to exceed the Beneficial
Ownership Maximum, such Purchasers&rsquo; Subscription Amount shall automatically be reduced as necessary in order to comply with this
paragraph. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise (as defined in the Pre-Funded Warrants) delivered
on or prior to 12:00 p.m. (New York City time) on the Closing Date, which may be delivered at any time after the time of execution of
the this Agreement, the Company agrees to deliver the Pre-Funded Warrant Shares subject to such notice(s) by 4:00 p.m. (New York City
time) on the Closing Date and such date shall be the Warrant Share Delivery Date (as defined in the Pre-Funded Warrants) for purposes
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">(a)
On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion of Company Counsel;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
subject to the last sentence of Section 2.1, the Company shall have provided each Purchaser with the Company&rsquo;s wire instructions,
on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
subject to the last sentence of Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent
to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;)
Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded
Warrants divided by the Per Share Purchase Price minus $0.001, with an exercise price equal to $0.001, subject to adjustment therein;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
such Purchaser&rsquo;s Subscription Amount, which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the
Company or its designee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a
specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed in all material respects; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein in which case they shall be accurate as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed
in all material respects;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Shares at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REPRESENTATIONS
AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. The Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. Except as set forth
in the SEC Reports, the Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free
and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully
paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries,
all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material
Adverse Effect</U>&rdquo;) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Shares and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.3 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s)
to each applicable Trading Market for the listing of the Shares for trading thereon in the time and manner required thereby and (iv)
such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Shares; Registration</U>. The Shares are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.
The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this
Agreement. The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which
became effective on December 2, 2022 (the &ldquo;<U>Effective Date</U>&rdquo;), including the Prospectus, and such amendments and supplements
thereto as may have been required to the date of this Agreement. The Registration Statement is effective under the Securities Act and
no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus
has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened
by the Commission. The Company, if required by the rules and regulations of the Commission, shall file the Prospectus with the Commission
pursuant to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement
and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to
the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments
or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed
and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. The Company was at the time of the filing of the Registration Statement eligible to use Form
S-3. The Company is eligible to use Form S-3 under the Securities Act and it meets the transaction requirements with respect to the aggregate
market value of securities being sold pursuant to this offering and during the twelve (12) months prior to this offering, as set forth
in General Instruction I.B.6 of Form S-3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company is set forth in the SEC Reports as of the dates referred to therein. The Company
has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise
of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees pursuant
to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding
as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive
right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except
as set forth in the SEC Reports, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any
character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving
any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments,
understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock
or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Shares will not obligate the Company or
any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers). There are no outstanding
securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset
price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities
or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments,
understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such
Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar
plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and
nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued
in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization
of any stockholder, the Board of Directors or others is required for the issuance and sale of the Shares. There are no stockholders agreements,
voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to
the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and
the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received
a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their
respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act,
as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with
applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.
Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent
basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the
notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all
material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results
of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end
audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports and except as set forth in the SEC Reports, (i) there has been no event, occurrence or development that has had
or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting in any material respect, (iv) the Company has not
declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements
to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director
or Affiliate, except pursuant to existing Company stock option plans. The Company does not have pending before the Commission any request
for confidential treatment of information. Except for the issuance of the Shares and the other transactions contemplated by this Agreement
or as set forth in the SEC Reports, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably
expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations,
assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this
representation is made or deemed made that has not been publicly disclosed by the Disclosure Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth in the SEC Reports, there is no action, suit, inquiry, notice of violation, proceeding or investigation
pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions described in the SEC Reports, (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Shares or (ii) would, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect, except as set forth in the SEC Reports. Neither the
Company nor any Subsidiary, nor, to the Company&rsquo;s knowledge, any director or officer thereof, is the subject of any Action involving
a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been,
and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company
or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the
effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which would reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement. To the knowledge of the Company, no executive
officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or
any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the
Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are
in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms
and conditions of employment and wages and hours, except where the failure to be in compliance would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator
or other governmental authority or (iii) is in violation of any statute, rule, ordinance or regulation of any governmental authority,
including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health
and safety, product quality and safety and employment and labor matters, except in each case as would not have or reasonably be expected
to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating
to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface
strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or
toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating
to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well
as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders,
permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have
received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses;
and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and
(iii), the failure to so comply would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits would not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. Except as disclosed in the SEC Reports, the Company and the Subsidiaries have good and marketable title in fee
simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the
business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect
the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company
and the Subsidiaries and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor
in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held
under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company
and the Subsidiaries are in compliance, except where the failure to be in such compliance would not be reasonably expected to have, individually
or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have would have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property</U>&rdquo;). Furthermore,
except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (A) to the knowledge
of the Company, there is no infringement, misappropriation or violation by third parties of any Intellectual Property; (B) there is no
pending or, to the knowledge of the Company, threatened, action, suit, proceeding or claim by others challenging the Company&rsquo;s
or any Subsidiary&rsquo;s rights in or to any such Intellectual Property, and the Company is unaware of any facts which would form a
reasonable basis for any such claim; (C) the Intellectual Property owned by the Company and the Subsidiaries and, to the knowledge of
the Company, the Intellectual Property licensed to the Company and the Subsidiaries, has not been adjudged by a court of competent jurisdiction
to be invalid or unenforceable, in whole or in part, and there is no pending or, to the knowledge of the Company, threatened action,
suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property, and the Company is unaware of
any facts which would form a reasonable basis for any such claim; (D) there is no pending or, to the knowledge of the Company, threatened
action, suit, proceeding or claim by others that the Company or any Subsidiary infringes, misappropriates or otherwise violates any Intellectual
Property rights of others, neither the Company or any Subsidiary has received any written notice of such claim and the Company is unaware
of any other fact which would form a reasonable basis for any such claim; (E) to the Company&rsquo;s knowledge, no employee of the Company
or any Subsidiary is in violation of any term of any employment contract, patent disclosure agreement, invention assignment agreement,
non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former employer
where the basis of such violation relates to such employee&rsquo;s employment with the Company or any Subsidiary or actions undertaken
by the employee while employed with the Company or any Subsidiary: (F) there is no prior art or public or commercial activity of which
the Company is aware that would be reasonably likely to render any material patent included in the Intellectual Property invalid or that
would preclude the issuance of any patent on any patent application included in the Intellectual Property, which has not been disclosed
to the U.S. Patent and Trademark Office or the relevant foreign patent authority, as the case may be; (G) to the Company&rsquo;s knowledge,
the issued patents included in the Intellectual Property are valid and enforceable and the Company is unaware of any facts that would
preclude the issuance of a valid and enforceable patent on any pending patent application included in the Intellectual Property; (H)
the Company has taken steps reasonably designed to secure the interests of the Company in the Intellectual Property purported to be owned
by the Company from all employees, consultants, agents or contractors that developed (in whole or in part) such Intellectual Property;
(I) no government funding, facilities or resources of a university, college, other educational institution or research center was used
in the development of any Intellectual Property that is owned or purported to be owned by the Company that would confer upon any governmental
agency or body, university, college, other educational institution or research center any claim or right in or to any such Intellectual
Property; and (J) to the Company&rsquo;s knowledge, none of the technology employed by the Company has been obtained or is being used
by the Company in violation of the rights of any entity. The Company and its Subsidiaries have taken reasonable security measures to
protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged. Neither
the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a material
increase in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions With Affiliates and Employees</U>. Except as set forth in the SEC Reports, none of the officers or directors of the Company
or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to
any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance in all material respects with
any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable
rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The
Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions
are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted
only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded accountability for assets is compared
with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the
Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company
and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the
Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods
specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the
disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed
periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently
filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls
and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal
control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially
affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. Except as set forth in the Prospectus Supplement, no brokerage or finder&rsquo;s fees or commissions are or will
be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker,
bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this
Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Shares, will
not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Registration Rights</U>. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities
Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which
the Common Stock is listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements
of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance
with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository
Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company
(or such other established clearing corporation) in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Shares and the Purchasers&rsquo; ownership of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or would reasonably be expected to constitute material, non-public information
which is not otherwise disclosed as of the Disclosure Time. The Company understands and confirms that the Purchasers will rely on the
foregoing representation in effecting transactions in securities of the Company. The Company acknowledges and agrees that no Purchaser
makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically
set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Shares
to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Solvency</U>. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt
by the Company of the proceeds from the sale of the Shares hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known
contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its
business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii)
the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature
(taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any
facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization
laws of any jurisdiction within one year from the Closing Date. The SEC Reports set forth as of the dates referred to therein all outstanding
secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For
the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess
of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other
contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s
consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection
or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due
under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to
any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Tax Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income
and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii)
has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such
returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material
taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no
basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)
<U>Foreign Corrupt Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)
<U>Accountants</U>. To the knowledge of the Company, RSM US LLP, whose report on the consolidated financial statements of the Company
is filed with the Commission as part of the Company&rsquo;s most recent Annual Report on Form 10-K filed with the Commission and incorporated
into the Registration Statement, (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its
opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending December
31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Shares</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Shares. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Acknowledgment Regarding Purchaser&rsquo;s Trading Activity. </U>Anything in this Agreement or elsewhere herein to the contrary notwithstanding
(except for Section 3.2(f) hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked
by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company,
or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the Shares for any specified term; (ii) past
or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo;
transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price of
the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to
which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock, and
(iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo;
transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various
times during the period that the Shares are outstanding, and (z) such hedging activities (if any) could reduce the value of the existing
stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted. The Company
acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>Regulation M Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Shares, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of
the Shares, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Compliance with Health Care Laws</U>. Each of the Company and its Subsidiaries are and, to the Company&rsquo;s knowledge, its directors,
officers, employees, contractors, and agents (while acting in such capacity) are and at all times during the past three (3) years have
been in compliance in all material respects with all health care laws applicable to the Company and its Subsidiaries, or any of their
products or activities, including, but not limited to, the federal Anti-Kickback Statute (42 U.S.C. Section 1320a-7b(b)) and other criminal
laws applicable to health care fraud, waste, and abuse, the Anti-Inducement Law (42 U.S.C. Section 1320a-7a(a)(5)), the civil False Claims
Act (31 U.S.C. Section 3729 et seq.), the administrative False Claims Law (42 U.S.C. Section 1320a-7b(a)), the Health Insurance Portability
and Accountability Act of 1996 (42 U.S.C. Section 1320d et seq.) as amended by the Health Information Technology for Economic and Clinical
Health Act (42 U.S.C. Section 17921 et seq.), the exclusion laws (42 U.S.C. Section 1320a-7), the Federal Food, Drug, and Cosmetic Act
(21 U.S.C. Section 301 et seq.), the Public Health Service Act (42 U.S.C. Section 201 et seq.), Medicare (Title XVIII of the Social Security
Act), Medicaid (Title XIX of the Social Security Act), and the Physician Payments Sunshine Act (42 U.S.C. &sect; 1320a-7h), the regulations
promulgated pursuant to such laws, and any other local, state, federal or foreign law, rule or regulation which imposes requirements
on manufacturing, development, nonclinical and clinical testing, labeling, advertising, marketing, promotion, distribution, reporting,
kickbacks, patient or program charges, recordkeeping, claims process, documentation requirements, medical necessity, referrals, the hiring
and supervision of employees and contractors or acquisition of services or supplies from those who have been excluded from government
health care programs, quality, safety, privacy, security, licensure, accreditation or any other aspect of providing health care or medical
device products or services, including without limitation requirements relating to any CE marking certifications and declarations of
conformity (collectively, &ldquo;<U>Health Care Laws</U>&rdquo;). Except as disclosed in the SEC Reports, since January 1, 2021, the
Company has not received any written or verbal notification, including notification of any pending or threatened claim, suit, proceeding,
hearing, enforcement, investigation, arbitration or other action from any governmental authority, including, without limitation, the
FDA, the EMA, Health Canada, the U.S. Federal Trade Commission, CMS, HHS&rsquo;s Office of Inspector General, the U.S. Department of
Justice and state Attorneys General or similar state, federal, or foreign agencies (collectively, the &ldquo;<U>Regulatory Agencies</U>&rdquo;)
of non-compliance by, or liability of, the Company under any Health Care Laws, except, with respect to any of the foregoing, such as
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The statements with respect to
Health Care Laws and the Company&rsquo;s compliance therewith included in the SEC Reports fairly summarize in all material respects the
matters therein described.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Company nor any of its Subsidiaries nor, to the Company&rsquo;s knowledge, any of its officers, employees, directors, agents, contractors
or licensors, has, for the past three (3) years, been excluded, suspended or debarred from participation in any U.S. federal or foreign
health care program or, to the Company&rsquo;s knowledge, is subject to a governmental inquiry, investigation, proceeding, or other similar
action that would reasonably be expected to result in debarment, suspension, or exclusion, or convicted of any crime or engaged in any
conduct that would reasonably be expected to result in exclusion, from Medicare, Medicaid, or any other local, state or federal health
care program or debarment under 21 U.S.C. &sect; 335a or comparable foreign law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the Company and any of its Subsidiaries nor, to the Company&rsquo;s knowledge, any officer, employee or agent of the Company has during
the last three (3) years (i) made an untrue statement of a material fact or fraudulent statement to any Regulatory Agency; (ii) failed
to disclose a material fact required to be disclosed to a Regulatory Agency; or (iii) committed any other act, made any statement or
failed to make any statement, including with respect to scientific data or information, that (in any such case) at the time such disclosure
was made or failure to disclose occurred, would reasonably be expected to provide a basis for the FDA to invoke its Fraud, Untrue Statements
of Material Facts, Bribery, and Illegal Gratuities Policy or for a comparable foreign agency to invoke any similar policy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has not during the last three (3) years (i) received notice that it is subject to any action, citation, suspension, revocation,
warning, administrative proceeding or investigation by a Regulatory Agency that alleges that the Company has violated any applicable
Health Care Laws or which requires or seeks any adjustment, modification or alteration in the Company&rsquo;s or any of its Subsidiaries&rsquo;
products or product candidates or in the Company&rsquo;s or any of its Subsidiaries&rsquo; operations, activities, or services that has
not been resolved, including any qui tam lawsuits, notice of inspectional observations, FDA warning letter or untitled letter or any
similar notices, or (ii) been subject to a corporate integrity agreement, deferred prosecution agreement, consent decree, settlement
agreement or other similar agreements or orders mandating or prohibiting future or past activities. As of the date hereof and except
as may be disclosed in the SEC Reports, (i) there are no restrictions imposed by any Regulatory Agency upon the business, activities
or services of the Company that restrict the Company&rsquo;s business operations, except as would not, individually or in the aggregate,
have a Material Adverse Effect, (ii) the Company and its products and product candidates are not, subject to any other enforcement actions
taken by the FDA or any other Regulatory Agency, and (iii) to the Company&rsquo;s knowledge, there are no facts that would reasonably
be expected to give rise to such an event as described in the immediately preceding clause (i) or (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the past three (3) years, none of the Company, any of its Subsidiaries or, to the Company&rsquo;s knowledge, any of its officers, directors,
managers, employees, independent contractors or other agents has, directly or indirectly, (i) offered to pay to or solicited any remuneration
from, in cash, property or in kind, or made any financial arrangements with, any past or present customer, past or present medical director,
physician, other health care provider, supplier, contractor, or third-party payor in order to induce or directly or indirectly obtain
business or payments from such person, including any item or service for which payment may be made in whole or in part by any third-party
payor or for purchasing, leasing, ordering or arranging for or recommending, purchasing, leasing, or ordering any good, facility, service
or item for which payment may be made in whole or in part under any federal, State or private health care program; (ii) given or received,
or agreed to give or receive, or is aware that there has been made or that there is any agreement to make or receive, any gift or gratuitous
payment or benefit of any kind, nature or description (including in money, property or services) to any past, present or potential patient
or customer, medical director, physician, other health care provider supplier or potential supplier, contractor, third-party payor or
any other person; or (iii) made or agreed to make, or is aware that there has been made or that there is any agreement to make, any contribution,
payment or gift of funds or property to, or for the private use of, any person, governmental official, employee or agent where either
the contribution, payment or gift or the purpose of such contribution, payment or gift is or was illegal or improper under any applicable
Law except in the case of (i), (ii) or (iii) as would not, individually or in the aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance
with the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s stock option plan has been backdated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are conducted in compliance with applicable financial record-keeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes
and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Action or Proceeding
by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect
to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Nonclinical Studies and Clinical Trials</U>. The nonclinical studies and tests and clinical trials conducted by or on behalf of, or
sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement or the Prospectus,
or the results of which are referred to in the Registration Statement or the Prospectus, were and, if still pending, are, to the Company&rsquo;s
knowledge, being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable,
accepted professional and scientific standards for products or product candidates comparable to those being marketed and developed by
the Company and all applicable statutes, rules and regulations of the Regulatory Agencies, including, without limitation, 21 C.F.R. Parts
50, 54, 56, 58, and 812 and all applicable European Economic Area Member State Laws governing performance evaluations and clinical trials
with medical devices; the descriptions of the results of such studies, tests and trials contained in the Registration Statement or the
Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading,
except where the failure to be in such accordance would not reasonably be expected to have a Material Adverse Effect; the Company has
no knowledge of any studies, tests or trials not described in the Registration Statement or the Prospectus the results of which the Company
reasonably believes call into question in any material respect the results of the studies, tests and trials described in the Registration
Statement or Prospectus; and the Company has not received any written notices or other correspondence from the FDA, EMA, Health Canada
or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable
authority requiring or threatening the termination, suspension or material modification of any nonclinical studies or tests or clinical
trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company&rsquo;s
knowledge, there are no reasonable grounds for the same. During the last three (3) years, there have been no material adverse events
or developments in connection with any clinical, nonclinical or other studies, tests or trials conducted by or on behalf of or sponsored
by the Company or with respect to any of the Company&rsquo;s products or product candidates that would reasonably be expected to (i)
materially and adversely affect any Regulatory Agency&rsquo;s marketing authorization for any Company product or (ii) materially and
adversely jeopardize the continuation of such studies, trials or tests. During the last three (3) years, the Company has not received
any information from the FDA or any other Regulatory Agency that would reasonably be expected to result in the denial of any pending
or planned application for marketing authorization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo) <U>Cybersecurity</U>.
The Company and the Subsidiaries&rsquo; information technology assets and equipment, computers, systems, networks, hardware,
software, websites, applications, and databases (collectively, &ldquo;<U>IT Systems</U>&rdquo;) are adequate for, and operate and
perform in all material respects as required in connection with the operation of the business of the Company and the Subsidiaries as
currently conducted, free and clear, to the Company&rsquo;s knowledge, of all material bugs, errors, defects, Trojan horses, time
bombs, malware and other corruptants. The Company and the Subsidiaries have implemented and maintained commercially reasonable
physical, technical and administrative controls, policies, procedures, and safeguards to maintain and protect their material
confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data, including
&ldquo;Personal Data,&rdquo; used in connection with their businesses. &ldquo;Personal Data&rdquo; means (i) a natural
person&rsquo;s name, street address, telephone number, e-mail address, photograph, social security number or tax identification
number, driver&rsquo;s license number, passport number, credit card number, bank information, or customer or account number; (ii)
any information which would qualify as &ldquo;personally identifying information&rdquo; under the Federal Trade Commission Act, as
amended; (iii) &ldquo;personal data&rdquo; as defined by GDPR (as defined in Section 3.1(pp) below); (iv) any information which
would qualify as &ldquo;protected health information&rdquo; (&ldquo;PHI&rdquo;) under the Health Insurance Portability and
Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (collectively,
&ldquo;<U>HIPAA</U>&rdquo;); and (v) any other piece of information that allows the identification of such natural person, or his or
her family, or pennits the collection or analysis of any data related to an identified person&rsquo;s health or sexual orientation.
There have been no material breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have
been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal review or
investigations relating to the same. The Company and the Subsidiaries are presently in material compliance with all applicable laws
or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority,
internal policies and contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the
protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Compliance with Data Privacy Laws</U>. The Company and the Subsidiaries are, and at all times during the last three (3) years have
been, in material compliance with all applicable state, federal and international data privacy, security, and breach notification laws
and regulations, including without limitation HIPAA, the Federal Trade Commission Act and the California Consumer Privacy Act, and the
Company and the Subsidiaries have since May 25, 2018 been in compliance with, the European Union General Data Protection Regulation (&ldquo;<U>GDPR</U>&rdquo;)
(EU 2016/679) (collectively, the &ldquo;<U>Privacy Laws</U>&rdquo;), the noncompliance with which would be reasonably expected to have,
individually and in the aggregate, a Material Adverse Effect. To promote compliance with the Privacy Laws, the Company and the Subsidiaries
have taken steps reasonably designed to ensure compliance in all material respects with such Privacy Laws. The Company and the Subsidiaries
have at all times made all disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none
of such disclosures made have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory
rules or requirements in any material respect. The Company further certifies that neither it nor any Subsidiary: (i) has received notice
of any actual or potential material liability under or relating to, or actual or potential violation of, any of the Privacy Laws, and
has no knowledge of any event or condition that would reasonably be expected to result in any such notice; (ii) is currently conducting
or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii)
is a party to any order, decree, or agreement that imposes any obligation or liability under any Privacy Law. The Company and the Subsidiaries
hold all necessary authorizations, consents, permissions and contractual rights necessary to use and disclose Personal Data, including
but not limited to PHI (including data aggregation and de-identification) in the manner in which it is currently used and disclosed by
the Company and the Subsidiaries the failure to so hold would reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>Post-Market Reporting Obligations</U>. The Company is complying in all material respects with all applicable regulatory post-market
reporting obligations, including, without limitation, the FDA&rsquo;s medical device adverse event and malfunction reporting requirements
at 21 CFR Parts 803 and 806, and, to the extent applicable, the respective counterparts thereof promulgated by governmental authorities
in countries outside the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>No Shutdowns or Prohibitions</U>. Since January 1, 2021, the design, manufacture and testing of each the Company&rsquo;s products
or product candidates has been conducted in compliance in all material respects with all applicable Health care Laws for managing cybersecurity
risks associated with such products. Except as disclosed in the SEC Reports, the Company has not had any product or manufacturing site
(whether Company-owned or that of a third party manufacturer for the Company&rsquo;s products) subject to a governmental authority (including
FDA shutdown or import or export prohibition), nor received any FDA Form 483 or other governmental authority notice of inspectional observations,
&ldquo;warning letters,&rdquo; &ldquo;untitled letters,&rdquo; requests to make changes to the Company&rsquo;s products, processes or
operations, or similar correspondence or notice from the FDA or other governmental authority alleging or asserting material noncompliance
with any applicable Health Care Laws. To the Company&rsquo;s knowledge, neither the FDA nor any other governmental authority is considering
such action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
<U>No Safety Notices</U>. (i) Except as disclosed in the SEC Reports, there have been no recalls, field notifications, field corrections,
market withdrawals or replacements, warnings, &ldquo;dear doctor&rdquo; letters, investigator notices, safety alerts or other notice
of action relating to an alleged lack of safety, efficacy, or regulatory compliance of the Company&rsquo;s products or product candidates
(&ldquo;<U>Safety Notices</U>&rdquo;) and (ii) to the Company&rsquo;s knowledge, there are no facts that would be reasonably likely to
result in (x) a Safety Notice with respect to the Company&rsquo;s products or services, (y) a change in labeling of any the Company&rsquo;s
respective products or services, or (z) a termination or suspension of marketing or testing of any the Company&rsquo;s products or services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
<U>Product Liability Claims</U>. Except as described in the SEC Reports, the Company has not received any written or, to the Company&rsquo;s
knowledge, verbal notice as to any action or allegation of personal injury, death, or property or economic damages, any claim for punitive
or exemplary damages, any claim for contribution or indemnification, or any claim for injunctive relief, based upon strict liability
in tort, negligent design of product, negligent provision of services or any other allegation of liability in connection with any services
or products manufactured, designed, distributed, otherwise put into commerce by or in connection with any product or service provided
or sold by the Company in any jurisdiction, which either individually or in the aggregate could reasonably result in a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Understandings or Arrangements</U>. Such Purchaser is acquiring the Shares as principal for its own account and has no direct or indirect
arrangement or understandings with any other persons to distribute or regarding the distribution of such Shares (this representation
and warranty not limiting such Purchaser&rsquo;s right to sell the Shares pursuant to the Registration Statement or otherwise in compliance
with applicable federal and state securities laws). Such Purchaser is acquiring the Shares hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Shares, it was, and as of the date hereof it is either: (i) an &ldquo;accredited
investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a &ldquo;qualified institutional
buyer&rdquo; as defined in Rule 144A(a) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Shares, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment
in the Shares and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
pricing terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Shares covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21pt; text-align: justify; text-indent: 51pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Furnishing of Information</U>. Until the time that no Purchaser owns Shares, the Company covenants to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Shares for purposes of the rules
and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the
transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges
and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company,
any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the
Purchasers or any of their Affiliates on the other hand, with respect to such information shall terminate. The Company and each Purchaser
shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the
Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of
the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any
press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law,
in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication.
Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser
in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except
(a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to
the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with
prior notice of such disclosure permitted under this clause (b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Shares under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.3, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information
and agreed with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be
relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its
Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public information
to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any
duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or
Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates
not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law.
To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current
Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting
transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Shares hereunder for working capital purposes and
shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s debt (other than payment of trade payables
in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption of any Common Stock or Common Stock
Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.7, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any
and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in
settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or
incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company
in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or
any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect
to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such
Purchaser Party&rsquo;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings
such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws
or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct).
If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such
Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with
counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense
of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position
of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such
separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party
effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.7 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Listing of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock
on the Trading Market on which it is currently listed, and as soon as reasonably practicable after the Closing, the Company shall apply
to list or quote all of the Shares on such Trading Market and promptly secure the listing of all of the Shares on such Trading Market.
The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include
in such application all of the Shares, and will take such other action as is necessary to cause all of the Shares to be listed or quoted
on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing
and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other
obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic
transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment
of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration
is also offered to all of the parties to such Transaction Document. For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat
the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the
purchase, disposition or voting of Shares or otherwise. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
the Disclosure Time. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until the Disclosure Time, such
Purchaser will maintain the confidentiality of the existence and terms of this transaction. Notwithstanding the foregoing, and notwithstanding
anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation,
warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the Disclosure Time,
(ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with
applicable securities laws from and after the Disclosure Time and (iii) no Purchaser shall have any duty of confidentiality or duty not
to trade in the securities of the Company to the Company or its Subsidiaries after the Disclosure Time. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of
assets managed by the portfolio manager that made the investment decision to purchase the Shares covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11
<U>Subsequent Equity Sales</U>. From the date hereof until the later of the fifth (5<SUP>th</SUP>) Trading Day after the Closing Date,
neither the Company nor any of its Subsidiaries shall (i) issue, enter into any agreement to issue or announce the issuance or proposed
issuance of any Common Stock or Common Stock Equivalents, or (ii) file any registration statement or any amendment or supplement thereto,
other than the Prospectus Supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. At the Closing, the Company has agreed to reimburse Duane Morris LLP (&ldquo;Duane Morris&rdquo;) the non-accountable
sum of $15,000 for its legal fees and expenses, The Company shall pay all Transfer Agent fees (including, without limitation, any fees
required for same-day processing of any instruction letter delivered by the Company), stamp taxes and other taxes and duties levied in
connection with the delivery of any Shares to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus
Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior
agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such
notice or communication is delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the
signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c)
the second (2<SUP>nd</SUP>) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service
or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications
shall be as set forth on the signature pages attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Pre-Funded
Warrants based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case
of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification
or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted
Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement
of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner
impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the
rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior
written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon
each Purchaser and holder of Shares and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Shares, provided that such transferee agrees in writing to be bound, with respect to the transferred
Shares, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise
set forth in Section 4.7 and this Section 5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Section 4.7, the prevailing party in such Action or Proceeding shall
be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature
page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Saturdays, Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>APYX
    MEDICAL CORPORATION</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Matthew C. Hill</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matthew
    C. Hill</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
    applicable</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
    a copy to (which shall not constitute notice):</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURCHASER
SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nantahala
    Capital Partners Limited Partnership</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nantahala
    Capital Management, LLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Its</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Partner</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Wilmot Harkey</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wilmot
    Harkey</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manager</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notice to Purchaser:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">130
    Main Street, 2<SUP>nd </SUP>Floor</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    Canaan, CT 06840</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Shares to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $<B>1,580,571</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
<B>677,388</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Pre-Funded Warrant Shares: <B>662,641</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: ***</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the second (2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii) any condition to Closing
contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate
or the like or purchase price (as applicable) to such other party on the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify">IN WITNESS WHEREOF, the undersigned have caused
this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt"><B>NCP RFM LP</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 5%; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 45%; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Nantahala Capital Management, LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Its </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Investment Manager</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; layout-grid-mode: line"><FONT STYLE="font-size: 10pt"><I>/s/ Wilmot Harkey</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Wilmot Harkey</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Manager</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Email: </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">***</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">130 Main Street, 2<SUP>nd</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">New Canaan, CT 06840</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Address for Delivery of Shares to Purchaser (if
not same as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subscription Amount: $<B>831,087</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Shares: <B>356,180</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pre-Funded Warrant Shares: <B>348,426</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">EIN Number: ***</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#9744; Notwithstanding anything contained in
this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to purchase the securities set forth
in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities to
the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing shall occur on the second
(2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated by this Agreement (but
prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement, instrument,
certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an unconditional obligation
of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as
applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt"><B>Blackwell Partners LLC &ndash; Series A, solely
    with respect to the portion of its assets which Nantahala Capital Management, LLC acts as its Investment Manager</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 5%; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="width: 45%; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Nantahala Capital Management, LLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Its </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Investment Manager</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; layout-grid-mode: line"><FONT STYLE="font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; layout-grid-mode: line"><FONT STYLE="font-size: 10pt"><I>/s/ Wilmot Harkey</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Name:&nbsp; </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Wilmot Harkey</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Manager</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="layout-grid-mode: line">&nbsp;</TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">Email: </FONT></TD>
    <TD STYLE="layout-grid-mode: line"><FONT STYLE="font-size: 10pt">***</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">280 South Mangum Street, Suite 210</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Durham, NC 27701</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">130 Main Street, 2<SUP>nd</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">New Canaan, CT 06840</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Address for Delivery of Shares to Purchaser (if
not same as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subscription Amount: $<B>4,588,342</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Shares: <B>1,966,432</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pre-Funded Warrant Shares: <B>1,923,623</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">EIN Number: ***</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;
</FONT>Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed
to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the second (2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii) any condition to Closing
contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate
or the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LEGAL
OPINION OF COMPANY COUNSEL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PRE-FUNDED
WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 38; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="width: 200px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Apyx
Medical Corporation Reports Third Quarter 2024 Financial Results;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Updates
Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;<I>Strengthened
balance sheet with a common stock registered direct offering with gross proceeds of approximately $7.0 million; and amended revenue covenants
for the Company&rsquo;s credit agreement with Perceptive</I></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;<I>Announces
cost savings restructuring program to better focus, optimize and streamline operations, including a nearly 25% reduction in U.S. workforce</I></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;<I>Announces
9% overall growth in single-use handpiece revenue and 15% growth in the U.S.</I></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&nbsp;&nbsp;&nbsp;<I>Management
to host a conference call today at 8:00 a.m. ET</I></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: center; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLEARWATER,
FL </B>&mdash; <B>November 8, 2024 - Apyx Medical Corporation (NASDAQ:APYX)</B> (&ldquo;Apyx Medical;&rdquo; the &ldquo;Company&rdquo;),
the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion&reg;, today reported
the financial results for its third quarter ended September 30, 2024, updated its financial expectations for the full year ending December
31, 2024, and introduced its financial expectations for the full year ending December 31, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Recent
Financial and Operating Highlights:</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            revenue of $11.5 million, a decrease of 4% year-over-year, including:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
                                            Energy revenue of $9.3 million, a decrease of 6% year-over-year, and</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OEM
                                            revenue of $2.2 million, an increase of 3% year-over-year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            loss attributable to stockholders of $4.7 million, an increase of $0.1 million, or 2%, year-over-year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
                                            EBITDA loss of $2.4 million, a decrease of $0.6 million, or 20%, year-over-year.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closed
                                            a $7.0 million registered direct offering with a healthcare-focused fund.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
                                            the Company&rsquo;s credit agreement with Perceptive Credit Holdings IV, LP (&ldquo;Perceptive&rdquo;)
                                            to significantly reduce the trailing twelve-month Advanced Energy revenue covenants. Additionally,
                                            a maximum operating expense covenant of $40.0 million and $45.0 million in for 2025 and 2026,
                                            respectively was added. Associated with the amendment, Apyx issued 150,000 shares of common
                                            stock to Perceptive Advisors.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Implemented
                                            a cost saving restructuring program that included an organizational reduction in force to
                                            better focus, optimize and streamline operations. Under the organizational changes, the Company
                                            will reduce its U,S. workforce by nearly 25%. The annualized future cost savings from the
                                            reduction in force is estimated to be approximately $4.3 million. The Company will incur
                                            pre-tax charges of approximately $0.6 million in the fourth quarter of 2024, mostly represented
                                            as one-time severance expenditures and other employee termination benefits. Identified over
                                            $4.0 million of additional cost savings and anticipate operating expenses to be below $40
                                            million in 2025.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right
                                            sized the Company&rsquo;s board of directors to five members down from eight.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><IMG SRC="ex99-1_001.jpg" ALT=""style="width:200px">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;While
our Advanced Energy sales decreased year-over-year, we were pleased with the continued resiliency of our disposable handpiece, which
grew 9% overall and 15% in the U.S. Looking ahead, we expect the strength of our disposable handpiece sales to continue, and expect to
ship a total of nearly 90,000 units for the full year 2024,&rdquo; said Charlie Goodwin, President and Chief Executive Officer. &ldquo;It
has been a busy few months for us, as we initiated a cost reduction program, raised $7.0 million to strengthen the balance sheet, and
amended the covenants with our lender and partner, which we believe will extend our cash runway and allow us to execute our growth strategy.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Goodwin continued, &ldquo;In addition, the Aypx team is in the final stages of developing the Ayon body contouring system, a new product
that we believe will dominate the aesthetic surgical space. This system is an all-in-one platform that seamlessly integrates Renuvion,
ultrasound-assisted liposuction, power-assisted liposuction, infiltration, aspiration, electrocoagulation and fat transfer into a single,
streamlined device. We currently plan to submit a 510(k) for Ayon to the FDA no later than the end of the first quarter of 2025, and,
pending approval, launch the system in the back half of 2025.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, as part of the cost restructuring, Todd Hornsby, Executive Vice President of Sales and Marketing, will be leaving the Company
effective immediately.,&rdquo; stated Mr. Goodwin. &ldquo;I will be stepping into that role, in addition to my other duties. In order
to free up my time, I am pleased to announce Shawn Roman has been promoted from his current position of Vice President Research and Development
to Chief Operating Officer. Shawn has been with the Company since 2015 and is well qualified for his new role. &ldquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables present revenue by reportable segment and geography:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Three Months
    Ended</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nine Months
    Ended</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    30,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    30,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-style: italic; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(In thousands)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">$&nbsp;Change</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">%&nbsp;Change</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">$&nbsp;Change</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">%&nbsp;Change</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 28%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Advanced Energy</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,288</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,836</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(548</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(5.6</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,507</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31,248</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,741</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(15.2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">OEM</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,199</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,140</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">59</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.8</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,373</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,439</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">934</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14.5</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,487</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,976</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(489</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4.1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,880</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37,687</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,807</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(10.1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Three Months
    Ended</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nine Months
    Ended</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    30,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    30,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-style: italic; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(In thousands)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">$&nbsp;Change</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">%&nbsp;Change</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">$&nbsp;Change</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">%&nbsp;Change</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Domestic</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,793</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,652</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(859</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9.9</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">23,459</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,660</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,201</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 5%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(15.2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">International</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,694</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,324</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">370</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11.1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,421</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,027</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">394</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.9</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,487</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,976</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(489</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4.1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,880</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37,687</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,807</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(10.1</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)%</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Third
Quarter 2024 Results</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
revenue for the three months ended September 30, 2024, decreased to $11.5 million, compared with $12.0 million in the prior year period.
Revenue for the Advanced Energy segment decreased to $9.3 million, compared with $9.8 million in the prior year period. OEM segment revenue
increased to $2.2 million, compared with $2.1 million for the same period last year. The decrease in Advanced Energy revenue was primarily
due to a lower average selling price of generators to domestic customers, fewer domestic customer upgrades to the Apyx One Console and
a decrease in international sales of new generators. These decreases were partially offset by an increased volume of single-use handpieces
sold domestically and customer upgrades to the Apyx One Console internationally. The increase in OEM segment revenue was due to increased
sales volume to existing customers, including Symmetry Surgical, under the Company&rsquo;s 10-year generator manufacturing and supply
agreement. Domestic revenue decreased 10% year-over-year to $7.8 million, and international revenue increased 11% year-over-year to $3.7
million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><IMG SRC="ex99-1_001.jpg" ALT=""style="width:200px">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit for the three months ended September 30, 2024, decreased to $7.0 million, compared with $8.0 million in the prior year period.
Gross profit margin for the three months ended September 30, 2024 was 60.5%, compared with 66.6% in the prior year period. The decrease
in gross profit margins was primarily attributable to a decrease in the average selling price of generators to domestic customers, changes
in the sales mix between our two segments, with our OEM segment comprising a higher percentage of total sales and geographic mix within
our Advanced Energy segment, with international sales comprising a higher percentage of total sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
expenses decreased to $10.6 million for the three months ended September 30, 2024, compared with $12.6 million in the prior year period.
The decrease in operating expenses was driven by a $1.0 million decrease in salaries and related costs, a $0.5 million decrease in selling,
general and administrative expenses, a $0.3 million decrease in research and development expenses and a $0.2 million decrease in professional
services expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense, net for the three months ended September 30, 2024 and 2023 was $1.0 million and $0.4 million, respectively. The increase was
driven primarily by increased interest expense on higher outstanding borrowings compared to the prior year period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax expense (benefit) was $0.1 million and $(0.3) million for the three months ended September 30, 2024 and 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss attributable to stockholders was $4.7 million, or $0.14 per share, for the three months ended September 30, 2024, compared with
$4.6 million, or $0.13 per share, in the prior year period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
EBITDA loss for the three months ended September 30, 2024 and 2023 was $2.4 million and $3.1 million, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Financial
Guidance for Full Year 2024 and 2025:</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is updating its financial guidance for the year ending December 31, 2024 to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            revenue is now expected to be in the range of $46.6 million to $47.6 million, representing
                                            a decrease from 2023 of approximately 11% to 9%. The Company&rsquo;s prior guidance range
                                            for total revenue was $50.6 million to $52.1 million.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            revenue guidance assumes:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9632;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
                                            from the Advanced Energy segment is now expected to be in the range of $37.2 million to $38.2
                                            million, representing a decrease from 2023 of approximately 14% to 12%. The Company&rsquo;s
                                            prior guidance range for Advanced Energy revenue was $41.6 million to $43.1 million.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9632;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
                                            from the OEM segment is now expected to be approximately $9.4 million, representing growth
                                            of approximately 5% from 2023. The Company&rsquo;s prior guidance for OEM revenue was approximately
                                            $9.0 million.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            loss attributable to stockholders is now expected to be approximately $25.0 million, compared
                                            to $18.7 million for the year ended December 31, 2023. The Company&rsquo;s prior guidance
                                            range for net loss attributable to stockholders was $24.5 million to $23.5 million.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is introducing revenue guidance for the year ending December 31, 2025:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            revenue in the range of $47.6 million to $49.5 million, representing growth of approximately
                                            2% to 6% year-over-year, compared to $46.6 million the low-end of the updated total revenue
                                            guidance for the year ended December 31, 2024.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9675;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
                                            revenue guidance assumes:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9632;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advanced
                                            Energy revenue is expected to be in the range of $39.1 million to $41.0 million, representing
                                            growth of approximately 5% to 10% year-over-year, compared to approximately $37.2 million
                                            the low-end of the revenue guidance for Advanced Energy for the year ended December 31, 2024.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9632;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OEM
                                            revenue is expected to be approximately $8.5 million, representing a decrease of approximately
                                            10% year-over-year, compared to the updated OEM revenue guidance of $9.4 million for the
                                            year ended December 31, 2024.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Company also expects operating expenses of less than $40 million for the year ended December
                                            31, 2025.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><IMG SRC="ex99-1_001.jpg" ALT=""style="width:200px">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Conference
Call Details</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
will host a conference call at 8:00 a.m. Eastern Time on November 8, 2024 to discuss the results of the third quarter, and to host a
question and answer session. To listen to the call by phone, interested parties may dial 877-407-9039 (or 201-689-8470 for international
callers) and provide access code 13749764. Participants should ask for the Apyx Medical Corporation call. A live webcast of the call
will be accessible via the Investor Relations section of the Company&rsquo;s website (click here) and accessible directly (click here).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
archive of the webcast will be accessible approximately one hour after the live event ends on the Investor Relations section of the Company&rsquo;s
website (<U>click here</U>).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Investor
Relations Contact</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeremy
Feffer, Managing Director LifeSci Advisors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OP:
212-915-2568</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>jfeffer@lifesciadvisors.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>About
Apyx Medical Corporation</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apyx
Medical Corporation is an advanced energy technology company with a passion for elevating people&rsquo;s lives through innovative products,
including its Helium Plasma Platform Technology products marketed and sold as Renuvion&reg; in the cosmetic surgery market and J-Plasma&reg;
in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve
their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also
leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers.
For further information about the Company and its products, please refer to the Apyx Medical Corporation website at <U>www.ApyxMedical.com.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Cautionary
Statement on Forward-Looking Statements</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
matters discussed in this release and oral statements made from time to time by representatives of the Company may constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company
believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance
that its expectations will be achieved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not
limited to, projections of net revenue, margins, expenses, net earnings, net earnings per share, or other financial items; projections
or assumptions concerning the possible receipt by the Company of any regulatory approvals from any government agency or instrumentality
including but not limited to the U.S. Food and Drug Administration (the &ldquo;FDA&rdquo;), supply chain disruptions, component shortages,
manufacturing disruptions or logistics challenges; or macroeconomic or geopolitical matters and the impact of those matters on the Company&rsquo;s
financial performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements and information are subject to certain risks, trends and uncertainties that could cause actual results to differ materially
from those projected. Many of these factors are beyond the Company&rsquo;s ability to control or predict. Important factors that may
cause the Company&rsquo;s actual results to differ materially and that could impact the Company and the statements contained in this
release include but are not limited to risks, uncertainties and assumptions relating to the regulatory environment in which the Company
is subject to, including the Company&rsquo;s ability to gain requisite approvals for its products from the FDA and other governmental
and regulatory bodies, both domestically and internationally; the impact of the March 14, 2022 FDA Safety Communication on our business
and operations; sudden or extreme volatility in commodity prices and availability, including supply chain disruptions; changes in general
economic, business or demographic conditions or trends; changes in and effects of the geopolitical environment; liabilities and costs
which the Company may incur from pending or threatened litigations, claims, disputes or investigations; and other risks that are described
in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and the Company&rsquo;s other filings with
the Securities and Exchange Commission. For forward-looking statements in this release, the Company claims the protection of the safe
harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation
to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><IMG SRC="ex99-1_001.jpg" ALT=""style="width:200px">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APYX
MEDICAL CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)
(In thousands, except per share data)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Three Months
    Ended</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nine Months
    Ended</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    30,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    30,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sales</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,487</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,976</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,880</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">37,687</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cost of sales</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,533</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,998</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,484</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,857</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gross profit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,954</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,978</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,396</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">24,830</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other costs and expenses:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research and development</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,142</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,409</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,963</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,037</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Professional services</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,648</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,831</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,318</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,165</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Salaries and related costs</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,508</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,534</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,886</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,329</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selling,
    general and administrative</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,291</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,841</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,026</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,474</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total other costs and expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,589</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,615</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">36,193</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">39,005</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gain
    on sale-leaseback</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,692</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss from operations</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,635</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,637</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(15,797</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(11,483</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">378</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">248</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,312</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">478</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,431</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(585</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,254</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,362</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    income (expense), net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">24</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(19</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">622</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    other expense, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,029</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(356</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,940</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(262</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss before income taxes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,664</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,993</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(18,737</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(11,745</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income
    tax expense (benefit)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">60</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(318</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">163</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,519</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,724</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,675</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(18,900</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9,226</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss attributable to non-controlling interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(21</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(46</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(65</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(120</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss attributable to stockholders</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,629</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(18,835</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9,106</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss per share:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Basic and diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.14</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.13</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.54</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.26</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><IMG SRC="ex99-1_001.jpg" ALT=""style="width:200px">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APYX
MEDICAL CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONDENSED
CONSOLIDATED BALANCE SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(In
thousands, except share and per share data)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">September
    30, 2024</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
    31, 2023</B></FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center"></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">ASSETS</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current assets:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and cash
    equivalents</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,013</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">43,652</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Trade accounts receivable,
    net of allowance of $750 and $608</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,036</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventories, net of provision
    for obsolescence of $930 and $875</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,000</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,923</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid
    expenses and other current assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,109</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,764</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    current assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">52,158</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">70,362</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Property and equipment, net of accumulated
    depreciation and amortization of $3,889 and $3,522</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,905</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,915</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating lease right-of-use assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,820</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,162</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Finance lease right-of-use assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">53</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">69</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,785</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,732</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">60,721</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">79,240</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">LIABILITIES AND EQUITY</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,914</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,712</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued expenses and other
    current liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,291</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,661</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current portion of operating
    lease liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">330</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">347</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current
    portion of finance lease liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    current liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,555</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,740</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Long-term debt, net of debt discounts and issuance
    costs</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,853</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">33,185</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Long-term operating lease liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,606</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,896</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Long-term finance lease liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">38</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">53</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Long-term contract liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,271</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,246</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">201</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">198</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">49,524</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">52,318</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">EQUITY</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 issued
    and outstanding as of September 30, 2024 and December 31, 2023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock, $0.001 par value; 75,000,000 shares authorized; 34,643,926
    issued and outstanding as of September 30, 2024, and 34,643,888 issued and outstanding as of December 31, 2023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional paid-in capital</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">84,289</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">81,114</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated
    deficit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(73,283</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(54,448</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total stockholders&rsquo;
    equity</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,041</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,701</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-controlling
    interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">156</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">221</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    equity</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,197</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,922</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 20pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    liabilities and equity</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">60,721</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">79,240</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%"><IMG SRC="ex99-1_001.jpg" ALT=""style="width:200px">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>APYX
MEDICAL CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECONCILIATION
OF GAAP NET LOSS TO NON-GAAP ADJUSTED EBITDA</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Use
of Non-GAAP Financial Measure</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
present the following non-GAAP measure because we believe such measure is a useful indicator of our operating performance. Our management
uses this non-GAAP measure principally as a measure of our operating performance and believes that this measure is useful to investors
because it is frequently used by analysts, investors and other interested parties to evaluate companies in our industry. We also believe
that this measure is useful to our management and investors as a measure of comparative operating performance from period to period.
The non-GAAP financial measure presented in this release should not be considered as a substitute for, or preferable to, the measures
of financial performance prepared in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has presented the following non-GAAP financial measure in this press release: adjusted EBITDA. The Company defines adjusted EBITDA
as its reported net income (loss) attributable to stockholders (GAAP) plus income tax expense (benefit), interest, depreciation and amortization,
stock-based compensation expense and other significant non-recurring items.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Three Months
    Ended</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nine Months
    Ended</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif; font-style: italic; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(In thousands)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    30,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">September
    30,</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2024</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2023</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 44%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss attributable to stockholders</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,703</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,629</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(18,835</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(9,106</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(378</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(248</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,312</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(478</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,431</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">585</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,254</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,362</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income tax expense (benefit)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">60</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(318</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">163</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,519</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Depreciation and amortization</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">144</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">186</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">457</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">540</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock based compensation</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">997</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,351</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,175</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,200</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gain
    on sale-leaseback</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&mdash;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,692</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  <TR STYLE="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adjusted EBITDA</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,449</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,073</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(12,098</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8,693</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>7
<FILENAME>ex99-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-2_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Apyx
Medical Corporation Announces $7,000,000 Million Registered Direct Offering</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CLEARWATER,
FL </B>&mdash; <B>November 8, 2024 - Apyx Medical Corporation (NASDAQ:APYX)</B> (&ldquo;Apyx Medical&rdquo; or the &ldquo;Company&rdquo;),
the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion&reg;, today announced
it has entered into a definitive purchase agreement with Nantahala Capital for the purchase and sale in a registered direct offering
of 3,000,000 shares of the Company&rsquo;s common stock at a purchase price of $1.18 per share and pre-funded warrants to purchase up
to 2,934,690 shares of the Company&rsquo;s common stock at a purchase price of $1.179 per pre-funded warrant (which represents the per
share offering price for common stock less the exercise price per share for each pre-funded warrant of $0.001). The gross proceeds to
Apyx Medical from the offering were approximately $7,000,000, before deducting offering expenses payable by the Company. The offering
closed on November 8, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price of $1.18 per share of common stock was calculated using the average closing price of the Company&rsquo;s common stock
on the Nasdaq Global Select Market for the five trading days prior to market close on November 7, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not use a placement agent in connection with the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apyx
Medical intends to use the proceeds from the offering for working capital and other general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities are being offered and sold by the Company pursuant to an effective shelf registration statement on Form S-3 (File No. 333-268532)
previously filed with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) and declared effective by the SEC on December
2, 2022. The offering of such securities is being made only by means of a prospectus supplement and accompanying prospectus that forms
a part of the registration statement. Copies of the prospectus supplement and accompanying base prospectus will be filed with the SEC
and will be available free of charge on the SEC&rsquo;s website at http://sec.gov.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor
shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Investor
Relations Contact</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeremy
Feffer, Managing Director LifeSci Advisors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OP:
212-915-2568</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>jfeffer@lifesciadvisors.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>About
Apyx Medical Corporation</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Apyx
Medical Corporation is an advanced energy technology company with a passion for elevating people&rsquo;s lives through innovative products,
including its Helium Plasma Platform Technology products marketed and sold as Renuvion&reg; in the cosmetic surgery market and J-Plasma&reg;
in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve
their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also
leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers.
For further information about the Company and its products, please refer to the Apyx Medical Corporation website at <U>www.ApyxMedical.com.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-2_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Cautionary
Statement on Forward-Looking Statements</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
matters discussed in this release and oral statements made from time to time by representatives of the Company may constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company
believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance
that its expectations will be achieved.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not
limited to, projections of net revenue, margins, expenses, net earnings, net earnings per share, or other financial items; projections
or assumptions concerning the possible receipt by the Company of any regulatory approvals from any government agency or instrumentality
including but not limited to the U.S. Food and Drug Administration (the &ldquo;FDA&rdquo;), supply chain disruptions, component shortages,
manufacturing disruptions or logistics challenges; or macroeconomic or geopolitical matters and the impact of those matters on the Company&rsquo;s
financial performance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements and information are subject to certain risks, trends and uncertainties that could cause actual results to differ materially
from those projected. Many of these factors are beyond the Company&rsquo;s ability to control or predict. Important factors that may
cause the Company&rsquo;s actual results to differ materially and that could impact the Company and the statements contained in this
release include but are not limited to risks, uncertainties and assumptions relating to the regulatory environment in which the Company
is subject to, including the Company&rsquo;s ability to gain requisite approvals for its products from the FDA and other governmental
and regulatory bodies, both domestically and internationally; the impact of the March 14, 2022 FDA Safety Communication on our business
and operations; sudden or extreme volatility in commodity prices and availability, including supply chain disruptions; changes in general
economic, business or demographic conditions or trends; changes in and effects of the geopolitical environment; liabilities and costs
which the Company may incur from pending or threatened litigations, claims, disputes or investigations; and other risks that are described
in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 and the Company&rsquo;s other filings with
the Securities and Exchange Commission. For forward-looking statements in this release, the Company claims the protection of the safe
harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation
to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>form8-k_001.jpg
<TEXT>
begin 644 form8-k_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "Y 2P# 2(  A$! Q$!_\0
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M-99(S%O#I!*5)V&FOKNEQH\DE[;1Q1Y\V5YXECB*H)2)6+?NB(V5R)0A ."
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MQ"\(Z9J$.$99[.[URQANH7W$!5:W>1R0,G:<#.!7[B?\%<O^2&>#?^RBQ?\
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M\UVRM9MT.D^+[-1IWBC2$3<62.SUVSO3 DC%UM9(6)(.3Y'_ ,%(/@<OQ7^
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MK_ ?_!7,*/@3X)8$EG^(D!(R,<Z5= X&,XP@/4]^W3\5/V83C]HWX'-D;O\
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MN;"+:"K8_%S]HCX(>(OV??BOXB^'FNPRW$-A?M?^'M4">5_PD/AZ;S3H]["
M,(_E2+:ZDJ<"Z0'"\Y_E?./#/CCPNR/@OQ'I3K0EB,7]?Q;IU'">65:ZC5P.
M&HOE:C3S&FJ<*ZE"2M5G%.#=W_8.4^*GA_XPYYQWX6P5=0I8.IEF&JY@J=?
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M3S=26ECIMM8:Q;VUG!%<7U_<B(*3Y]Y/(SYD*KXC_P ./?\ @EUT'[*/A?
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M*]&$:$ZL:]10INGSS49*<Y.--R:D?V'F" _NC&I1@<K_  D$X))X8DCKR05
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MOK?Q.U 26,TD!BG7PEHLGV/3!&)5$JVVH74=_?AR3YUG-;LFTAI7_,;]E_\
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MI"(I4-N+>5PH5\2#O_\ @F#^W_H7_!1']FZW^-5MX?T[P5XPTGQ1KW@KX@>
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M:M/&_LW[4G@_PY\.O^#CO]F+P%X/TV+1O"G@GQS^PGX5\,:3",QZ;H.B>"/
M.GZ79(Q^9O(L[6%"S$O(ZF1R6+$^GPUERX8RS,N':[3SK-,@XBS7'5>:+G#!
MY?&M2P^#;:_@RNJM./+%MMOGFM%SYUC)Y_B\'FM/W<MR^OAZ='=>UG4E3?.E
MMSQESQ>K=HI**U9_7_\ M]*A_8>_:_5MWEC]G/XR;RI(D,;^!=;,I!#(6?9N
MVIN'F'$9R#BOYY?^#4:ZM+?X"_M6QWMY:VTO_"T/A\!%<.D3H8O!,B2E8YP%
M7+;=WV=3$"%1G>0,3_0[^WV0G[$7[7QP<#]G'XQ.R+LW,G_""ZT74;_E&]-R
M[NH!)0A@#7\('_!)7_@E#XZ_X*,?#CXI^+O!_P"TCJ/P-A^&WB3PQX;O],L=
M%U_5$\03ZIHESJ5MJ32V&O:,JK%#&T"JYG^;>RHBOO;XOA;"Y;B.!.**6/S!
M972EG& E+$M5'3HSDJ<YSG"G*[=2<5"]G9SYK1U/H^(9U:/$F3U</AOK5:.%
MJ2AATHOVK5*NE%\R<>76]VK::.]C_1CCU'2V8QC4=,FSC:BRVQE.2V?E5L[>
MF68*%Y(9C@"YY,0C4IPA57"QOF,E)1(I1P P7=D_NV16#L64LV1_(QX4_P"#
M:/XQ>%_%OA+Q%/\ M]Z_J,'A[Q1H7B&YTW_A%?&<2:A'HM\E_P#8WFC\8RBV
M%PL+1&:8R0@,?W1;(;^N:",0V5I &5A!:P0Y V@B(1QYVEG*@A<[69B <$DU
M\/FV7Y9A*^'6 SNEG%.4DY1IQKTU1E3<)4ZDE4<;N;E*,;.6J=T]$?0Y?B\P
MQ&&KSS'*HY5B(T:W+""I.$Z?(U&2<(NTKI2LVK7O;J?P]?\ !OY&O_#VK]KB
M/YO+'ASX^OL+%E8_\+?T_ ?<27PSNX=RTH=V_>;&*5_9C\<?@1\*OVA?AMXG
M^%/Q=\':'XV\%^+-+N]*U'2=;TZQO%B6YA:W34=.GGM9)=.U73Y7BO;#5+5H
M[ZRN;>.:WE7:Z2?QL?\ !ORH/_!6C]KDX!/_  C7Q\YQDX/QCTL?ED@?4@=^
M?[B)=I1BP#*HD+ C.%Y)8<?> &!CGDU]=XCUJM#B;!UJ-6K2K0P>3RC.%6<9
MQG[&,FTO:)7;2NN6W2R3=_#X5H4:F5YC&I1IS4\3C'/FIP?-^[IJ[O&_?5-=
M3^'[_@WEUK7_ ("_\%-OVJ_V2HM3O7\%R>#?B?:M8W5PUY%+K_P<^)/A_1O#
M&IN7^;[3%X>US5(+F4*CW,CK,S)\RR??/_!U%Q^R-^STP&/^+^2>AX'@3Q#Q
MD<9XZCOR/2OST_X(^S+K?_!?K]J76;$F>R2P_:OO9Y?OA;=OB/X-M(Y-W( G
M<QKNSF16AY.^/=^A7_!U'C_AD7]GOI_R7V4<=/\ D1/$6/\ ZPKZ/%)1\3>%
MJB253$Y;A*^(E97K5IX6NIU*EU[TVDE)V5[)V6YXU-N'!6=0A[L:.,K0HQ5[
M4X1K0<8P3O9)MV6N_6Y^P?\ P2C0'_@F=^PF,\R?LN?!L#@%=Y\%Z&%!4J1L
M)P&!'0D@@X8?R<_\$_?A[X<_;P_X+W?M">+?C5IEMXZ\/>"/$/QX^+B:-XC2
M*[T^['P\^(/A;X9> K2ZM63R+G3=)77[*]71'0Z9<"P^T36K-%NK^LS_ ()/
MX_X=H?L(YY'_  RU\'?S_P"$*T3'Y'!K^7+_ (((R0Z;_P %G?VP=)OWBCN[
MCX:_M,V]K X&Z:2U_:(^%LK(J$9#QP7$JE1\P0RJ1@-7EY)+V5/Q.QD$EBZ%
M-*A7B^6O2]MFF)HU/9S34H<].T79)NR2:TOZ.<14Y\&49ZTJLKSIR_ASE'"8
M:2YHNRDTY3>M_BEIO;^T+X@_"[X?_$[P3K/PY\=^%]%\4>!O$&E-HVL^&-4T
MRRO]'N=*F0VRP-I]S#-;PFQB4SVTMJD-Q;36\#6\D<<0B/X=_P#!+_\ X(\_
M%'_@G%^U+\6?B=H_QT\->*O@A\1=!\3^&(OAK!X?\06^NV>EIXMAUWX=7U_K
M.H3)HUYK?AC3HVT:[U)(M]Y'-=1VL4<,BQP_T%,L10Y1&Y8E<*X. 4X'/!$C
M Y&/G;(P:I1:MH\UZUG;:CITU^F])+..^MVNXY(&?S(G@1S,IA82"1&7]WAM
MR@*37YWA<YS/#8'%X/#NK/"XZE;&4'*=2E*U=M5)*HJG))R^U&5-NR5VDD?3
MXG*<NKX[#UYTZ5*O@ZO-0J0BJ<VG1C'V:<904HJSDDXRLW>^K0SQ%KFD>&M#
MUOQ#KM]!IFAZ!I.HZWK6I73*MOINEZ59SZA?W\[,&416EM;RW+Y5MJH<JX^6
MO\XL? [XI?\ !7_]H;_@IG^U1HZ:M<6'PK\(^-?B=X.AQM74Y-,\0/IGPC\!
M6D;;T5[SX9^$M=U.XM(V+Q7ED(VFA-W$LG]9_P#P7V_:J3]FG_@GKX^TO1M4
M>Q\>?'S5++X*^#&MIBUV+?7++4-4\8ZJJLKQ?9X/"NA:O!OE40M/>V\8D\RZ
MCW_'7_! B[_93_9D_8.L[WXD?'/X%^'?'W[0&OZOXW\7^'];^)OA*PUG2_#A
M5_"_A+P[K-C>:S%<6'_%.V,NIR:<(HHM._M2*$0JX8+^A<(5<7PSPWF_$F78
M7ZQF^*JX7*<JH*C*JN6-2G4S*=E"I91P]9ZM-7V]Y1O\WQ%3I9UF^!R6O4Y,
M-"C7QE:\THU'&%14G)7A>4)TU**YEYW6A[G_ ,&XO[4W_"\/V$-+^$VL:M)J
M'B_]F?Q#-\/)X+Q]U_%X%U;[1KGP]3:S!VL-*TF23PW;2E (%TJ*VD+21%W_
M $9_X*B'/_!/7]KDX^]\$?&1.1@G_B7[^1P1Z8[=.<9K^4/_ ()?_$OP7^PA
M_P %L/C7^SMH7CCP[XA^ OQ^USQ3\-_ WB3PSXAM/$OA>XTS5-7;Q_\  _RK
M[0[R]L;S6-/M[F/P%J=[/(U[]HO=0:X9!.['^KO_ (*@!1_P3V_:X3<6V? W
MQF#N<R,,:<$!=R27)(.7)RS9.<YKS^(LLC@>.,KQ-"ZPF:ULNS*A>#@G#$UL
M!5ES1E&/+*.(]NK-)ZJZ3NC?)L>L1PSBJ:K3K3R^CB<%.M*2E.:I4\72O*2T
M?-!I-VBK))=S\6O^#4X9_98_:*S_ !_'6T<X]3X%T"3 R3A0TS@#DX"C)P2?
MZI4ZGZ+_ "K^5O\ X-3@1^RQ^T0Q! _X7G:+D@@;O^$"\.94D]"""".N0>.#
M7]40=5SN('"\]A@<Y/08R.N*\CCI?\9CG&FKJMOU?(_U[+T._A**60Y<HJRY
M-$KM;?/\R6BFAE/(8''7D<?7TIU?+>77MU^X^E"BBB@ HHHH **** "BBB@
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M0Q"LHCB\"ZVS[QAOW9VD/E<A"V.S5_$M_P $3/\ @KA\!?\ @FW\+_C3X/\
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M0S7"0HT.5<E.G44W%-72;27KW5^IZ1^S%\=?#'[3OP ^%G[07@W3-7TCPO\
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M3^./LJBY?5N-E?IJ$YTZ<>>=6G&&B4G.-G=I+K?5M(VZ*J),)%WJ2P)*DJV
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MA\<>*YM>%OXIT&_T+2(M*LH(=2U&>YN8GU$Q/;SP^;<JR2+&:X_"5\%Q#E^
MS"A1A4Q^3XZC#$1YU7HX:4'B/9NE&E&<Y3Y^96@YQA!OE<6I;Y?A*].OA9U<
M,XP>#QE"4XJ2G%UH-*SG*5G=65TTM=&]OQT_9^\7>+KO_@W9_P""B?B6\\7>
M+KCQ#8_&_P")YM-=F\5:Y+K=G"GCSX3R01V&NM=-J5I)#:R/:.UJT-O(\MT#
M^[=]T7QF_P"">+_"_P#X)0>!/^"CMA^TO^T;=?M9^"/@O\(_C18>.)OBOXJ;
M0;70+ZRT%-'^'.BZ&;FW.@Z1X8\,:C9^'--N;.2:&\&DR2:G8W"WANC]\?"/
M_@EI^U=X,_X(]?MD_L3ZU9_#E/C;\;_BEX^\6>!$M_&DLOA*72?$?BWP/K6G
M2:MKQT02:;<M9>';Y)(5TZ>-9?(17(D./N'X\_L;?&WXB?\ !&Q/V)/#]OX4
M;XZ1?LS_  L^$XM]2UQ[/PD?%GA/3O#5KJJ/X@.G2L-+3^RKQX[PZ=ND1 #
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-*;;=V[O:X4444Q'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $_!5P# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH \C\36GV+Q#>1 85G\Q?HW/]:R:[/X
M@VFV\M+P#B1#&WU!R/Y_I7&4 %%%% !1110 58L;8WM_;VPZRR*GYFJ]=+X'
MM/M'B!9B/EMXV?\ $_*/YG\J /2U4(H51@ 8 IU%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '.^-;3
M[3X=D<#+0.L@_D?Y_I7E]>V7=NMW9SVS?=EC9#^(Q7BKHT<C(XPRG!'O0 VB
MBB@ HHHH *]#\ 6GEZ;<79',TFT?1?\ ZY->>5[#H5I]AT*SM\898@S#_:/)
M_4T :-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6V[NHXFQ:CA2?F/X#)KZ8H **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFR1QN;Y /R9C^%?55>)_LX:1Y'AO5M79,-=7*P*3_=C7/'XN?RKVR@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OAGQ9_R.6N?]A"?_T8
MU?<U?#/BS_D<M<_["$__ *,:@#'HHHH ***]O_9K_P"1AUS_ *]4_P#0Z /$
M**^_JS]0T/2=5C*:AIEG=J>HG@5_YB@#X1HKVOXQ_":R\-V/_"1Z C16(=4N
MK4L6$18X#*3SM)P,=B1CCIXI0 4444 %>Y?LX^('@UG4_#\C_N;B+[5$I/21
M2%;'U4C_ +XKPVN[^#EV;/XK:&X.!(\D3>^Z-A_,B@#[#HHHH **** "BBB@
M#RCQ;:?9/$ET ,+*1*/^!=?US6)7<?$*TYL[T#UB8_JO_LU</0 5I^';3[;K
M]G"1E?,WM]%^8_RK,KL?A_9^9?75V1Q&@1?JQ_\ K?K0!Z#1110 4444 %%%
M% '+_$?_ ))MXC_[!\W_ *":^*:^UOB/_P DV\1_]@^;_P!!-?%- !1110 4
M45]7_ +_ ))?!_U]3?S% 'RA17W]10!\ T5]_44 <A\+](&B?#;0K4KM=[83
MN#UW2?.<_P#?6/PKKZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME&C2R+&@RS$*![U[39VZVEG!;)]V*-4'X#% $]%%% !1110 4444 <O\1_\
MDFWB/_L'S?\ H)KXIK[6^(__ "3;Q'_V#YO_ $$U\4T %%%% !7U?\ O^27P
M?]?4W\Q7RA7TS\$_%'A_2OAS#:ZCKNF6=P+F5C%<7<<;X)X.UCF@#V6BN?\
M^$Z\'_\ 0UZ'_P"#&'_XJC_A.O!__0UZ'_X,8?\ XJ@#H**Y_P#X3KP?_P!#
M7H?_ (,8?_BJ5?''A)V54\4Z(S$X &H1$D_]]4 ;]%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)LN;65HI .F0>H]CU%?=]?.?[1?A@6VJZ?XE@CQ'=K]FN2!_RT490GZKD?\
M * /#:*** "O4/@KX[?POXH32[N4_P!DZFXC<,>(I3PC^W93[8/\->7TH.*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXC_[!\W_ *":^*: "BBB@ KZF_9Z_P"2;2_]A"7_ -!2OEFOJ;]GK_DFTO\
MV$)?_04H ]8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTO5&@:X-T\P,#EEVD*!R0/0UW5% !1110 4444 %%%% !1110 4444 %%%%
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKP'QE\1+SPO\
M'N,O=S?V5;Q0VUU;[SLV.H9FV_WAO#>O&* /?J*:K*ZAE(((R".].H ****
M"BBB@ HHHH **\$MOB'<ZS^T19VUM>2C1X7EL%A63]W+\C9?'0YD (/HJU[W
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI>32;;"X_P!'NQV$;'[W_ 3AOH#ZU]D @C(Y!H 6BBB@ HHHH *X?XL>+/\
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M5N(3/' 0?F49[],\$X]C0!L4444 %%%17%Q#:6[SW,L<,,8R\DC!54>I)Z4
M2T5EQ>)-"G!\K6M.DQUV72''ZU)_;NC_ /05L?\ P(3_ !H T**S[36]*O[@
MV]EJ=E<SJ"3'#.KL /8&I=1U"UTG3KC4+Z=8+6WC,DLC X51UZ?RH MT5@V/
MC;PMJ42O9^(=,D#=%^U(&_%2<BKW]NZ/_P!!6Q_\"$_QH T**S_[=T?_ *"M
MC_X$)_C1_;NC_P#05L?_  (3_&@#0HK/_MW1_P#H*V/_ ($)_C1_;NC_ /05
ML?\ P(3_ !H T**QX?%/A^YOTL+?7-.FNY Q6"*Y1G(4$G@'/0'\JDC\2Z%,
M2(M;TURO4+=1G'ZT :E%9_\ ;NC_ /05L?\ P(3_ !IUCK&EZF[I8:C9W;(,
MNMO.LA4>^#0!>HHJCJ>L:9HUO]HU/4+6RAZ![B54!^F3S0!>HKA)_C+\/[>3
M8_B*,M_TSMIG'YJA%6++XK>!;]PL/B6S4G_GONA'_CX% '9T55L]1LM00O8W
MEO<H.K02JX'XBK5 !1110 45E:IXET+1#MU36+"R;^[/<*C'\"<USDWQ?\ P
M;M_B. [>NR*1_P#T%3F@#N**X>+XP^ 9MNWQ' -W3?#*OYY7BM>Q\=>$]2(6
MT\1Z7(YZ)]J16_[Y)S0!T-%-5E=0R,&4\@@\&J5]K6E:;(L=_J=G:.PW*L\Z
MQEAZC)H OT5G#7M'(!&K6)![_:4_QIDOB/0X5#2ZUIT8/&6ND']: -2BHX9H
M[B))H9%DB<;D=&R&'J#4E !116;<Z_HUG=&UNM6L(+@8S%+<HKC/3@G- &E1
M6?\ V[H__05L?_ A/\:C?Q)H4<BH^M:<KM]U3=("?UH U**HWVLZ7IKHE_J5
MG:.XRBW$ZQEA[9-,&OZ,RAEU:P((R"+E/\: -&BL_P#MW1_^@K8_^!"?XT?V
M[H__ $%;'_P(3_&@#0HK-?Q#HL2%Y-8T]$7JS7* #]:;%XBT6;31J4>KV+6)
M<QBY^T+Y98'& V<=J -2BLR/Q%HDJ;H]9T]U]5ND(_G2MX@T5$+/J]@JCJ3<
MH /UH TJ*JV6H66I0F:QO+>ZB#;2\$@=<^F1WJU0 456O=0L].B$M]=P6L3-
MM#S2*BD^F34']NZ/_P!!6Q_\"$_QH T**S8]?T:6Z2UCU>P>X<X2);E"[?1<
MYK2H **** "BBB@ HHHH **** "BBB@ HHHH *^0?C;_ ,E>UW_MW_\ 1$=?
M7U?(/QM_Y*]KO_;O_P"B(Z /3_V:_P#D7M<_Z^D_] KV^O$/V:_^1>US_KZ3
M_P! KV^@ JIJFS^R;SS<>7Y#[L],;3FK=<I\2=930OAWK=XS[7-JT,?/.^3Y
M%Q^+9_"@#XLK[?\  ^F/HW@;0]/F4K-#91B53_"Y4%A^9-?+WPD\&/XO\:6X
MFBW:;8LMQ=L1\K 'Y4_X$1^0;TK[ H HZEI&FZS;K!JFGVM]"K;UCN85D4-T
MR P//)YKYS^//@O1O#5WI-_HUG'9I>"1)H8N$W)MPP';ACG'H*^FJ\-_:4C!
MT309>=RW,JCZ%1_A0!YG\'/#6G^*/'\-KJ< GM(('N'A;.URN  ?;+ _A7UA
MIFC:9HMN;?2].M;&%FW,EM"L89L8R0HY/ YKYN_9R_Y*%?\ _8*D_P#1L5?3
M] !1110!GZIH>DZW'''JNF6=\D>=@N8%DV9ZXW#C\*^9/CCX3TGPOXHL6T>V
M6U@O+<N\"?<5PV"5],C'%?5=?/'[2P']H^'CCDPS\_BE &K\#O 7A^_\''6]
M5TJVO[JXN'1/M40D147CA6XZ[N?\*];\0:Y8>$O#=UJMV EI9Q9"(,9/144>
MYP!7'_ K_DE&F_\ 76?_ -&-7/?M'7DT7A'2K5&Q'->[GQWVH<?^A?H* .%T
MN'Q1\=O%4QOKYK31K4AW1.8X%.=JJO\ $YP?F/H?85Z]IWP0\"6%N(Y-*DO)
M,<RW-PY8_@I"_D*YG]FZ>W;PIJ]LNW[4E\'DYYV,BA?U5Z]JH \QU?X#^"=1
M@86EI<:;,>DEO.S#/^ZY88^F*\\^'O@J\\&?'B#2;Z1)3#:RSP3(N!+&R%0V
M.W<'W!Z]:^D:Q;GPW:7/BRQ\1,[K=6EM+;JHQAE<@\_3!_.@#6FACN(7AFC6
M2*12CHZY5@1@@CN*\K^*GPY\,_\ "!ZKJ.GZ+:65]9Q>?'):0B/[I&00N 1M
MS_.O6*Y?XC_\DV\1_P#8/F_]!- 'QWH&FC6/$>F:8S%5O+N*W+#J-[A?ZU]H
MZ'X0\/>&R&TC1K.TD">7YT<0\QEXX+_>/0=37QYX$_Y*%X:_["MK_P"C5K[>
MH *PO%VNZ/X=\-7E]KGEO9;"C0.H;SR1_JPI^\3Z?7/%2^)/$FF>$]$FU759
MQ%;Q\ #EI&[*H[L?\\5\]VUEXE^/'BTWER6LM M'V\'*0K_=3^](1C)^G; H
M Y#PAX&U+XB>(KA=,MTLK 2F2:8@F.V5CD*/[QQT'MVKZ.\/?!_P;X?MD1M)
MAU*XQAY[]1+N/^Z?E'X"NKT+0M-\-Z5#IFE6J6UK$.%4<L<<LQ[L<=36E0!'
M%%'#$D42+'&BA511@*!T %>3?%WX>>&T\ ZCJFG:/:6-]9A94>UB6+<-P#!@
MN 1M)_$5Z[7'_%3_ ))?XA_Z]3_,4 ?(GA_3EUCQ+I>F.Q5;R\AMR1U =PO]
M:^T=$\(^'O#FTZ1HUG9R!/+\Z.(>8R\<%_O'H.IKX[\"?\E"\-?]A6U_]&K7
MV]0 5\0>%?%NJ>$/$$6KZ=,?-!Q+&Y)693U5O7^AYK[?KX5T?0-1U\WRZ; 9
MY+*U:[EC7[QC5E5MH[D;@<>@- 'V3X-\8:;XVT&/5-.8CG9/ Q^:%^ZG^A[B
MNAKXD\&>,M4\$ZZFI:;)E3A9[=C\DR?W3_0]J^P/"WBG3/%^APZKI4V^)^'C
M;[\3]T8=C_\ KH VZ*** *6HZ3IVLVRVVJ:?:WT"MO$5S"LBAL$9PPZ\GGWK
MPSXY_#_0-%\-VNMZ-I\5C,MRL,R0C:CJRM@[>@(*C\S7T!7F'Q]_Y)?/_P!?
M4/\ ,T <'\!/!6B:[8ZGJ^KZ=!?-%.L$*7"[T7C<QVG@DY7KZ5]"VMK;V5K'
M;6D$5O;Q+MCBB0(B#T ' %>/?LW?\B;JW_80_P#::5[/0!6O[H66G75V<8@B
M:0Y_V1FOD#X5Z!;^)_'D&FWJEX)K:X$AQG&8F4-]06!'N!7U)\0+K[%\//$,
M^<$:?,H/H60J/U-> ?L\6WG?$6XE(X@TZ1P<=RZ+_P"S&@#S/6-+N=$UF\TN
M\4+<6DS0R =,J<9'L>M?4_P5\7#Q-X&AM9Y-U_I86VE!/+)C]VWXJ,?537G?
M[0_A(VVJ6GBFVC_=78%O=$=I%'R-^*C'_ !ZUQ'PE\7#PCXZM9IY=EA=_P"B
MW63PJL>'/^ZV#],T ?8=%%% !1110!RWQ#\5+X/\$W^JAE%SM\JU4_Q2MPOY
M<M]%->!?![P6WB+^WM=O%,D-O:36\1;G?/)&P)R?13W[L*M_'CQ-)X@\96OA
MJPW2QZ>0A1.?,N'QQ[X&U?J6KWCP/X7B\(^#K#1@J&2./=<,O\<K<N??GCZ
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MBS#RWQC=@'!X/?- '@VD?LW7T]K'+JVOQ6DQ7+06]OYNWVW%EY_ _P!:TO\
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M_P E0\/?]?8_D:^SJ . ^*GQ#7P%H2&V5)=6O"5M8WY50/O.P]!G\R/>O+_
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MV]O7D=FNX1+M5795"A@0.%S^->&?$?\ Y*3XC_["$W_H1KZ?^#__ "2C0/\
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MP/T-=/110 4444 %%%% !1110 4444 %%%% !1110 5\@_&W_DKVN_\ ;O\
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MOJ/X3^)O^$I^'VGW,DF^[MA]EN>>=Z  $_5=K?C0!VU%%% ' ?&S_DD.N_\
M;O\ ^CXZ^>/@_P#\E7T#_KJ__HMZ^A_C9_R2'7?^W?\ ]'QU\\?!_P#Y*OH'
M_75__1;T ?8U%%% !1110!YA\??^27S_ /7U#_,UXA\$O^2O:%_V\?\ HB2O
M;_C[_P DOG_Z^H?YFO$/@E_R5[0O^WC_ -$24 ?7U%%% !7 ?&S_ ))#KO\
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M@ HHHH K75C:WK0&ZMHIC;RB>$R(&\N0 @,OH>3S[U9HHH ^6?VA?^2DQ?\
M8/B_]">O1_V<?^2>W_\ V%9/_145><?M"_\ )28O^P?%_P"A/5?X<^,_'7AS
MP_<6?ACPU_:ED]TTKS?89Y]LA1 5W1L!T53CKS0!]745X!_PM/XO?]"'_P"4
MB[_^+H_X6G\7O^A#_P#*1=__ != 'O\ 17@'_"T_B]_T(?\ Y2+O_P"+H_X6
MG\7O^A#_ /*1=_\ Q= 'E'Q'_P"2D^(_^PA-_P"A&OI_X/\ _)*- _ZY/_Z,
M>ODWQ'>WVH^)-2O=4MOLM_/<.\\'ELGEN3RNUN1]#7UE\'_^24:!_P!<G_\
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M3,EG.1_K(_?_ &AT/^!%?:-<I\0/!-IXY\-2Z=-MCNH\R6EP1_JI/_B3T/\
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MJ,C\: /N>N7^(_\ R3;Q'_V#YO\ T$UU%<O\1_\ DFWB/_L'S?\ H)H ^2?
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M\4J+)&ZE61AD,#U!%?+WQ;^$\WA2YEUO1XVET.5\N@Y-HQ/0_P"QZ'MT/8D
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M+35+&:QOK:*YMIEVR12KN5A5JB@#YF^)'P0N]#$VK>&5DN]-&7DM3\TMN/\
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M$C KJJ\N^,_BW2+7X>ZGIL6I6LFH7>R!+>.56?[X+$J.0-H;GUQ0!\Y>!/\
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MS\HU$D#W,:?X"O'/BMKUKXB^(^JWUE,L]H&2&&13E6"(%)![@L&-=_\ L_\
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M:K:Z?9V]I;KTB@C"*/P%6J** "J>I:3IVL6WV;4K"VO(,Y\NXB5USZX-7**
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M>S=1^!K7HH \\F^"'@":3>-&>//4)=RX_5JEL_@QX!LI!(NA+,X/!GGD<?\
M?);'Z5WU% %6PTZQTNU6UT^SM[2W7[L4$811^ JU110 5D2>%_#\TKRRZ%IC
MR.Q9G:TC)8GJ2<5KT4 9D?AS0X5VQ:-IZ+UPMJ@'\JB;PIX=9BS:!I98G))L
MX^?_ !VMBB@#-M/#^BV%RMQ9:186TZY DAMD1AZ\@55U#P;X:U;4&O\ 4-!T
MZZNWQOFFMU=FP,#.1SP .:W** .?_P"$%\'_ /0J:'_X+H?_ (FGVG@OPO8:
MA'?6?A[2[>ZB.8Y8;5$*'U&!Q6[10 4444 %4]1TK3M7MQ;ZE86M["&W".YA
M61<^N&!JY10!SK^ O![J5/A71<'TL(@?S"U$/AUX,5@1X7TGCUM5/]*Z>B@#
MG(_ '@Z/.WPKHIR<_-8QM_-:>? WA$X!\+:(<<#_ (E\7'_CM=!10!SDG@#P
M=*H#>%=& _V+&-?Y"HO^%<>"_P#H5]*_\!EKJ** .2B^&/@B%]R>&=.)_P!N
M+</R-=,UG;26+636\36C1^48"@V%,8V[>F,<8J>B@#FX_A_X.B!"^%M&.?[]
ME&W\Q4G_  @O@_\ Z%30_P#P70__ !-=!10!@6?@CPMIU_'>V7A[3+>YC;<D
ML=LJLA]1QQ6_110 UE5U*L 01@@]ZYV/X?\ @Z,MM\+:,=W7=91M_,<5TE%
M'/\ _""^#_\ H5-#_P#!=#_\33;;P+X4L[V*\MO#FEPW$3B2.2.U0%&!R"..
M"#7144 8VM>$_#_B-?\ B;Z/9WCXP))(AO ]F^\/SKE9?@AX E?<-&>/_92[
MEQ^K5Z'10!P%K\%? -K('&A^:P.1YUS*P_+=BNQTO1]-T6U^S:786UG!G/EV
M\00$^IQU-7J* "BBB@ HHHH R]5\.:)KHQJND65[@8#3P*[#Z$C(KE;KX+^
M;HECH*QL>\5S*F/P#8_2N^HH \X_X45X!_Z!<_\ X%R?_%5<M/@YX"LV#)X>
MB=AWFGEDS^#,17=T4 4=-TC3='@\C3-/M;*$]4MXEC!^N!46K^'](U^../5]
M,M;Y(B6C%Q$'VGOC/2M.B@#GE\!^#U4#_A%=$X]=/B/_ ++22> ?!TB;6\*Z
M*!_LV,:G\PM=%10!G:3H6DZ# \.DZ=:V4<C;G6WB"!CZG%:-%% !6/JOA;0-
M=NH[G5=&L;V>-=BR7$"N0N<[<GMDGCW-;%% '/\ _""^#_\ H5-#_P#!=#_\
M34<GP_\ !TH ;PMHPQ_<LHU_D*Z2B@#$E\(>')]+@TN70M/>PMV+Q0-;KL1C
MU(&."<U$O@7PBA!7PMH@(Z'^SXL_^@UT%% '/_\ ""^#_P#H5-#_ /!=#_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !12>U% "T444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1124 +1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
80 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0W!K\# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M* "BBB@ I,4M% !1110 F**,T4"%S29HHH 6DI:0T %%%+0,****0"44M)0
MN:3-%% !10:2J(8M+24"DRD+1125(PHQ2T4 '2C-!I*H!<TE%% !UHHI:5AB
M44446)N%%%%.P7"BBB@+A2TE% 7%HQ110 E%+12&)12T4@$HHHIC"BBEH **
M**!"4444K@%%+15)BL)12T&@ S124HI,84444@"BBB@ HHHI@%)2T4 %%%%
M!1113$%%%% !1110 4E%% !1113$%+24M(84444#"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M44450@I<4E+0 E%*:2@!:*3-+0 4449H *:33J0B@!N:<*3%**  BC%+29H
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M%+3:7-;6(;'9HI*6@ HHHI#"BBBD 4444 %%%(: %H-)12 :12#K3\4F*I
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M0M+3<TM )BT445)0AHI:*8!1110 4444 %%%% !1110 4444 %%%% !1110
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M3YS7KPG='CN-F%%)FC-:W%8*6@"EI@%%%(:!!F@&DI:0Q:**:34@!-(1FBG
M4KC&@8J&YE"J:DE<(*P]1O0JD9K*I4LC6E#F9FZK>[<\UQM]=EV/-:&J7A8G
MFN>E<LU>)7J'OX>E8BDRYS3 A!JRBY%/V"O,G-GJP@B%5-*P(%2X ICGBH3;
M+:2*Y!)J:WM6D8<4L4>YZZ'3++<1Q772BV<56:1-I6G'*G%=KI]OY:CBJVGV
M(51Q6W'&$6O:H0=CP<353=D([;5K+NGSFM"<\5ES'DUU2V.2FKLSI$+-2"+
MJS@$TK*-M<<GJ=\49<[;:KI)N:IKT8)JI!DN*293B:D,>X5(T>TU8M(\H*6X
M4"MDS*2"U;#"MVV.0*YZ!L.*W;1N!6T6<LT7^U)2@\45LCF"EI*!6B =124M
M4(2BEI*!!24M)3)"EI*6@$+1112+"BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1112 ****8!1FDHH 7-%)147 ,T445:$PHI*6F*X4N:2B@8M%%)2
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MB\TV-<FK   KRYRN>M3C8>H %(U-W4A-8V-KB&F9Q2EJ -U:QC<QE*PFXTX
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M(:2@+#LT4@I: %%%%)3 7-)113 *444M @HHHH **** "BBB@ HHHH ****
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M*ZJV@"J.*IV5L$ XK508%>W0IV/GJ]2[#&*6@BDKM2.00TE+2@58@%.I!2T
M(:;3Z;BD "EI** %H%%+0 4E+10 V@4N**8!12&DS0 ZEIN:6@ I:** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW%)@A:6D%.J0"EI**:)%I***L0E%+13&A*6BB@8HHH%%2Q"4445+&)24ZDH
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MAJWI/4QJK0[/2+C&.:[2RFR@YKS?39]I'-=GIMUD#FO=P\SY[%0.F4Y%.JO
M^X"IZ]-.YY#5F)2T44P#-!IN:&; I-A8HWDFU37)ZG==>:Z#4I<*>:XC5+CY
MCS7D8F1[&#B9EY+O8UFL,M4TDFYJ9C->-.1[\(BIQ3R>*8.*"U0C1HC?K5JS
MCW.*K8W&M;3H<L.*ZZ4+G'5G9'2:3;Y XKJ[6':!Q6/I4&%'%='$F%%>O0IV
M/"Q-6^A*O I3245Z4=CS&**6D%+5B"BEI*0PHHHIC"BEI*0@HHI*:)8M%)2]
MJ8@HHHI%!24&BDR@Q28IU&*0""HI1D5-4,IP#6538J.YC7T((/%<AJD(7-=?
M?3  \UR&J3!B:\3$'O8.]CF+CAS4<9J2XY8TV-:\R1[,=B9:7--Z4F:S9HA2
M:2BDJ+C&GDUI6$>YA6=WK4T]@&%=%/<PJ_"=AI5N,#BNE@B"J*Y_2I1@5T43
M@J*]K#I'S.*;N3#BG4P<U(*]>&QY[$Q2TM%62%!I:0T( HI*2@0^BD%+2N,*
M2BEI@-I10:*8A:***0!1110 4444 %%%% !1110,**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,4E+12 2BBBF,*!1
M0*!"TE+24"84444Q!0:**!@*6DHS2&(:3-*:0T,!U,D.!2@U%.V$-83=D6EJ
M9][/M4\UR.JW6<\UL:I<[0W-<=?W.YCS7E5YGKX6F95VY9C4,8YI[_,:5%P:
M\:I*[/>I1LB51Q3'X%2 \5%)TK!;F[(LY-7;2'>PJD@RU;VF0;F'%=]"-SAK
M2L;6EVN,<5U]E'M45DZ=;84<5OPIM KW:$-#P,3.[)^U(.M.QQ0!7<D>?< *
M6CM2=Z;(%I&.!3J@N7V(:I"9EZK=".)N:\PU[6-DC#=76^(K_9$_->+^(]3)
MF;YJZ8Q,FSJM+UK?.!N[UZMX>O!+$O-?-^C:@WVA>>]>U^$]0S&G-$H%Q9Z5
M3>]0P3!U'-3US;&@W-+332@T"N.HHHI6"Y!<)E#7):M;YW<5V,HRM86H0;@>
M*X,1"YW8:5F><WT&UCQ6:WRFNGU.VP3Q7-SKM8UX56&I])1GH-4YJ8#BH(^M
M61TKD:L=B=R&0<5'$Q#U++TJ!>&K2$K&-2-SJM(GP1S7;6,^4'->;Z?-L8<U
MV&F760HS7J4*FIY&(I:'6(V14HJI:ON45<[5[--W1X<U9V"EIM.K8@****!"
M&F]Z<:;WH92''I6=>_=-:)Z5FWO0USU'H:4]SD]3[UREW]XUU>I]ZY2[^\:\
M7$'OX4H]ZF6H>]3+TKQY[GM0V!NE1?Q5*U1?Q4H;A/8VM+^^M=WI7W5KA-+^
M\*[O2?NK7NX4^>QAT"?=I],3[M.KVH['A,**#2"F M+24M4A,2BEI*8@HHHH
M*"@44M( I*6DIDA1113$%+112&%)124#"EIM.[5G(91OONFN+U;J:[.^^Z:X
MS5NK5YU<[\-N<K<_>-5>]6;G[YJMWKQ*R/HJ#T'KTH-"T&N2VIW7T$'6M?3O
MO"LA>M:^G?>%=U!:G'B-CM])/"UTD?W!7-Z2/E6NDC^X*^BP^Q\KB?B'TAI:
M;76<C$(H%+14M"0C#(JA=P[E/%:%1RIE36,XW1M3E9G"ZM;XW<5Q]XFUS7HF
MKP9#<5PVHPX<\5XF)B?0X2=S+0X-39XJ'&TTX&O)DCV8O05AFF!<&I0,T$8%
M5#1D3U+%K+L8<UU6E7.<<UQ2OM:M[2KCYEYKU:$SR,1"YZ/8R[E%:&>*PM,F
MR@YK:5LBO7ISNCPJL+,=FBDH%;W,K :@EDPM3OP*R[R?:#S7/4E9&M.-V96J
MS_*>:X?49<N:Z#4[K.>:Y6[DW,:\6O.Y[V&A8J@Y:IE'%0J.:G7I7F29Z\!K
M<5$3S4DAXJ$<M500Y;%J"/<PKH],MN1Q63I\.YA78:;:X XKU:$#R,3.R-G3
MXMJBMA1A:IVT>T"KG:O8A&R/ J.["EQ24X5NC%ABEHHIB"DI:2F 4444P%H-
M%)0(*2EHIDB4M%% T%)3J2D4)12XI#4L89HS3,T[-1<=AU4KR4*IJ>23:#6'
MJ5WA3S7/5G9&U&%V9&IWN,\UREW=;V/-6M4NR6/-8+2%FKPZ\[L^DPU.R)&^
M8TJKBA.13JX&ST4A#3:?BDQ4-E(0"EQ12]J2 B;@U9M9MC#FJ[C-,#%36\'8
MQGJCLM,O@,<UUEE=!U'->8V5V58<UV.E7F[;S7JX>H>-BJ/4[*,Y%.)Q5:VE
M#**L'FO9IRT/$DK,<#3LU&*=FM;D,?FBFYI<TQ"&DIU)1<5@%*:*#4C$I<TE
M+FJ 6C%%%,D**** "BBB@ HHHH ****!A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE( H%% I@
M+24M)0(****!!2TE% PI*":2@H6D-+2D4F!&3BJ=Y+A#S5B5MHK%O[C"GFN&
MM.R.JC#F9SVL7'+<UR5S+N<UMZK-N+<USDAR]>-6G<][#T[$BC-.QBDCI[=*
M\^1ZD59#2V*8QS37-"?,:F*U%-DUO'N<5U>DV_*\5AV-ON8<5V6E6^ .*]7#
M1/(Q4[(W;*'"#BM!5Q4=NF$%3U]!3C9'S]25V%%%!-:F04G>BEH:$+69JLWE
MQ'FM%F"J37+>(+T+&W-7!79,V<%XIU' <;J\?UBY,DS<]Z[7Q/?;F<9KSRY8
MR2FO2IQT.64B?39=DP.:]6\+:EMV#=7D<(V,#78>'[XI(HS1..A<9'T)I%WY
MJ+S70#H*X#PQ?;T3FN]B8-&#7GU%9G0G<&I!3F%(!69+W%%+2"EI%(:_2J-S
M%N4\5>-1R)E36%171O"7*SB]6MN&XKC;V+:YKT;5(,JW%<3J5OACQ7CUJ9[F
M'JW,1.#4V>*C9=K4!J\JHK'L4W<5N:CVU*!FAA62>IJT+#+L85TNE77*\UR6
M[#5L:9-AAS7=0EJ>?B(71Z7ITNY16J#D5S.E7'RCFN@BDW**]ZC/0^<KPLR:
MG"FBG5V)G*PHHHIB$--IQIO>I92%/2LZ]^Z:T3TK.O?NFN>H:4]SD]3[UREW
M]XUU>I]ZY2[^\:\;$'OX;8H]ZE7I47>I5Z5Y,SV8; >E1_Q5(>E1C[U3#<<]
MC:TO[PKN]*^ZM<)I?WA7=Z5]U:]S"GSV,.@3[M.IJ?=IU>U'8\-[@:2E- IB
M 4M(*6K0@I*6DI@%%%% PI:!10(****!!1110,*#244A@:2E-)2 2E[4E+VJ
M&-E&^^X:XS5NK5V=]]PUQFJ]6KAK'=AMSE+G[QJKWJU<_>-5N]>+6/?HL<*#
M0.E!KDZG:A%ZUL:=]\5CCK6QIWWQ791W.:O\)W&D_=6ND3[HKG-)Z"NC3[HK
MZ'#['RV(^(<:::=3374<C$I<TTT T"'"AAD&@4'I4R6A2,34HMRM7%ZG;<GB
MO0;J/<#7+ZG;<'BO)Q$#V<'.QPDZ;6-0@\UI7T.UCQ69C#5XU2-CWH3NB=:'
MZ4(>*&Z5ALS1ZE9CAJU-.EVL*S67FK-LVUA773G8YJD+G?Z5<<#FND@DW**X
M/3+K!'-=?83;E'->QAYW/#Q5.QK@<4=Z5>5I&.*]!O0\P9,V%-<UJEQM!YK<
MNI<(:X_5[C[W->?7F=F'AJ8.H7.6/-8[MN-37<F7-5TYKQZLKGOT8Z"J*DS@
M4F*:QQ7(SMB(YIL2Y>D/-6K6+<XK:G'4BI+0W=)@R1Q7;:?!A!Q7-:1!C;Q7
M9V2805[N&@?/XNH643 J3M1C%%>FD>3>XE.I*6@3%HHHIB"BBBF 4444Q!24
MM% "44N** $I:**!A124M  :C:G$TWK4LI#.]*6P*",56GF"J:YIRL:17,RM
M>W.Q3S7):G?9R,UHZK>8#<UQE]=%G/->96JGK8>C8@NY?,8U2"\U*#N-/V5Y
M525SW*4;")Q3J;THS7.;CLT%J:<FFX-.Q-QV:44P TX4["N+MJ)UQ5@4QUS3
M0F01.5>NCTN[VE>:YTK@U:M9_+8<UV49V..K"YZ9I]X&4<UM1/N%<#I=]]T9
MKL+"X#J.:]FC4T/!Q%.S-3'%'>@-D4N*[XNYP"44[%(15L04M-I147 6BBEI
MB$-)2FDJD M+244Q"T444 %%%% PHHHH **** "BBB@ HHHH **** "BBB@
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MGH9][<B-#S7G?B74OE<;JZC7KORD;FO)?$6IY9ANKII1,)LY/7;HR2-SWKG
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M_2EH3]J@EJ;-1N,UG$V;&0'#UTVES[2O-<T@P:T[.;81S7?1G8XJT+GHUA=
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M02#-,CRK9K:G*S,:L+H[O2+S[O-=?:W 9!S7E^GW9C8<UV.FW^X 9KVL/5/
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M.)HI!2YQ31#(I*2!<N*<W-6+2'+BMX1N<M25D;VDP;BO%=E8V^U1Q6!H]O\
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4 %%%% "44W-.IBL&***0FI8Q<T4S-*#20#J3%+15"L-HIQ%)BF*PHHHI#0
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MX&DI:*"K@****!A1112$)0***0Q:6DI:8@HHHH **** "BBB@ HHHH ****
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ME_[-=6+(#M2_8QZ5SO#E_6SE5TO_ &:F73!_=KI1:#TI?LH':FL.'ULY]=-
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M(8444AH&+124HH8Q:***!"4HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BBB@
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M5N^'=/615XKT*PT1&C&5KGJRL5!7/)&\*'^Y^E,_X10_W/TKVLZ#%C[HIO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !110: $HHHH **** %I*4TE
M @HHI*9(M%)10%Q:6DI>U(I"&D%*:*3104"BE%)""L+6?N-6[6'K(^1JTCN1
M(\I\1]7KSC4OOFO2?$8Y>O--3/SM7HTF<DS&?[U&[;0>6I70[:Z^A@7=/NRD
MHYKU3PI?\IDUXW Q205W?AO4/+=.:YJBN:19]#:5<AX%YK4SD5POA_4PZ*-U
M=G;2^8HYKSZD;,[8,E-)3B*0"LC5BBH[B0)&233W;:N:PM5OQ'$PS5Q5V8R=
MD<EXJO0%?!KQK6[PM*W-=YXIU+=O&ZO*]2F+S'FO1@K'))D!??4##YJDC!(H
M9>:W,F7;#[XKT'P]]Y:\^L>'%>@>'3\RUG/8<=SUC0ON+76I]P5R6A?<6NM3
M[@KS:FYWTQU(WW32TAZ&LC4Y_5A\C?2O*?%(^_7K&K?<:O)_%)X>MZ;,9GEF
MH?ZX_6K^AG]\M9^H_P"N-7M$_P!<M>C'8XY;GLOA=AM2O3K$@P#%>6>&/NI7
MIVFG]T/I7%7.BD7Z**::Y#J'44W-&:=AV'44W-+FD(6BDS2$T *330>:0TJB
MF)BMTK'U(_(U;#=*Q=2X1JJ)G(\R\5?=>O(-7_US?6O7?%)^5Z\BU;_7-]:[
M:9A(=HQ_?K7L?A4C"5XUI'$ZUZ_X6/"5I4>@HH];TT@P#%7JS-*)\H?2M,UY
MLMSJCL%%1\YIPS2L5<& (K,OK!9E/%:=*5!%5&3B0X\QY5XDT0;7(6O(=?T_
MR7; KZ0\06RM"QQVKQ/Q7:A6?BNV$[HY&K'F,9,<_P"->A^%;HATYKS^X79<
M?C75>&Y]LB<]ZN6HXGT'X<N=T2\UUB'*BO._#%SF-.:[VV?<@KCJ1.F#+-%%
M%8&IF:J?W+5Y!XM_CKUW5?\ 4M7D7BS^.NJ&QA(\AU7_ %Q^M7-!_P!<OUJI
MJH_?'ZU<T(?O5^M:W,CVGPD>$KU*S/[A:\L\)]$KU&R_U*UA4V-(/4LFBEH/
M2N<Z"K<2[%-<'XGO?W;\UU^HR[4:O,O$]R=K\UTTXF4F>8>)+@O(W-<G!&7N
M/QK>UF3?*U4-/BW3CCO6^QBSLO#6G>8R<5[%X>TE0BG;7 ^%+893BO8]%A"P
M X[5E.=AJ)>MK=8E'%6:*:3BN5NYTI6'45'N-.!H"Y6NK594/%<'XET<%'(6
MO1ZR=6LQ-$>.U:0FTS*<3YG\2Z6R,^%KAS!+'<=#UKZ#\0>'?.+82N%G\)-Y
MQ/EUVJ5T8V,[PO+*DB9S7N'AFY;RTR>U><:1X>>%U^2O2=#M&A51BL)LW@CM
M('W**L#I52V&%%6ATKE9L!I*4TE*PA:6FXIDC[%H$4=5G"0-S7D/BN_P7&:]
M#U^]"Q-S7BOBF_W2.,]ZZZ2,9LY:_N#)*>>]0QVQE[575C+/^-=7I.GF51\M
M=T6<LC"_LY@,XJM)"8GKT)]&Q%G;VKE=7L_))XIMD(LZ!=[)E&>]>T^%[X%$
MYKY\L+@Q7 Y[UZQX4U'A!NKEJ*YT0/989 Z U*:R=-N?,C7FM8<BN&2LSJBQ
M,44XTTU)84X4VE'2@0V;_5-]*\[\4CY7KT2;_5-]*\\\4_=>MJ6YC4/$O$8_
M>O7.V?\ KQ]:Z/Q)_K7KG+3_ %X^M>HEH<CW/3?"A^9*]CT7_5+7C?A3JE>R
M:+_JEKCJF\#HDZ4ZFITIU<3-T(*=313J&4A#10:*0PI:2EI %%%%( HHHI@%
M%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *#110 E%+10 E%%% "TE%+0*PE%%%*X6$I:**=
MQ6"EI**!V"BBB@84"D-(#S0#'UB:Q]QJVZQ=7_U;54=R)'E?B4??KR_5#^\-
M>H^)OXZ\KU,_OC]:]"D<LRC$FYJO_9"4Z5'81;W%=-#8;H^E=:,6CD9+?8V<
M5>TZZ,,@Y[U?O[ J"<5@MF*7\:B2!'K?AG5"2@W5ZSHUQYL:\]J^>?#=_MD3
MGO7M?AF^#1IS7GU8G739VE&*:C!E!%.KE.@JWTFR(FO._$>I^6K#=7::U<B.
M%N:\=\4ZC\SC=713B<\V<IKFHF1V&:YAE,KU/>3F68\U:L+,R$<5V19BT0PV
MAV]*AG@VGI76Q:;B+[M8VIV_EYXK5,AQ,RT.)!7?^'3EDKSV XF'UKT#PT<L
ME1/8(Q/7-!^XM=:GW!7)Z"/D6NL3[@KS:FYV4Q>]!Z&CO0WW369J8&K_ '&K
MR?Q5_'7K.K_ZMJ\G\5#AZZ*2U,9GE6H']^?K5_0_]<M9^HC$S?6KNBN%F6O2
MA'0XI;GLGAD?*E>F:;_JQ7E/AN[5%3)KT?3M1C"#YA7-7@^AM2E8WZ0BJ9U&
M+'WA49U./^\*XE3D=7.B_BC%9W]IQ_WA2_VG'_>%/V<A\Z-'%%9W]J1?WA2C
M4HVZ,*7LY!S(T*::K+=*_0U.K;J7*T4F+3Q330*D!QZ5B:I]QJVST-8NJ?<:
MG$B2/+/%/1Z\FU4?OF^M>M>*!P]>4:H/WK?6NZF<\ANDC]^OUKUSPOT2O)=)
M'[X5ZSX7Z)6LUH3$]7TG_5CZ5J5E:1_JQ]*U:\R6YUQV$(I,T,:834E6'YIW
M:HUZU)3$C$UOF$CVKQSQ7%G?Q7LNLC]VU>1>*5^_7129SRB>0WZ8N#]:U]!;
M$J_6L[4E_?GZU?T/_7+]:Z;F=CVGPO(=B5Z-9-E!7F?A<_(E>DV/W!7/4-X&
MF**!THKE-C+U7_4M7D/BS^.O7=5/[EJ\A\6G[]==-:&$SR35/]>?K5[0O]:O
MUK/U3_7'ZU?T$_O5^M:6,3V?PIT2O4++_4BO+_"G1*]0LO\ 4BL*FQI#<M4C
M=#2TAZ&N<Z3!U4_(U>6>*&.'KU/5A\C5Y5XI'#5VTD<\V>5ZF<RFGZ2FZ=?K
M46I?ZX_6K>B#,R_6M9$(]5\+18"<5ZQI/$('M7F/AA?E2O3],XC'TKCJ&T4:
M-,:GGI49ZUB:B4\4 4N*5Q!3)$#C%/HIIB>IDW.E)-U45FR>'8V.=@_*NHQ1
M@5JJC1/(<Q%H*1G[@K3M[(18P*TRH]*3:*3G<M*PR-=HJ6D I:SN4% HH%,0
MM4+^3RT-7ZPM<GV1MS3B1)V.'\3ZAM1QNKQG7KOS)FY[UWWBJ_\ OC->5WTI
MEN#SWKKAH<\F6-+A\V<?6O5?#FF;T7Y:\_\ #MKOE7BO;/"]@/+7BM^:QDT+
M-I %O]WM7G/BBP\O?Q7NL]F/LYX[5Y;XPL^'XJ%4N/E/&)',5S^-=UX6O\,@
MS7$:I$8[@_6M7P]=;)5&:):EK0^AM N]Z+S781',8->8>%[S<J<UZ5:/OA%<
M=2)O%E@]*;2GI3:R-1:=313J &2_ZIOI7GGBG[KUZ'-_JF^E>=>*?NO6]'<Q
MJ'BOB3_6/7-VG^O%='XC_P!8U<[9_P"O'UKU%L<CW/3?"G5*]CT7_5+7CGA3
M[R5['HO^J6N*J;0.B3H*=34Z4ZN)G0AHZT\4RG"AC0&B@T4B@I:2EI, HHHI
M %%%%, HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?BG[KUZ+-_JF^E>=^*1\KUO1W,JAXGXC_P!8]<[9_P"O'UKH_$G^L>N;M/\
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M "4M)2T@"DI:2F M%)0* %HHHH **** "BBB@ HI**0"T444 %%%% !1110
M44E%,!:*2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10 E%%%(84444Q!0**6@ HHHH **** "BBB@!****0"T4E+F@ HHHH ****
M$HHHI@%+24M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHHK,U"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %!HH- "4444
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M/+&MIL]#6WHD,PF7.:[1O"9S_J_TJ_IWADQR [/TJ920['3^$58*F:].M_\
M4K]*XS0=/\@+Q7:1<1@5S3-(K4DHHHK,U"BBBD 4444 %%%%, HHHH ****
M"BBB@ HHHH **** "BBB@!,48I:* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@04444 %%%% !1110,****0!1110 4444 %%%%, HHHH ****!!1110
M 4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5H4E+F8<HQ4"C IV:6D(I#L)FG"FXI:!H4U6E@$G:K!I104S(ET=)>JBJ_\
MPCL><[170447)Y3%BT2.,_=%7H[18P,"KE(2*+ARC ,4ZBEQ0,3%&*6B@=PH
MI,TH-2PN&*"*6DH 8R;A52:P67J*OT528FC!DT&-S]T4U/#\:G.T5T%%/F9/
M*9L.FK%T%7D78N*DI#2N4D-JO+:"7J*LXIU V8TFBHYY45%_8$?]T5O44^9D
M\I@_V!'_ '12_P!@Q_W16[11S,.4P?[ C_NBC^P8_P"Z*WJ*.9BY3"_L&/\
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MEI,0 4M)1FD(4TVEHI@%+244P%II-+FD- "9IPIN*6@!U)110 4444 %%%%
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M4AIV*2@FPVEQ2XHQ2*044M!I@)24M%,0E+110(***2I8T+FBDI:DH!1115H
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MEHHI@+2444!8***6@0E%% H&+BFFG4E(!*6BBF 4AHI:8A,4"EI* %%!HHI
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M !1110 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7,2XHS2U3N[@1*>:5KC;L66E1!R:J2ZC$G<5S.IZZ(@?FKCM0\4E2</^M:*
MN8],;6(L_>'YU+%JT3?Q"O%6\5ON^_5JV\5-D9?]:;@',>VQW<4@X85,&!Z&
MO+]-\3[R 7_6NPT[51.!\U0X#YCH::QQ0C!E!%1W+;(B:D8C7*J>32"\B/\
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MJ]BJ=HNU15VH92&FDI31B@ %+BD%.I )BEHHH&%%%%( HHHH **** "BBBF
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MABZ,D:Y-;FK$FV)'I7+>$V^1:[6[M_-M3QVK+J)L\7\03R1SMR>M5-(U1TF
M+5T7B?2R'<[:X=0;>X_&NR*T,&SV?P_J/F*G-=W:2;H@:\<\+WN609KU?3I<
MVX/M7)51K!DVIW CMVYKR#Q9JA5F :O1-?O=D+#->,^))S-*PSWJ8HT;,>#4
M))+G&3UKT[PKOD"$UYEI5F9+D''>O9O"5AMC3BJ>@([&R0A!6@.E1QQ;!BI#
MQ6#=S5!2GI2 T'I2!F)JOW&KS+Q(.&KT[4^4:O-?$8X:NB!C(\VN)-EQ^-=5
MX;U<0.N6KC=3;;*:AL;YXW&#70U=&+/HO3_%""W4%A5IO%,8'WA7B=KK$HC
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M 8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:*3=R;6'2E2,&LJZM8I<Y J.]OO*!YKGY_$ C?!:A-HEHNSZ!#,?NBH5\+Q
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ML,J:U31-C!M[*2XF!(-=]X<T0Y4E:M:3X<&5)3]*[[2=(6$#Y:SE(TBA^F6
MB0<5K2'RXZE2((,5!>CY#BL+E,Y#Q!=$(V#7D^N74C2, 37JFM0-(&XKA+W1
M6EE/RU:9DSB;>VDN)AD'K7?^'=%)VDK3]*\.?O%)3]*]#T?2%B1?EJU($BSH
M]EY"+Q70@\"H(X1&!Q4HK)NYLD.--Q3J,5 Q*=244@%I***: **** "EI*,T
M"%HI,T9H&+129I: "BBC- !1245("T4E+FF@#%-Q2YHI@)2@T44QBT4E+2$&
M**** #-)FBC%,8E+110(*2EI*0"T9I,T9H&+FBBBD(*6DHIV ,TM)FB@!<"C
M%%% "4M)2T""DI:2@849HHH&&:**6D 8I,4M)3$PHQ11F@0$4E.HQ0,2EHHH
M 0TE+12$ I:2C-,8M%&:3- "U6N!\IJQFHI%W"F2SD-;+!6Q7F^K7,L<K<FO
M6M4M/,5N*\_UG1RQ8A:I,@Y:UUB2)^6-:_\ PD#^7C=^M8EQI<D;G"FH?LDO
M3!K5) 3W^JR3Y )K&^QRW,N2":W+72GE894UU6E>'=Q!*?I5Z"9C^'M"8.I*
MUZUH5D(8UXJIIFB+$H.VNC@A$2XK*3!$X %(:7-(:Q-D,IPHQ2TBA:6FT9H$
M.I*,T9H%8,449HS3$%%&:,TPL&*7%%&:0!1244#L+129I<T %)2T4@"BBBD
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M*8@HHHH *2EI,4QA2TG>EH ****0@I:2EI %%)12L M&***H HHHH 2BBB@
MHHHH **6@T@$HHHI %%%%4 4444QA1112 ****D Q12TE-""BBBJ&+1112$%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% "44M%2 4444T 4444P"BBBD 4444P"DI:*!"
M448HQ0 "E-)10,**** "BBB@!:2BB@04M%% !1110,*2BB@ HHHH *6DI:3
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MHHH&%%)2T@"DI:2@!:*2EI@)12T4 )10:*8PI:2E%(04444 )1113)"BBB@
MI:2BD,**6DH&%%%% "T444 )12TE A:*2B@!:2EHH&)12TE "T444@"BBBF
ME%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !12446 6C-)10 N:,TE% "YH
MS244 +FC-)10 N:,TE% "YHS244 %%% H ,48I:*5P$HI324 %+24M !1124
MF M!I!2FA )1115 %%%% !BEHHI, HHHHL E%+0:8"4444 %%%% !1110 44
M44 %)FEI#0 4HIM.% A:*3-&:!A2XI*6@!II,4ZBF(3%+2TE*X[!124M(88H
MQ113 ***6@0E%+24@"BBE- "4E+1188"EI*7-(0449HHN 44E%,!:**0T7 6
MB@44Q!1110 4444#"BBBE8 HHHHL 44446 ****+ %%%%, HHHH 3%+BBB@
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MHHHI %+24M PHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% @I***!A1114@%%%%,!
M:***8@HHHH ****!@:2BBD 4444T)A2T44 %%%% PHHHH ****0"4445("T4
M44T 4444P"BBBF 4444 %%%%( HHHI@%%%% !1110 4PT44 (#3Q112 4TE%
M%,!:::**8F**6BBD"$-(:**12$%.%%%(&%%%%4B6)1113$+2T45+*"CO110@
M"BBBF(2BBB@84M%%(8AHHHH$+1110 4444Q!1110 4445(P[T4450@I*** "
MBBB@8M%%% !2444 %%%% !1112$ I:**8Q*4444 %%%% !1110 4444F 444
M4@$HHHJ@"EHHH$!I!112&+1110 4444Q!1110 4444#"DHHH$%':BB@!#244
M4P%%****AC%HHHIH!#2444, IPHHI#$-%%% A:2BBF,****H HHHH *6BBD(
M2BBB@04444@"EHHI@%)110,****!@*4T44A"4444@"E%%%- )1113 ****8P
MHHHH 6DHHI$L****8A:0T44AA1113*"BBB@ HHHJ20HHHI %+113&%%%%, H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex99-2_001.jpg
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !? )@# 2(  A$! Q$!_\0
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M\TPF5Y7AOKF:XUVRV*2]YR^ZUK-^BN^I]DL$(7:%VX&=V2#CD>@[G/J<U5E
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MVUH?#^JD C(U'1#9EK_Y<ZK:ZA@G'&7_ ,%0_%6K^&_V6_$UEI,TEN/%>O\
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M]Q/!_A#2_!O@O0?!FBVD=II'A[1]/T/3K/(Q#I^E6EK9V=L!W'V&VQG.,#H
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MQWE?!>0\2_V=ALQ?&&=065Y9FCY5EN596T_[2>76_>+,YM-*5K)+2_*?&O\
MP4%_95M/B[\*$\2^"-)23XC?#/3KC4M!LK2VW3^)/#UM;EM5\'?93_Q^9LK7
M^T-)7HNJ68"@)J6I;O.?^"8'[40\=>#_ /A1?B^^$OBKP'I<$O@R\N) )]8^
M']K]DM+:U)O.M[X.-W:6!&#G2[S03][^TR/UY>*-YMCI'B10#C[YQQZD[1U
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M]=RW%S]@\.Z'IUI]N\0^(-5N[N[O?]!L+ FZU+5;_4&73%!RQ'(KGM5_:?\
MV<-$^%&B_'K7/CI\(]+^"GB&2P_L#XMZC\0O"UC\-M976;N[L=*&D^-;N_3P
M_?'4;VSNK'2C8:DPU(VS"-G'RU_+]\6_VR_C-^T'^PEX-_X)BSZQ_9/[<%[\
M0/BM^RK^U3J%Q,T\WAOX,?LF>&+WQC\3?C)="ROS?WFA_&;X=:7X3T_2=1U
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M;WK;)T\OPU.K[6EB;=-_7IZ_\ Z2DX8>WZ@_X_YZ5Y/\-/BGX$^,GA^3Q?\
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M6P_^T/W=M-^OS_S/YW#_ ,$]?&OQ+\4>%=-^.GP!TCQYX&T,_P#!9?6/[/\
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*KS3U0HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>apyx-20241104.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa+F2bP9z5Z8GekhvWB6bWkaHyooHCdXyCiqRe6GcY0D -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:APYX="http://apyxmedical.com/20241104" elementFormDefault="qualified" targetNamespace="http://apyxmedical.com/20241104">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://apyxmedical.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="apyx-20241104_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="apyx-20241104_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>apyx-20241104_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>apyx-20241104_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://apyxmedical.com/role/Cover" xlink:href="apyx-20241104.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://apyxmedical.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45721892000336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 04, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  04,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">APYX
MEDICAL CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000719135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2644611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5115
Ulmerton Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Clearwater<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(727)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">384-2323<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class
    A common stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">APYX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3),
MZ)Q17B@%JXUF X?)8Q1\V .7\@%:^*VZBMU7)/3B4PEM(+#52?2$1C&$"0K$
MOXP68E^$O?VML*01C\9][/QN]*!_[XSC]Y97HA_TOIKS8]$7>'36-/+T08I:
M*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#S
MGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[
MBK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1
MS;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG
M_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P
M%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/
MK O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8*<D3?,\C@ 6
M9Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( *0[:%F7
MBKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E
M\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!
M2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/
M06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3
MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M/UY_ 5!+ 0(4 Q0    ( *0[:%D'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ I#MH66XNX6#O
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ I#MH69E<G",0!@  G"<  !,              ( !S0$  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " "D.VA9YQP/D$D$  !T$   &
M            @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ I#MH69^@&_"Q @  X@P   T              ( !C0P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " "D.VA9EXJ[',     3 @  "P
M    @ %I#P  7W)E;',O+G)E;'-02P$"% ,4    " "D.VA9JL0B%C,!   B
M @  #P              @ %2$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ I#MH620>FZ*M    ^ $  !H              ( !LA$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ I#MH6660>9(9 0  SP,
M !,              ( !EQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  X1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://apyxmedical.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>apyx-20241104.xsd</File>
    <File>apyx-20241104_lab.xml</File>
    <File>apyx-20241104_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>form8-k_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "APYX",
   "nsuri": "http://apyxmedical.com/20241104",
   "dts": {
    "schema": {
     "local": [
      "apyx-20241104.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "apyx-20241104_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "apyx-20241104_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://apyxmedical.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-11-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-11-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://apyxmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001493152-24-044154-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-044154-xbrl.zip
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M&AZ-Y5.#AE'>=O]I>LUTR*5.%=WV876F[16T?MD/F8.9<X6U',[)&Z7L970
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ME'84&5QZ^>>6"=KT=46A.7B,"*\#/#)?"?;6R["WX-A1\M!2F:\$^\G+L)_
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MSTZ[YW^2H?5#_^/%V_\'4$L#!!0    ( *0[:%FA+NZ0PYT   \:!  *
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MW#TSJ=CC-C[PQXJ=\@/_S:K0.SKI[UU>DT/P#LSUJM16?K-$0>K+!1P08L*
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MUTZQHF0CGC;H+#B@,%8*G\'=00DDI&OX:_JC%(\:M8ZITQR\^GE2?FQ0HWQ
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MQ&0<%]TPVP^(0>! (,T]"5BWKKP,65]C1#SWHG);IJ5$);](4K"D;Q+QL@=
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M1VL-_1W+8^K?1>LB*9M>EG:[FX!A/7F<[WM%T;ZQ!_5&YJJ0Z)GLFO4F!F<
MI@;$2OP*T>*V5U1_**>@F4#7\$GC:[$LC5MH^YA_X4T<1F^J2.*\^.I=)A)O
MO<AKNN^B:S"*[$NSIA/Z3>Q_NJ:T<+YVR2H&0NOJ+4)]NY\9%_'<FOP6@W74
M:[4U=[0BN[9 S').EC/8Y;JP380IMM6@\"_J%#!:;(8F2@KF@8#KP>YMG2%
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M(]?HD".WJ70,LH$E[BP47GT)IPT_;HGA\2L;./3F9DFV8NIY= '> &5@F<8
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MT;U!QMY(,L< W+87,2;XO&G4BY@C-7C$YUQ>V]?+FMK=J+<0FJ:_]Y7%QWD
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M\T@7&"SRAZV?TP 008(8Y+HJ\Y1=W 7)7UUUY[QD+PRUO*WJ#3@#") )M;'
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M1NVYO%JPL7-,GV?&\BT&TIQ2#O50U[)$%U^HNRC.A1*%^>PAZMAFJ6W^&Y_
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M,00*O'GX.^P0BXC3^&K*8"&,Q97L4B'/F5[(2/.#;24;T,$.!?T9V-<>4X_
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M[&D:7I-H&NT.M4S_$T=H6AOZH,S10'5B;A ';#9, 86NGS#Y/4, ;M5.+,8
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MN'#P<;JN(K<O\DX&&4*!E,\@F)+:X$A4$Q>OVSI+LE$:6O(I+G]9H+F>,$E
MEI?'" =A1&9LK$5+<M'L\,\PZ4<IIUC1<#3+/1(&A,D$)5'41$6)8$7I:_:2
MQ*^3-R@98#<OR[W#55E<"(9!M[#N*"B?DF$O:@80';32&(4:;&(VN@X-W'(,
M@#- _,U_1%G20Q,-D^PG;E0*M\P3<<FW/+3.,G:7];AH)H0B2M%SJNW5L6Z1
MOD043@)KOMG(U04(CQNM).L@M ZIUVM+5[FG<+D3R^?G$#U'B][SBG\CE 9
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M,\KIMJA[D*''UX9;'FPVC79TP+&JG08*:Z-LT86!7JRA&>,4N4C<_,UT,.2
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M(39]PL<X*E!.%<3).,WY]$YAD;A7S[:&@^V[85=WPD?NTE/0OJ"=[1]N=DE
M9G):_=Y3I+#M #XZP+-D9L&?[4<S8"X9_# 6#C3'FXH7"F]=@=?N$NE!40&S
M&"&?\PAX!9+--(GR-)]4%B-)<V*AQ%&C%&8!TYF7\&Y8QK&BW=U)F21T6;SK
MUWS"O8G(M6*C4?Z5-0:@5R#ZB7V#-)M4]Z4$EH2<.JJ+<L%LI2Z^*3'?^-D_
M<')^ILE9<2OZX$&M]W:/$&?[3985#6 5YMQ04%E:V'9@?V%?6C9'*E#"9B P
M48.-@^'"E6C3:('R;!K%(+> ^UR>%UE"ZED>S**R=M2@?@^^J&GVOD+4JNP0
M&^$GAPDP.&9[ON:"<XJ3#-1$9"V%PX=@15$0S[,%:G"C.:[@^.!MOS<J9@M4
M($#)DU4ECZ<1*%);\"[Y:U37T>@<N:!6$#X6M8A]/<^4%4DT,F"Z.;R&V35,
MQ..NS1_;W'6[W_LUA:WEX9*HS%+8&GAX*QT$]26,]FP0G)51#!P?EKU@K74K
MQ6_A!_F<6#(\[SPS@GTHTRH5]GQ:PX^B,@92J4$3)AEP#%13Q*11B;CI]QRM
M(Q[@%%@$#6"A659<J@%)CX67&OT8YH4G545IS!H8Z^(BN^2<Z(MH E)F@@.X
M^@\IE_  ;(CC40FJ63)",R%6FQ[-9AGHFL.L]63@4"]3I!DR G%SR@ ,P'/8
M5ZWAC<X3T-3B,KK,D="BX&>@0W@!;%0-;QQ&^>=^;YYG256QV@^_IW_H!<_*
M8I3$<WB/,SVS?2-0IQ/8,K1 KK>";?@,'OS\N("+"!0/"F/+,K5.68)2">N%
M;<\+M=]X!Z9)#'_%R4SF$>YGDA"9DYH1U(L9C6>^@Z] "XG*]#]TQXCX<1S]
M[G[/[+%Y+<ZVO@02KI#(D$#@1TC0$Z6^R-T$TPF.I%RTD =J/]:0^(O9^:)"
M>R+#^UJ6B5:J#7EX=UY91'ILX&6:IX&6!>^1Z^S15W0!UY[.0AL16I%1C^)8
MPR0Q%B'?%K2PA/^EHW,DDZ1E>>X"@H[YCXE.\U&29<SDT-8I^+]@C55%#G-<
M .%%HUIH1U]*,"GTK523(?:$Y-/*OBIU)WF[K8EL!\? P)$IJ[56O''6U&';
MYEF-9XS\7O88CH;X+EAY-'_9[1J(*K,8U0J[[RF\R7B,!A_\%E8+;$N84#&O
M-<TUAE?VGIJ=]P:8=I2C @M4PU:9V@7K:G;.65,56X=RV(IFU('2*OH]$"HY
M*N7HU"C*& [UW##2JU^AAU4\MYK#X>H]YQDXK]3<EB0A&<NDRJ'!;-]G0PV7
M+('0IMUZZH@;?(R<,;-:OSNG 4 GW'OCK9Y, '+-)' /@!%'HU$RJY&H%0GI
MZPL:PNAS7EQF23QAB1^A]2&N(/@MT[Q63LKB @0:^66$&$'/@)]$L_/0DTY:
MD6DC1Y\^/,?!"G2*%U6_PF(9K/!,8.MS]OZ(DB12)!+6SS17H:0!)B(.J7$T
MXK&*\?9MNB>_F3*ZS/D*Z_M?CQ\';],DBU\"]YDDKV"<?\\3H!OX_:O@TXRL
MZ)?X/I&PKX)?T%,(7P>/'TNZQ>N#HU_49'GUCX=%71?3E\&/Z!N6&)3Z;"\#
M"@R>PK9419;&,,>;BFA9<:JVK;AV-*(C;,#>92\L9F^EVL17P1F(^Y?!;AD-
MT]&KX&,T37BC0=. [7MJ_^B)^A5^8^(!*AKP^@GL<LN&#^&^?G[,^OI+N)MX
MB'((L"HZ@?7886<W%<TNW05[\W!3F2+7[M8^6$-XZ!G"9&ZP#7SF&"26=I\:
MD15HB95\07'&7G 0@U/2KIH_^M/.]L[.TV &0L$1(F&_=XDZ:9D\'J/,\#4O
ML7EA'+2$BN4&<H@*=457M<X6J/P'4<RQ"7@<OTOA\HB[771^D4']WO7G/F@:
M'#A%^.<,3#[V#VA=0#0-,#%1@L._1(/##Q/C=4"MU6ROHTLY=H$*X*@] 2M[
M7M)6E0EN),EY5,0+UGE$XH=&6X(=IVEV'34:>[%H3*.T',VGE6@MI<0\M#YR
M"?I)5207J#"D^2B;QZ(&DZ9Z@:9UB^\?5T+ZK&M$N&=M>3CZ/3QGWI(R0142
MWS+/:17>J<UXOZX9BN"##J\*I_1[6[2%5TS"C[HT[YIV>#PX]O) N>:(N>:^
M<GTX_E\@3,\;&&45L0--V]U^02(HTI"'"XIF5*RI"_DTG"U".F1Q&]O6X10>
MEY#X,7+I+GW>,?I@^#I%NB^&:*JQ:S!.+U*ZW/_<VGV\-PBV?AO\"SZ'&[$[
M"&$B<$5>/KA3;R=FH[;9:IJOQEU[Z8X6UZGMJ6R<D^N_H$7[>Z2T-J/Q77_"
M_N&($GE;IW!V< .3WME^UB"JF\\UA;NQCM/^^XU,&F9TIX&P&XX755*UL.(?
MXRE[R=$*8*2__+I['(A/PW8CI=-I$J>@TI '$[AS[(<27-_;]6;2YN 4U:_=
M]XE>KB$HQ28\A XHXQ&=S<MJ3EZBZTP#A(GQ_T<#\>=P@"&.%ARBA[>C,ABY
M7K:2XCQ+IG2]F:CY+YV2/0%'#RUF"6EZ\*"(9%":YUE48DPE)G?S=29S7L!L
M1(;;\2;4"4[FH![\N+.S-:1XPPF]AZ;[\<,I.OVF\VQ"Z0=*ETV"<8*&3194
M.L?A>O/)HLMJ@%M !&+M0LAQM:B67;#=AJQM@ F8DBFUM>BD]^M-YFLN1QM1
M(P7]A^>T!]KY,5LUUYF)288R!H2L#*@C'Z4SV'.U6Q^B\G-2<V@"S2W6F/:R
MHD!U:Q*\WS[>QF]YT&M>(\J<L[==Q^WX;EC'LGQ37"9P[>VP.8:^E?&< A#M
M%\.E]<8MPQN=7I-:#5,2+[T*"M.KK%0](%YMCDHLS'G2!-U'65%=?S>^9L6#
MJSC1-6>!BTQ;1,WJ]R0=-X,I-T >S7->(GWN3/)X1WZ-4[19X[49FFL^X(?K
MK!8U+"([1QZ6IK/D;VF1:%O<\0JO#LH\V\1?;C#^\FP3?[G7\9=[<2$W3IB-
M$V95)\S>=^R$:541;G*:VJ#Q\A<;X4),BJ20BN2&D@G["A6^EFJ[>W*YUN9"
MW2XI;J9Z*U>GLT)W0_WWB:2V?KLI^;$1&+; Z Q&DF?XLIAG,48RTZJ:D_^"
MZE6MA FOWC/'_$I0V"A3 ;U#5FUKXV'V=? \])"7()6\("Q&7\T#960R1Z)F
M&OQV^U6^>9/XGL5#UWQ9H.>#Z3TI"]!(4-<ORI<86*\3JOT2%]%>&O=[?OH&
M4TJHDV+0CQ8J'_$(*Q=K2F))=$K0."VK6OGF3)[N*(OFE:)\<MDA=@;ZKM*F
M'[K?2\G3F0=92MH4O!U#]DGL>AS9*\WS&::QG<;E.;:EUH1]S7"1P.*N)%6*
MO\@3O)BUY8_'I0YTPJ[G"'>R[ITW=<Z\RW<NM!;<' VC,QZ(UAZO\_RWAI1T
MWG!=4Z'W3R^?[P31]G0[V,*W_Z,H/P?[:<U57@/T0KYXN?,LF'4],0C[/8ST
MP!%_.MO_?WNX&_B7WYI1,?LH+XIL/D5FA75IN',@]M',7WZ\Y,(D/V_GF?9[
M=*BX6F\^J+IK/W(88#5/"UVJ:;<?,-&8+*?E#1@+&/,:JGY/$:0S?,2E;[DA
M%/@*4\*.T_QS\&D&WPC];5%*8I4"@418\32)<JGCH:2X29*/L)!F-$HDN%0@
MD$(PGN>C6B75\TMH6WA6 ][^:5'5E%$#8L3<*B?KK#'SJM!SIK2\K7A \@J+
M<$BB8*E,%4KN>UHB>\1U,/P#"2(:G$I*W#VI/"8#D@G9Y"PA7HG'5D8@FF!V
M29:,:HXS3HHBQA>!C'12%47H3:/?BQ+)-,7!8/3$\*Q3*\Q(AV'7G> I6L4Y
M4N^ LMM-[925)@G7[R5?8+I26,-\0Z<QV>F4JB)'BY\')86^/^%J\B,Q>&6)
M503;X4VXL;W].D%-]^T/2.IN<=<IJ.,(UN?S^'[OQIA\H'G\U\CM?F]EP<U!
M[UL2H,![6((&(D!QPBQ2?@$JQD)4)0H,E='W+N))J7_X6["'^]3^J]]\$!U'
M.O=[=R*>@]6D,^@4MRR>@]6DLU8.F^+9 MO [_AC]V1FF*UOKB-,0QZ#6WR4
MC[:O*^.IX*];R =W)>.Y-G69D&_DK=^&C,="S%6$?'#+,K[?:Q?RJZGG&U5@
MG9:U1!4X&C=P#O FH.N'J9GX8XO+180XEFCC;SIK:-O<0RI'Y#E([ZV?%+R%
M@Q:T.Q*N?@YWA]@$XT2TE\X/$RI^X4E+N6L-<V(!*->C;22_[$<N 8A]7("P
M;?AY]#F1DIZ*2ILTB@ /#L/8B O?26W)\M2,YYO4C!M,S7B^2<VXUZD9]^MF
MKO^R8J[Z^I",SD&]'%4^;M%WPF)O:EE/O]FRTFTZR .%D-4,.OV,T26_JL_'
M$AFA\=\F^@U B8' X()@ E[2"%NL_I\I,*;=26*@;Z2$#Q3A49E@[;*DO:/>
M@B 9[4G@# (+%@(#C>C/AU%&JH[Z-:D\N**#A-2'HH3)G)6P_7J-]3GH9I-S
M&D^>PN$1D0O!H2)$ POVX1=%G((-4BW AIS:UMS!K[O[KJGL0(IJ=TC$&ALF
MT6-NK]+O9$ R%Z2P8'? .=V459Q+Y336,I;)!$Q8J>@F^!"JU)VAF53KK:/8
M86[L;C_06'#9=!5EB?;U^$J=4\N-AMW>H.TYU%>!NB:I D7A8;W?XRF -:6\
M! 5:@7D.LJL8/^99V)B[=KHXU88\??$":T:J^91\40T<+G<):,X2>%RMH#1A
M,@I*RJ#%<:"3T8='Y!CCS>5"&ZGE]E%AV515#ZJ*[SSRBQ5\^@RU]Z [_%LT
MZEHIY*5+6NUM(<+1ZU>H17%<XKX8I#'W%&2V[7!I.B%>%2CA!PQ%)Q[!;C Z
M VW<#<77_F:IMFD#'>)1[>,B,Z43.<Y[I2#DW11$7G.-&L'WRD4&6]K/U0%,
MS#00:#[M@S)O,Y_V-D/7+#@;:AVXCB?$B.C*WB[BYX+"3"A)P/"8^@2: /8D
MT28;[QF#5G5P$^*P\!<@NIKV1%&QE7C01$X+@[24'R%?*]R*#'^A[BM#!H(B
M[ PDUEFTH*-2M1^*0BRL.B81&P)#+L-(0T0UV JY/!4(N;HB2PYL.SAR^?XX
M2C-R&P+5&NP(V"&-A.A(P):]M7$9EMS;)9,*[1GU>TP1LVCAOIO*]'$#*%\Q
M2_\]3QGO-XZFH+!7&IX8G:X@;?(HJQ?,TY((#OM/3\.=G9T6IF8MP&%9& )6
M+O):U_%T%Y^M7-L#O/]/3W?(:6DS$RR+POV7L.>?GM$CJ E8]9<""W^> JUO
M/7]]^O/QFS)^_03_V\::KMCY@=F>YF]I,UP4,O?74KUE/V>+7%,K!.\0^H'O
M1J!)5NY.N_J<>%9@"S0B7:1!,I&Y,G0)2P!'7U$7YNWNZ1G>OTD93='[FR'\
M<U0%'C0@#E\U/*@R*3R[[6!7H*\9(3*TN*+BP^B4\AAQ(PV%)E4IQEV9Y]G3
MA'@]B& K:/A1AR0(U>G[ A_$ ZCT"T,IXLRWN9XE>ASW=9IKU,)\*7MK@?]\
M<*;(0[6P6DPL_+721=L,K",O+<]"NO20@31@BBU6Z/%052@C$!/',+#1@H7#
M2'F#!G74SP5T-%\9BQ*A5A"_[?(+[I99>+^7H(3.1TJW$CQI5TM&C%<%HH@?
MSW-C47I<#V%@187Q<*A#T3BLM\N6(@B^B43);:THNQ+)@>P!29FT?-$/CD:_
MPG_\8N,_OD'_\8N-__@^^X_OV<U<_V6E2BJ>H$I:(6)O<$+\WQ* OIT$LL#X
M&5M<A>)0O-IH:D$;Z/<4E/V*%E/N>J]L(&H29(PO1OJVIVX_N,-\J#1ZP22*
M1)CD%7M44;O8FR\>'U%'@+= EYA3!6>-@V4+12@K.-%A!(7$J9 P10MA/<@@
M2=<%>\>U)7ZKEZ.C7L0@:Y,WR6\ P3W*[(L5V34I?I>.I;=+DJHL.UC<CL9/
M66EXT7X/+BPZ4H=E\=E3&+<8OQV!BE12$>U#-%+I4-H#K'/>O"@"CXHB99R6
M4\MCK*'50^DZULQ!MOPXZ,D' JK&ZM64U=1T@W<XT'PTPRAGHQL=,.Q_(CB7
M&?(QU_&[%5E6,Q.NV[5)LS(WH(,!!G0"B=>GA6P8H9RHD;*:L*$&S7/KR\"F
M5[V5C/#O]4BST&C,5H]@%UDH5&K\@7:/2X\W?[.KPHHU(0)O$L.1*  F@5.W
M<1NGV)I@EBWPU>A97NYZ/Q<#2.W2961(L-MAEU(F2JY$C+Y,IB%*S6DQTO<&
M'>=\V7!OL-A+GWR5H)F"ZAABQ^.D2W'L.TC_L$1@DLRK<(X*/X9OU=8>',TJ
MP%7H;Z'@$4^G%1N?_36P!1= Q_#/SLW#DY/4-M?#AQ,DR-LB+W ?MYP6&5X(
MPW=5BW!-8KJZW0Y3,ZUVRD%:U65UQL26;*7SR.W64#.;Q[! E@K:$K$?IP>D
M,8_U:5@M!+:#M^CW^Q+!&(EBY_V>S%DS%I>^86;D(VN_1@C)_)1=K"@("NKK
MH 25[XG"(KVZ3J:S.HF=$%D7(Z,!\%<ZLD*LBU^]*C72%'=PBJ&@M''*.+$:
MH2P+X@RK2U2"+W670FG4Y%-^/YC(8:?L=6Z!C);P@'NE2PQ&Y]*X C-)T?>A
MVZ8P"\%^$@L[J]/<=+7#LA;9?,+@)D^+\</8KX4KQVX0X[V>JJ@V[6565!5U
MSSFGJ3C-_B@F&D0^I]4**,GCQ-8M\.I01J"E70#]VOTMX#)DT:6@\>+>4BZL
M<.E016KM@&R(R(7)"',*<=8<7!RA?Q4;7W&T/8^?T(B_4YHQ!:KA HV[W*2.
MBW5LU"RY?^JZ=U%L2TFLQ;<LUFUK+.3@HK)8W6+C@:FT#U13%T7]8Q&\+5G!
M @XIP@>([G14IC-6NN&1L7FDTH]@X]J9:66'3*?YG.8X(AMTGV CT1I9J[N5
M4N[5>'9&>T.Q8REDY26X@-6:KXKKUI*/;6$\NLLDG#)60;1\1SXI1=P6G+O+
MQ&AX;@VEY][>$(F?5,^(8I6*;H[3\B%0@!%ALK,T[R4I#00B,."T-9N[MR;+
MNA!'SCZ<V@0?/(N^2#CX4$H;Q-ZU4H[\&+"Z6-@H4J<"C6A$3\ZJ0C76FKDV
MATW=.OI"'219T"$2*:Z8NE?0-%I$M)T%U1)'#54W.+FF>F&Z9F-9.2:VM5:^
MGZ[UFCS^)4E"<M'YVY+^6Z$,DT3Z&.38J/93>5YA+U:5!($'$-(IG1>7V)."
M/@A4_C^QL L=UVT))G/&GIEM)+.I[7XA+?,/W8C2)57*Z8B3!&N:&C[Z'W /
MK02E7>H71ESJ+373I/:;IINFV\73-:K]CFNP<?V>:  ,OV0:MN.#.*"JG]!Y
M(\"RYU/XWQ@TFU2<*J")38>@0"2H02G*M G2)D,9V"MD,.D6^%_/;T-%0EI5
MH7(XV.+',2$Q%Z.DJ@1_N:-A&Y5ZP+!CB>CCDDR68^ D.8*M3 O@,P4]%93#
MM,(='F5)1&"V=FMVT>U(.Y=2,UU -NB8,TFALLA!-5P>/]PP_S59UH5RX^^#
ME2*TN%<4GZMFGC"YR-'89XQ9U$HJ5-4EAVR(O^*D4VY_2)K&0K) A0.#=H9L
MJM*AZ&S1K7N%&]W^JACN#YL8[@W&<'_8Q'#O<PSW@9:.?+ME)5P#Y/F>M/+Q
MWN3K=U6-H#AH[_GF<7)29)I-WU3$%;0YY?&RW+ +UV_=)1ET),N)!X5*:, 6
M:LV8(U+B\)2)*_-7V1*@]=-3=L_S*B'UL#Y7:7Y+$U2=!.VMNI@DI)+IX(&W
MX;N@D6;H,ZU"W5V7EM'O<6<]+/\ECP9INEAFC%9W^ZBJ-UY[28UYE22LRPOL
MS,S=NB[3(7=?..;R8SO@A-A."L$N3U"7CK!Y=W%)O@6,VU0Z!6Q//Q%\N@0M
MH#I/9Q99.4U"J(GZ@#WK.F5=@Y24R:2P'<DA4\U5H8'&'%M-"U1EK)W!CUHV
M02><H2,UL2(3I+ATO']%B#_?AVH%6Q1  N]8JFJQT= . YBA3 LV'J?%GNXK
MMX7'[P BQ&BP[WG5;0&Q 65N]35LOZ (?G#%QALZ];8?OFC;?2GVL*=6HM4'
MDJVR0EMS:W*8E0^SY8=J=[;&HV[:RWB.?2NTJ9WF@>,SUV,XFWNH(VI@2$EV
M/'?EMGX=<(V[GKW-;_(H*R;%7%M\UJ^P+)X#H!)&N-X^]WM7;O0VL#'J?NJP
MO50UB/$C.J%JDVU=6*=:']/US21IBL0'E.4\Q *-;(3M@,0UT0%F\/0Y H_(
M$<$<SZ,<=(S=4:W= ^4\$T(I=7^ARFDN5%M1DK3FJP3\WH K-#J<^F%C@9IQ
M',U^R%*U/E3KDHM+L62,.G:L3=?IM2[.)$Z FHYV$[(+[/ZJJO)(*J-'A7;!
M:]X*A][87=H,G 9(=EM42CRUD_*(%KPS5H!1 O7D\"SROR7B:;*A2G7,E7C/
M%KGW9+LP8Z9Y/5O(VY6#N =7<_(!UPXJMV '#_/F9]&K7 8\AR!.JU&9M 7B
MU<$!!Y!<"/9"M;AY_,BXU-<VY;>SL40O7[&S+7SO#VXL*"I_8&>I,HF*:"1I
M0-<3K:!#A+YS4)T3J99Y80>P8<0+5(47(CHH(8BTN1%L131::#>RL\].IA='
M2FWRCG2 B#4SS+J8 Z>-*KHS"=QXXCV<8&4=M08^NEVF1RJ!D[AP!;=.<STY
ME=EO% J[W*==N0B-HH\.[A)Y%9+(=<?A*._8X#Y)R70CN&QC6G%%4#IBL9=C
M>(NQJY@#6AD\^SI%*>3:)BD49*=\2,70$8Q-M< \]AQ(:83#%G,X*/(KNQ$#
M*J+>]W_GI26H4GGK-W4SXP^KG"B(2>)W):7.VE(I)L6?J;>C;532=C2+25J*
M3U07LK:R775U<+Q,NIWE]*(V:;A: H^+Q<57#IMT1\J<NA;IM-VR#MN/#EXK
M8A2 <C)JNK1#NRNX:YLV]*_5%-PJ50DR,16V1C:B&,6/KK,#EQ9Z(5ON5A;A
M<I;JX%7JG?QI^Z>?_JSVH.U$U:5JHT>G]>&2@W#B>=["^KWKF%1VRI"D[\C]
M\\'<II0D2:6C"2>BR=^[I$^_9YFP)JNV@YNZ=<RK6,4I3E7B>9('V;;[GMEY
MV]O?D9>#=]>N D^RKN#=%3NE<$@*U*GG=$RH4RZV@]W<.B#1O:X\%QVMP 0,
MC:TA_1)A@!^?4O%O57/Q+_5MM?*550I9997ANH3#!-9<5+\WB\IH4D8S"^P7
M5E75Y5RZ *:8-HCB0\5B)49BLD94^3K\*(7C08:+L;IZT07_[^PD)1"6)9N=
M^*V9T988"DHSXUC*0-B,"D@G:K\H>HV31RP,Y:<@2D'K#ZGZ*F)F,[7?,^8#
M]Y^=(N(;JS.<OS.?R:: @96@$PG!W^@Z5FFI\MQ@NT'" Q%/<':> \\8*WPV
M-MZ(?KW ?CB;PL=$U,9E^ 2N657P=@.0<!?U@_?,P[T\]O3C)O9T@[&G'S>Q
MIWL=>[H_MW*]EX30#ZJ:XCF'E3#[ $@$@2IV=2IC=:L@= _P-+^9Z(@XBLCJ
MX4%*N? Q>R1.9UG:7A!*B:VJ' .UCRQIN(@L!?8E!25FA$3%62=!+&]R@GX(
M_OP9W2'HES,F%JH1UK\KZGRL]5LTSUS-N;1<^Y(_7^B_604SEG&HB@I2-7(S
MI7V+E"R!ZK\HTEBIVG$Q']:A%195,2:QQKL"2XF?L=AN$FD XH% <57S(>]>
MM8HE":H>A2XPE[-L6'ZA('"-BND0]*O*J0?#*JL%HTNA?8T^5#;/D2X&UWAY
M-45HB+:W4ZOPBP'O!V':@=Z;157%P!?B?73,I'[/=3,YFSR*9BDF^_%$?9.?
M_!2.M[)N)D>;9%B=1TW8YDX".=&"=HHA)'QA@7FMY._9XI@?.2#0.)J7"[TM
MJN:NRPB42DY.0+\@I[_CN64O?EZ0E_/:,UMN>IJ7&N>M'I(\#E3%NEKDU"3P
M@FG 1HV\2W7DI-=IX[L36ZX1P>21.? )AB/;*C&;HU;*/64\NXEJECV&"-QZ
MC@2[9HS1YLYPI)6 V*A@EG#%6@,J5N9=Y108")B9N+$M'NDP1,IKOL:L^CWS
M ,VL :TF/(7]J<P,(L5[_1OYG9A/Z[^LH8CV^; B@Z06B(?@$U #9A17G97P
MYH:THC7PQ:"0"#,K2QNP!=J$$)9"1,DD_EY0*XBLHJ>[HNY$<SQ1N^2FXNC$
MI< VA8YO5Y4=L(>AIOQL[(H8*;</W\M^3UTZR2$@RE[&I&O']7JL)F.P,EHJ
MN6U0"J^ *!IQUGN_IXN7V!-D920IAXCWLM!C@-[7S5JFD:FHE=?&"KI GCB/
M<$?0Y[>27.!1#%>G<#BPMF[VOJ7R+G#.9:RHRW;M6-*!BRN+L>V;;TO<6,$+
M.V@3E\HY;]H)18I?(YHJJ)ZYX=D3C@88GVK)1;<JQM@XG8*1(7(Y/6_@T+S=
MC@Q8(L.BS"X5U)2"6($159=O3?C*V09;?G5*T%J<PI<'Q(>5A-<2US;UK@J-
MD&4,Z6;-UTOF$BP1-"PEBX0DV6.N I=7^8F;E\YHX7[IGCNUMFD9"$Q:[19!
M9C137]2F:EVG)?(9J=6U'X#W*HZ[KS EK2[1I<4='B8+SGI49"#[8(%3(E<F
MTL3#I6@IFDQR9E*^PR?"J3%?=2KVW=LH"&NRK!$K",<@*T]05A[85C;K!@=S
M*CW2A-0 $G4M_08X#E-LC"ID*;#BTBO&TFY5LI!K];-I#_(Y08;E* 4BSZP'
M*&S28*'-Y ;;J*WG96X9C:9ZD8(XJZ0/^A-F@-Y*N2'\3)W0Z"?X[8PEH)E2
MI#<%%(1JAO'[\3AL*."A!0\-EB.>PX1B+R%ED'$1H/6Q-14I%;-0> 8N1(U-
M HYZ0[@E6LDS!H^+9&\'TI$UF^0@2:GKPK^^BE7;\]*XWEC9%K3+)AM/Q!I/
M<@BQM9BO"05?HPB)'G?3FE#P-8I0O_<5FM!XF2;4W/J5U!SNU[NRGM/<WF5J
MCCE,";8WYMA4;CI*;ULJ#+Y&N7'>O8IJPPKFE9EQ?TBU<2;5HMBDDM+5I> L
M\5VVJ3=+7C<P*00FG[#E3G?J-OKH>:Y>OY&;U710U=VH.M<,)?]U$TJ^P5#R
M7S>AY'L=2KY?-W/]ER6MS-[.\SB:,E3#F5%/5?3QFA''D'OAV,$?QNG(%IP5
MI?Y%"BIFR:(5(FF_G/!MZ<B5.-C9;SE-*)3&2>C$K;1?W[9\*-F*WD6Z'BO@
M7+ G@3P_]1C_B\[:%+2U<H$J=]><[>F@GR>$FT.J=9:.$!D%99_"ZP@U(D;(
MF;(+Y<_21I=NVXF"GV .,2" >UE399)@M#OKT_J1&&AZ&S&: $>=2!_CYF:J
MF*-U*O;Z0@N];DRSKA4^/G7 H Q?R:2GCS RR[4.S71N=]^I7XS2U5WL,593
M+=VTH9%*!R]2N4!;21#>2<W,FA*\+E6X:*2Y-(U @GTJ+&<U*DBZ 0\W+C;!
M86M./^S\F4SH0K=ZANVX.@H+/VG^,K@HN+\TJ,4:]W3$/U-!<R]\2I':UCM%
MI])ZJ8+5[E33Q 7[QVN=#<^PH:X_:Z;-TD3(L0]3G&=5H8*JYH":I][(O4TK
M$U$CL$E5@4AWV3KMN/V$^SW_B#G2W;5]G2QIR>XA[YE/IUS/8UP.O%AU@Z11
MK^L$&,XK#/573ISO2F^'=R!AXSC" #T6C\EC85@D.R3(E6UY) :J+,F^G?@X
MU^# PZIT^A+5]J%86NU/BS.H:B/RYNUH>M5OYGH$6^3FL'TI2T2:Y59A-PFY
M$=BDU-&Z[GK\AE78AGU.D62K!92+^>R!KF+)KZ"NF@"/"P!K^Q%F95IHL-<"
MZZ_*Q ;RZEBZ[F/2!GZK?20(#M7N),&;X>1*%RX H+]3 [_XI(M#\CQ,XC!R
M$2(K,M=MX*6B;/#%%#V5JB%?-2\O.#G?^I5!!E"!UHARY4'4)S*N%VG<S<":
MP%P(>(WUF$T[N$UXQG1>;49YQR%P-HN=&KW"#AD,84_K0HO9U"JVTLC2R5SI
M&%OUS$V>5+-,3OMJ7+3&1E[&LG2@:(;,O$R]_!15Z* 6VN]U'%W@M%,S(+-=
MC^NKZ.+FH6!@)M],MFKL-#7%LBZ?!\2F,^?%,=.R?)BGN$(ZYYD3Y6'G/)JN
M5$-([9\X4I!6L;@1N-0%N@K4H<0I:G#([%!@P]IRTX&HXX64B[A,4</B BD_
M.R]H#94.9"Y5P]CGJ/L)TL(Z&5F[=VZH7J_=T_X<S+(PD<W9R%J]NS+BH-.A
M/ ;SN[C4L9F.>7;W"I8KP?P.+C'Z$Q=+UQQH='";AJ2BWK ^5'0L7G:J>>HA
MO4*WX,6+@PUC$ZOZT#$T;.QN3]9*'V-[/Q1MLXY@3_N@&,TYD^7*U@J&EYA$
MEWC@JHQ2D*D5*QIV3)B(%,0ENVF4F"NQ,*T'BM)KZ\AR 3F+U<&R(0[GN76_
M8KA(B\&*W%5GBBV5O%W]PA@1AM5F28RP=URIO%H5\L]:0VM+!J7:NY3*J4@K
M=>Q,'9]JWU')SM.,7JC1*Y>G_%RNH$*$!5+]VL1;(U64-K*QA"VI )U%Q*;X
MG@RL-&(3C;HR:X;+O+7,7IX:N5K$R):$#0B^%:F$!8,"F=<38GAY"0\Q/H0K
M>/D!IZ^XGQ?A;O(6 M[4T6=*+"6WB/0 Y_"0+R"6;&JCTW+'TC@OEO1Y-2IW
M]&Z?8>B7ZG:M1.=K>)O!Z#XZ5L4J".7%PA6OC3P,$M#^BFDZLE=KZU5=NK8V
M^^Q 2L?BI<NVOB6&(\$1V2QIR753O, J27?5?:U:+9.4S6M%3 F-#M2(374F
MZF-*<FA'$_<2;>'Y6U7!=LRX+'CV)BYMS[*\<ML\18E-.40:)I!4+2 :Y[2*
MU %-*"E+J[:^?7VR(_0T<<@DHFVAN7CR3[VVL:V(MNY^1JK.[P5<-ZGUKW!-
MR&T'8><XY$99>:# 1F4P5=GZ:O FLF6*/W1L:K4DH7*)TLG$0 ZOM$*ER;(^
ML9H.X;[P*HW"(1#K</72.1=!P/0J/PU&\XL_=&)AOX>)"F2I(]ASK* OU&LX
MMX'M'[(R6NI4KLJ^L"*M>L^NU)!81F4"'H>^=X-L8TT/0:D,@G,T!P%7IO])
MXF569^TEF;A0Q<3@GU 9B?72;AV6V$+E\M2C/$7]PY@^U"O\P05:OB*R^[=-
M9/<&([M_VT1V-Y'=[RBR*P"U^P9'3Y)*=\D+83ZUI:\6*UY7"MVG!+E^39=2
M82^ISYX^ 6JJSZ6B"<6#PH:B@(P"A[H"1>OYBCYC!^Q-ZCFI",\*.7 *7"0^
M(08&<FKQL*?!JB[850H&V^?QG<BR]5_6>""-E!34$2MJMUI,_S#/\!NVK>6.
M# 8+ <_1]:HS%_SU'+3L"U&1/;<[\",=87";NK99HQ[K\IN;@'$\JZVF;:Z3
M;PB6VC1*,VPJPW37!*_S@P*F$-@JI54A+HY"$?O37VHG66>32C9T[!='P;#$
M#G74!U.U@<$QT&VA(%*U ]R\ZSMI+;'^RU+-2PR[V\68AJ$V($V+ 6+<QP.1
M],I+3/V$1LIJ*2RA, :0%%X%='L--+ZE6RJ"$)++WD5]%B/,R,Y+=(1SCQX,
M*IG2EIP3HLHDQG:?'4DK(:%.U@)M8$?FE(%,/Z$"/W$C4<S?Q, :&2Q2*H-!
M6ZF794_I$!OM#=E)7IA>IVZZ-VI+GF_<JI4MU;]+*7S<.I >OQ3&B#+M%;2+
MW#WG2[-YJ-.JE]PJ:-JWXT$T-Y!3?IQLO%)EH?AY/IRM43@ YCKMCE!PD?M2
M5OV"1D9O:>8V.^M(E%.N)U.7%"HXDNZ$))7BTI:&Y*8>-4&5FU%,SC0Z;"-=
MEYPNBFR>UP+3EN;FGW!98!^EW"-+X7S,EEZF.5<P<)8.'?MX'*6-$_;+?TSE
M3ULP4E5[**P^+9.\8!EW4P1ZJ/E[()$X+M'K1+G^)J -%H%I#ZDDS4DR02"\
M9@('=EQ-<-!G.VB7P,V%G\<(5^/XB:P:;:EEP=0:E2@F52_L@A,)R9U8J?NS
M%JX8O,&6UU_XB)84)#.,M"[&<2,*+D1$Z+"X$-W(BN.$+<R B 1M!NMU%,4U
MKUQ2L+R,\5#.)PV)Y.JY%I=,N0J#Y5-NKPI"6E^T;:0J3G*S"@G(T# )E:@6
M2A*MN=ZE?TDIR#AC,&.:A8>[@3$&;*QE?.J-K4MK>Q2!:5]M+UL=M>TIIVT#
M42E7"\\0S[9.@) +Z"6 M94??M4FOFI!4S6MA>'^J*;"%H2G<$_&M&1O?9I+
M6T9.X9%&=C67S%E54M%8_0:#;,#=3:#:U$^*6]C"VR>JU3?7M'^D^7A8^[P.
MG*!,5R]0P50JWD,0HFD]KP7U2! M*PR5 #6#]*#6'(\%I3HEQ-"(0YCL7%>1
M0R>[V0J]&P'6QF>K%.&,HCPIYA7(*833=O:Y!5C;-3Q -Z%X&K)10N2&!Z@3
MY-\>_W=+@V\!WG'I5=0Z9V-B+C FYD;HWY1EF>0C:F>76U=;5=V[0, >LHUL
MA[33!#8R28R-(+],=(<,= BYS7Z_8&,(W"'3/$."*@]._?Z*>,!/FWC #<8#
M?MK$ ^YU/.#^W,KU7I(-&OI"@X:>6;:4"(,-:.B:N&X%-%0=(;"W#+0K/MI3
MTP!FY/5+HDP(8T19 %Y9=%EIS5DW@_9:6"DWYPO,.&!U3_*[BI8L!?WT]E.E
M%6APG5V5O.DUR%8-F\7\,*EM5Y3'*%<%VI>2S<M##-ALT?LD[7(NSXM,X-G)
MSQ J=5LZ<S?SC&I9(3:TGI&/9:QA#RV/KR0K(NKZ).>^-1->IML/R*2QFK[>
M_CM=SX;HV^-5FG^S-\WMH$'S(*45U( R3SBU93Q'L%FWJS<UX_8:>5L0K=JL
MGW(BH3*%U>.2J2:9B'I'([0XT['6]"753SJ,MZG,LB":IS)-P(R'2Z)V"%;S
MJS)/6WK(\]XF"1>ER3\J[GBN;T&H&K"P-2.8G>)NL?]=M1@E5B(M>J2LFD\#
M$<F 8&C7F#D5_DHD45=KXAV=G]"LJ@JUEE@9NPU 3QURH/9P</^S#+$W/Q8U
MDI\*2]*MP38U$]4.SR0YPFF6BY9D)8&_L/NCS<X7%>H:J+3KXW8FY;9^".8Y
M)2J9L3&MJM*K\C(Q<R!2S)_6V>\=(#:KO5OZ\M3GP(""K>=.9YY*MY!S?1G6
MJX0.D5?:5Y=NI?<F_MKO;Z/6PR:;+BB#BZ&;,ZA]H%X+5KZ\ZC<7JD83IE4C
M97<C/4E5D>6N4I6\?KQ'<='SB(JE7'+D,/8FY+DFRQ*@T8_F!'7+88OR5'N2
ME#TDY 0AU&G)/6??MF:HQ.>E32,S1/'P*"A@-'FJ*(V-+'0Z<W7+/.6))7:Z
MT$W2HJF$(5VNJ^^]1:"V-Y)I%<0),X\5I=]2/<DH.M$@M#K4:8GH]'LAW_V%
M)144DB_)':O(]T:$G%T0XGC7[>?$3\LG;4VCO5N>XU_#W"#S/DYG08$O2Z_L
M\NO*.$9C!>X5')&\.]#.(!L4V@9.#E#BD9&JG%\6K1H7T55Q:UVF9[QEK!5M
MN->:+$M0$/TH45?3]%)%D=R2;&)7[*Y7](\>4.F:Y"%3\-V):AW/V:+HKRG_
M;9N,01INT34E4*#@[)A34ED$@S(7]%]W/<@_,(N-M;@R8<9*_F9Z::+':Y@C
MK#U%0PH4)@P=IM_:C%4YE8SRF/+L>\AAAG>&?%^IG@O#JL3*5=I>B"^GK)-1
M/:<@O.T45@KDY@ZNR;)BUZ$ =,^]TTS.J$  X>D21>N2_2Z3N9E0X,K05E %
M]6VCE,Y#WTN)&+'.P;HL;J*6%9EP' ,FG4EEO28H\)4G1#6'I2_A!ECN$ORA
MAWH^Q.*QZO."'2BJ# +D^$0WED8E*4NTOHUQ_JD@L6*A]N-B_)@>**TM)^5,
MPCT<D4)C0(>DE/G5Q(<_F<-(3U^\<%4-;B3+R.>,5*!=/)))854R&[0B']*3
M*E#EVZ0%%:.M#RRI5HNN6E^E:/VP_==N']%WPD261WZ>[FQ"/S<8^GFZLXG]
MW.O8S]W<S0<KSZ7TXR1Q#'@'W\#HUPJ$0+YF #3M<BH( 5O&80/=Y#2>4TH8
M)>PIN)ZFR1>VP&FHD:E)AX(3M\U9W[QK B(QM!)525[FNI0=YX=:@O@<+E+8
M,\K<8Z^847?1=4W2.<DR+?R\MXN.C"$"G> ">LU%6F1.,J2G/\C/EN@._1XH
M#*$R<YUJ^@@;TEM:#=G;F)B5Q)T:RW<B(M<[%FF'87_08=@/:87N><X,V@1@
MUX0\(U4HI!JZ@.Y[:O*M@Y\)%%LETH/^@:V;ZII;-",+V8^J\Q8?;5PDG DJ
MB5NV^BU.2 '&D^QOQ"A5/2,UPF"IYQ396> =%?@JH<YU#T0=P=]G6_$ [*[0
M<M'II"W$=VKYR?/MX%<[9DOQ!IW SA5Z9HVJ!9O/BG.#[8?YDQ1"4I-6& Z*
MD5*YBYGQ:"!ML]78E( IH<?V!ENR3.[#Z7QV,9!H6>BTFF?[U-[>(;ER3)PL
MA[VA%U=$"0[6BV=+;?CYFBQ+(B_OBPH> EUJ#&;P 1KR\Y&*(7\ 7<-H"W:F
MC>,,'!5 1D:I4N[,)(7U^;BZ8PWLU(TI P1GH/HSFE_-\XO=^4V=^3D^%]%C
MN IEA&8%Y2 KK""#J.+>57$<H@-(8H_6^Z4IO9I!2.4:<#S37- X-*C5$@"O
MM-;M8+U6BM9L0E6 9_>$Y>AZ54OF MW3(H\%B\7+ L&/)'RN-\A1$W&Z_N90
M,%<V%>-23ET1J;O2@F=)P*>YX[B)Z6<$Z*'D@3R6B LGN$MS%S-3VI<L3>;^
ME$D1;@R_X3=KLBR)E9Q&];S$ AEX$H%6\"_OJ"( _Y;4(Z=I--7K(-7,9HAJ
MDR#M+'28H-9I/&2S:+[ 2L$L+37I:YFMTS^(FJ@N3I*1N'^S<=1&=GZ%JDGB
M>E%^D<10N<JFD-H#?DDCRT'RCG+8889.Y#XA\H9^#UZQ(>0U698$''8-!!'+
MCDVI_?4K&%9;U-.;7=*9+=9<Y85[1: V3&,V*TQLE:'1OZYF(8F.F1)4=8JA
M4@J'(16.STAR E=:]7N"]F@G,S8@/3!;C2N$6J&M6OQ/.MO15M7)>%)Q"K%B
M)%[D:/&.@C>>EV2<>8I>*FD6;3W<5(VFKEVBU#&U$[6H0I4DX)2(UEY@9DR_
M!U,K)RJQAS+:YEQ]A:_2&3<)PIYAR>DJBW;RR>Q%!YUK[O?H*&O2=[),E;-I
M*%4%DEHI7F]F).BT"BB]S3FGTF\$<J4RQ5\BB31^J^.O\SQS673)?L#)7*E.
M5HFU'6>3/5 "[4-4?DY$4>_H8R SS-"5%V_W>TOT_<BDW>@,/2?)B%>Y\LEH
MCZU*?K!]LG@J81O\Z;7&82Q!-J)-MSK??]N1PHC&,:4MFVL=<ID@YCI+2A=2
M.WI?TUC<NCD6=5>5!G,=8QR2P2>)SKX@QP*U-V<_-=^"*AAA;D4S"\0 >^O$
M3TG6%1_(%KM3X(!R28)VL<#=>/9(8Q  KTRF6."HROU,FA6]X-;:EGT;4? U
MX<RGFW#F388SGV["F?<YG+GBO;S7P<P[64,+*1R2G]DI-)+B;Q#YEQ&U"A"$
M8193F/QG!SK;TF[)/%U8%J_5ZK6C 0^(.38S4>/R7#/P6[=%27U>%O/)N2@1
M;N,>!\1$0$HZ*OH=*!"GLSQ)+#<7R<#M&"P1#3".0+3L74L^DW)%'^#&%$-4
MM%5/,M#0*<W(0I<6T8B8#Y6OH8;]'F**<Q375OI!4$X*4/7'$<5AJPIT(..K
M*TM*^\8]%B073CVB5UCU.)9O0CVC^B^U*(U<YV/:A(BZ7RL4 A-O4'@F7HS#
MU6XFB ^ 4."@@)24B-0,8^"PDR1'>& #;T#-X)-)0;3D%I_ *C"J(!Y)5(7%
M)1F5;F,.'YUK6$B#(6E<HJJQ2%5!Y:L9'P=*[>P&HU_.!7#\;M46SU'7E^CH
MWFX3+@3; Y(WILT _*E2[O!XLV3"16U$TDO5O-5,$T\KY09WB&Q#8 ;E2-KH
M6;9',L9C)Y.P&&*6L+5D44DC 4;A\+O.RV-&4RG0\X5DZ"D3 EW4PR)>J,J:
MW^&*5C$G]BG-$CWDE<Z1<ZR>)%?GJLD&R9BO)5M[%J9VBP'VP-C_@Y1I>Z1D
M]7O"WRS'*QM]?A=KK#8S0'\J_;RK)**S5Y33IT-CN/1[+KQ@F[Q<?D5,C@K]
M2Q&Y<UND*B-LY21XE;B&M^,N8:IM$:.@6W*K-J2_%LY0R4W[O]8)&EAB,%PJ
MIB*@'-"R<B5ER0FF@X8*4 B8,Z9%CQ*-@(D!CG(&I-8>TC0%2QK$RJ^S[.Q+
M]!TG)Z__LL8J(](O;# 9D$ $G_/B,DMB=!II+<97Q4:2TG&E*D*18.YTK[+Y
M*,SL%"CJC!^,&",V8".Y19(DJ<6D4R0@.0)4/0!::B&5P)QK2.ZQ!)N;93[0
MPX9FUV19$Y5EEI.=RW'_PR\S;#$MU/L1JU?G)1-?G$29Y+4R:%L6D>@T(&^&
M5DTPUZ!L"#U3NJNQDJ0Q#E:G"Z1>%,A\5'(!#Z3RSRZY'U/R.YC3(SN%3?>L
M5M"EU(FF8O\[FBJX&;D+4D _Q]0/NI!\=723U79(,]54,M$=NLZL-I/47*0]
M(4U*W+JZ#85>5QEVI+/U@B>#S .&0G@WV/!*5Q8O3/73DK%98V.=C_WF5+G#
MX'1!'$VC2:++82W/A@]:B_ =+FPG:VQD-Y+=K&6@B_N!$0F%E5I)IG<BQ&9[
M1]#@1X9%6T?^EM *ZH :)R76E1PWL"&"R,\U>OZY*DN<S2AAA42MA//Y24S!
M\?OQ44%9III:DLXL:XKG5ODOZYG2$=LB2%84]%$S2&PW(9IK\9VPRRL<]L\V
M#ON;=-@_VSCL[[/#_I[=S?5?UKG=64.UH=&XK2%%VI/*Z!"@%W.+-P,UQ-[I
M*6*(J+8OW->E*"WHZD9SA88S@P!FS0\ZC#\;4'9C SZ,9:62K6UZF\.9OD\=
M^+R/A:6D*4>6>-P(\L $1B+0GJ@B^T*GLK@:2Y>&2N4).M/"2YX6'SCH*T#_
M$E%2L,MC)XZ!JFIZD6;)Q.!.*\60=;P)5;^GC/#.W6MEL1JMYUT'8A3W4Y65
MNK#8Y565):%N!$BJIWEIRK#\93,9@_0U^&@$5S(%_=''L]_<L359UN_*S\)J
M=+/*%/EM+. #Q,51)6_%J;:0(%6.\9"0%FQC H%7"( <[5\VDMAATD2_9_B^
MD1_C-'; 5?ELW'1<7$-P(1+NUR"F&3OM5>)S#&*+^HVA"0@V%%_DL9CF6!#A
MV#EL0'$M%.IU<&W@4U/!T>P Z@2\I(6%FE_!!KHNAD5[B"\>)P,F8[3JE)$I
MO(M2N-KVB!/4V#):4+.&Z%)6:ZUT<T/79%F?I89 =;UE2W^74 >K!H9L-UYL
M"W:K)9VH!9X5J32MZ(5611=+<_%,X6^E[RV+':*N(3<\,<[6RIVVT0@9-K'1
MZ49-ZZK?44*%ZK5]=L6-*Q.*,^2QUD25_'16L-#2U0>":KW$1CN5H ;MNJM2
MP&N,R'4UA\T%7)-E95+[@!E%:#]T8S5.BY@!9U%L3)G>E*)FR%.R52472ELP
M"FY10K -'4UUW0(Y%IP33(.Z*^VH8Z'RIK*!AC_9D-R:+&LJ/)\ZF=OFSJ](
M/.CWG8%&DA(>,BD?G8YJ"[]115HMZ$O&M!+<QJ'='01IBZ*V_1YK66X./KN5
MT_%R+[EY.3QRG@Y3T0FY@Q:.'K0/SEC3>EC#:=/<3-'-+E2Q#?4FR>R3]U#L
M6>4)RF>13@GC[BNQ%2&QI4EI/4,9A=VB9G/!UF19.5^P=PD5AUAFS[E\@MEH
MS;9$J$DHU8%ZS>6I\C"4"<*LT3]R"3#IW-50&Q*"QQAR2@-JZ*#IZPC>AI2N
ML2QVFN]@W,*+9=!GS3C 3:[E_[3\N1L@F)M?RT,ZE]=';[9.J9?#'!/V*-;P
MMD# Q&KP^LG1FW4](UB7.J;&(JZ(!#[?1 )O,A+X?!,)O->1P/M24+?."SKZ
MV._]>G3V\?#T-/CUW>')X:>W;I8Q]O^@5K1>]P^Q(DQK&[O>F?-^Y[GJ@&-7
MB&L_$+7R&*=E57,1!7J<8BK<N3WK]=Z0C+GQ]@WW.<"U%^TP@$Y&\8BNJ,4.
M5G]!"^-XI"Z\81:KC]?"<VYKYX%9F8GN?\*-__CW1\^^8I=O;](R-A>B%27(
MX_ELEI2(H00OV7NS>_R/WW@1'Y*8.C18Y6VOG^R]L5=+K/G>G+20Y@](F=_J
MU+]ZTFLXYQ=W/^G[17!K<V"W.=&]Q<NELURN_?. WWX5&U); U(C^VD-YKDA
MIC4XI#-,#EEW:A*K^ ':+U<XHEYL'%$WZ8AZL7%$K9$CZ@^ZA._6R70+_NN]
M-Q\_G1WM'_9[G]X&A[\=GNP?G1XZMNGZK4@=27,1U[HQ7QE@:817B%^Z?.4:
M5TK$!BHIS7O5$C2\0Q?'6>'(_ [.JA=P]VZ75?]\.#PXVM]]'^Q_.CG^=+)[
M=O3IH^^>@=VW6=;M^SGO:+\>G(]\Z^F $2(I@T6ZV4JN9()5CPQ?JO+S_T?^
M-/HD>#T>K-X&'HI38OK(JS&V,-6@WTO'%NJR-*P6A'1*>BPKC>2H 2!E2)V\
MS?4#NGNWUPLXR^P4';?3?"AI0 _?/;_&"]IZ-L!H.)^]]+Y W"BJUD:D(H3/
M!-I"2%YST,/BR^#E ]J%VP4G6CFQYF87]4]>U1_Y_W]1^X'H$NX^U4EH$+F?
M<TK9.T6(BNI54)0/;.\V!-%)$&.[>I-0 %L::W1B6D6(DFT0H\*NLDWD/?,L
M<G']JOFP4IVWL!M0V(T=00,IB%^1F=/H2SJ=3[LG)T+9:T,NK9!].!?&.H@I
MG:ACEM2RZ-;0K![BU?@F(O YBL",810)R+!"",,F #:5$UN]PFT%CU$JB/8Y
MK9X>9&J78BS,>TBRXG(C..\YA?_/\C]W>GQK<UBW/WWJ5.'=2@L&S@,.&!>J
M&_;!K[O[P:ZT%?U(O/]NK^#:G.'FPFT.:W-8F\/ZS@_KFRBA+Z28=,3(&2#(
MCO*+I*H+J\&WK7 B!$>N&JE&YE>I_$JU4@45-$[&:<X>P!/='B<X0 ,&;*Q)
MY'2D[O?\)MCCX.E/SY\3X*_4KFX\>O?D(BSUK/_S].B_/NZ>_7S"L;5WG]X?
M')[\ZR&N=*W/D%.A"+: ;SSJK(>(=P)#7<&_5_YSQWNC#F3=3N+UT1NK2 Q.
MQ.YK2%\4C%#CGQ167WW%:6V.Y7H7I.TX;N22; YB]3R[VSV)S5&L=A0(?_RR
MW[N)';\'I_!M$Q!_^+[2#J^?$W?MS,!C=P^)".R[MBG]7*?:^;TWA[^].]H[
M.NOW]NXN-6_-W08W?0[RP66"N&PO@QQ1_;)';W9/T<S[</@1#N?MIY,/5RQN
M6&3Q?5WA[9S/71@-6V<,S BO4-%K[AMG,+>D]IFCU)190T@P8,5F"X.-G.:$
MUH@.FNW@H."&(I7]*S?BG=@5UBJGK-_C-MG;=XALT<%4=[9_F-UH <4RO(O[
M3BAP/?N]7W;?_WP8G!SN'Q[]<G@0MI,+T09&M@2$T8 NU@HAM$PT6&@E+L&Z
M>%AGO:F%7Z5P]Z<_WXG]O;RZ2B;S[,\W5\APN_6G=[A[ZU1!>"?+UW.]55JY
M-QNPQ;E%/,'C,LWKP888OE=B^,Z9P6X<@V):M0N3-1$=&PK9<(B-N-@0PX89
MW/KRC\^+7&Z"G[BY$1P;6MGPBLWYZ^4?3J,TX^EMM,P-L:QZ<@^0-WQ?I]N1
M&Q&_Y/EY>0WP[S#P4AP>.#E\Y[=_HRILSM];OMO%GN>I\SZ79K%M:.9[I9D-
MS_B^S[^-9R@[8VG>ZX9D[A':Y=WT+KHBW?3'5\&G&773?!F\CZIZDWUZKQ 9
MU[/KU4-.I=Q,?[7I/]G[=/ /0@I\=_;A_9O_#U!+ P04    " "D.VA9!&$.
M-<<0  !P7@  "0   &5X-2TQ+FAT;>U<;4\;N1;^'BG_P1?=6X$4WA>Z"[02
MK[MH:8N [FH_73DS3G"9M]HS0/;7W^<<>R8SR=!M>FD7NJG4EDP\]O'Q.<]Y
M-7N_7+TY>]WM[/URO'^$_P7]V;LZO3H[?KVWZO['MZO^Z[V#=T=_B,NK/\Z.
M7RT,TB3?$>MK62ZN=*RL>*ONQ$4:RZ3G'O3$I3)ZL( 7\>KYK._MBEB:H4Z6
M\S3;$1A>/>BG>9[&_EFN[O-E&>EALB,"E>3*++S>.WGW]JJ^WO) QCH:[?S5
MBCS6ZC^5(Q S';Q^D?1MMKNW>@".T+SX[_S1MV3T\#K_S%WRV$?>Y/']M>[K
MO-O96EE_U*TR_>._S9U\*&RN!Z.%BL>/S]B_EI73-S^+RXO#5POJ?FMY_;]K
M:^LK'[+A@M@_NWJUL&#S4:1>+=SI,+_>^6%M+;M?^&9<>;P3+OG[30_U\<C_
MW6B<U0MC/Q;IKNUVCK1102Z.M(QVQ-;Z]O+V]B;^KJU];SL\D?>-#:X_VPU^
M50G<7-G2R5<&R;?IK8K[RG0[/_;$QMK&#_.C^'O(W\]&]]W.&Q7J0$;B,#59
M:F2NT^39[FAK?7VKVWD?Q<KD:8*79/AL]W(8*6GN),"LU^V<1*G1H12;FR^W
MGR\V/W-].9.A5C I,@G%SW!Z(A6K9.?9;N=O. W_4">AHLG7R-H\JO%7W<ZU
MO%5"!KD*A;0B2(O$JDCDJ2"X$RUHUQ-2'*E(WDFC,+YZ+A;S:R5>1"%Y$GOO
M7Q^F<2:3T=[J^]<O##]<Z@F=X)4D@8M!;]SI_%K@K6XG,RJ3?AZ2EX&.=#*L
M!F '00%/!?+$7Q_?!]<R&2K0%<?:VO;E_3=U"D0Z /GG)K49:"BLN"RRC 4S
M!VR$DMA0&ESA[>WDS*UO-[<)]M57Z0DW\Y$*W,P;///&PS,WINMVP Z\GA7&
M%C+)W?07:JAM[GEVF6,!HD/@PTEJ8G&YO-EKCGF;K@ 0-Y<WMG_<VIQ:NWVZ
M.AU.DQTI_1$?BS_C\3G5SJ. U)K)P]N';XDC6/]I$]1!WB06"3'?!#'--^I$
MK'0[5QC:>@;"0"QSO /^T'P@!.P*%%;<$8MR26SVUM;6Z*^PUY!>.[4L/YV4
ME]I&2S\90AS':=+MV#P-;GKBWVLK"-\$1%C<RJA0(L/6>8TVL60&X[VFS"SV
MEP348'E0,$>@7@9G/47C.8:<N"&_^R'-0\+F(2C0#ZM$D1$O-GH_;?[0V_ZI
MVC8V5:=C<@D_KYAB!^M>G@X5QIN:<KI9^4M2YA82>^*A VXR@>98#)9X=).,
MWH3XUT3DO-SN_M HI\M.X;J=2I=?.EWNB;[*[Y1*&N+K*:_X9JQ(()G\T"@]
MA2W3"S9$=&[BGHZ)NV*!G#HO"&\4018\G!$2)4*Y7)23K\/"&!IXH6#@QK#Z
MX_*O+"XZ*4V?0T.C!A 5 AN=>/AI1U0&, T=S'1"7^#'OB);9P@)C0H?L)&E
M2?2 U Z +3B\(O:QTT!F.@?G_R2A5B:&6U98_.SEFW:4I-@E"?R=!J="-=#)
M> "  [.PKT#30Q]I<8V/L9()Z+)BB$^)A]Z8-O$)'LPUY.EHR"G,V+2\C26T
M)^Z4._E%O00=P3(D&"0RL+<:/Q99"G(7]Y<^<>2]":GM5: [?M;MU+PQL7C@
MYAN0VD'JIZV*N+O6P?5CJW*W\]FZ#"(/EUK]@T-$U'H USDG[T.<)G5'F18]
M&,&#MNP#!8Z\:$1*HP8#\ (3'Y$I)_:T&#>VDL=N902Z$"09X;P,<"/3SK[;
M IPQ"LN&Y'ZF04&OXL=@3!D^Q2H&50E"99J3U1]48*=N.#T%4A PY?(&ZLW3
M#@KC!WXLM!G1'D!Y6AB(;#AD("+/!Q*EK)48 ,IDEIDT,YH8 IZJ1/8C^"?L
MJSGD<[MQ,F=Q@/"%+$%47T7IW:YS/A<U1%#"K7/&6>:3_B5F@R38-&IQ49V4
M\'=X4<+9TCABWG?B0%$HFX,N;:_'+NY!*DU(''69T=1 3)M.(6]/A 4.$'H$
MG<T+DB2:G@";7$6=YTHY;P+O$N &=#+LG++"77KM6]_:+!&^BK$0.RO3C,'$
MF;R;@^@3 M%]RXXW*9?$\0X04!<XLECBX(T=0V@-,2$&!&WN/ <F)9"#7I+S
MZ;"5% #42C*S=B(0X2$\(YEMVE:F>&\1\.N6B*1E6%L]#2L (:]I))7M"#]6
M+26&*BF ] FTD%>3!9XF.80Z'W$8#7VRX+',"XXI$OZDP@IUNIT:DC2!AR>L
M0&F7UVO,3]]#<6 ,<D>!7[!Z!WOKLUI10$(X(NT8"MV$4$9B,*;CLZD!Y6?,
MY9#44Q8 7V0PZC5):F-*8Y/XG!6 D\"=K";*'*A':BC9*9-U;C(K\1S!HP60
MN,7!P/RZ5]'0RAD.=L?2U&L(#Z$IO>0#2D))<(;$E (D[Z>U68H).]#<VUB@
M;[6Z4^%N9<_#PITE^/VG)T?= Z$KTQ="!R"BHZESZ';N""%GF('@D8 <;\$4
M6>V,"U'A["BYI,2C$GD7U7V@ !(E]:0\L0R5TQ26_HQ6 26$RM[-+>?TNO>]
M!7C8P+^6E\6)5E&X(\[E4.UB@H\%>4!X42PO^P:-O:/3WTHR)JK<VU3E[D.$
ME*F>'40RN!'KV!ALK@ZQCZO]@[-C<7A\=G:^?W1T^O;G5PMK"_SY\GS_L/SL
M5_"S!6D4R<R"DO*G7>&*XMC3VG_:N@JN+LHY;DED QF5+,W3K,GC2 WXC:/R
MC>E*?6.Y,0NOCJA1Y8+^H5WA?W"GA5%]H^3-<E]!.T%AQMRM]PQL.Y+_*9RI
M2=HJB9J3KN?3Z+'SX H/Y<N_YIJ3J>KGUC;S%%PW*H*0'8F9DY4]/9"F_)'C
M/?I D_Z1FIL5\0[!3BV#$VGX#\Y]H!<>\-BGYJM<?!@UN$NRRERW9%#'L06Y
M;[?@D8O!^V ,YX7@: R]N6_ZBB[TIG#SP0VYD!)6T8==W4Z25OMK,X7E;!S^
M<##X 2&8A?#GG'."KRG#4#OC79M+UR,[GUMJF_\CO&?G:[ U+ND>!WKCZH(=
M/T0@UJ?LN[T9-2BT;K^&/Q 00[Z:!']?%OV9*R3D@9(P0PJ\R7&OZ1J4 &YH
MXB*81]:3[ZTT/9-/,>4X?$'WXW3O8\/E^/Q96YP3:N:M.2.?/Y??6"FE[)T\
MPCR/=G:+>JDZN"^E[2N+%XR=[]#^S#\UM$=H_<'ANK,Q-6/9AV6BJJS,,L3(
MG _LR^3&%%E.L38"-C.4214"(AQ-(\1S^&XV:BC#F2.6+.*>&!A9A$5$*4K@
MQ*T:40H.4:_JYVP>$.4:N'#XX,BUH#6")\#6Q*6;79$9&YJ1)YB>8])J!>NS
MQ:YET%+"A;R&:.03O/VE\A'E$I- (^9GS*)8-Q^)13R+"@*U&1E"!C<M<G<0
MGKL,K%G.\\?41:4A3SD?@[0I9VLIDNZ)89J&8B#)9G,[@-0&[)-4FUJ:C0R'
M\)'/82#T9S^"X%M7A3 *[M- *89N2H^[K1,S<SJ4E8;NU*..1T7PE9=3?9YS
M&)_#> /&_RDX/NV?CRLQ\E8"+OLZ\EE-\NEI&*4T.3W):*N3#T7"R;E9 2/2
M:D#*[T(.!@.V&T;%BIH-6R@-M07@,IG>W0O@4.;"960<IL]&ALN7?BR4S;EZ
M;]("^/VMD&@.1',@^@L@>OI(]/N,FN]S!O5,@DN64$ /#^%6VYJ"MT6%!%&N
M"9"'AR 7^C\;%9$&X+A.SE#&<D@[[!<C1,+CSW&:J)QJWIE*9$19B5X-L.#<
MI#'@L,(K!U*S,B,G_Y5+%M7>+72E7G\610+W:%!$=4+(I:SU2,KPUE6@)553
M[(RV82""2.J8:D9JH!)+"Y2>+/'<E=!!!#,@2:&!P/XTHQZ,(B$#@0,0UTI2
M/;(G%!U*DFOP;E:K0%T(RA>M*-53^.+;V+^E_D/R:(FB#X49,4GL689<<7-T
M][CU$(*&L4$^(S^2-%F^,U1%3" $864<R^(;LQ@KA$T)='V'<N1Z=P>^,CAN
MQL#8@>)&+AG-1M! 49F."VI.5/PBVM7_# DIA""BO*0I"Y59BG\I+E,-25'W
MB#2LOJ6(8$9AC7QG [GL05#$121+8^RE!=^4^L#GLCBHL8A=BYJ43ZGX;.14
M>$!95ZMP)NP_E$5#IUG4/V0M"V-$/;UYN:JD%IR0N.&ZS\'*4%'GB*NESD*(
M:U31R3A!522*2KB!(HKFWL3<FW@:WL3M/\>9*%,0TA<,7*"0%CDE).KE$M?Q
M-5 A)V?\L,'L4<3[A!-A7(X!5J=%%'(;K>]>*&$IN$YUT"2 4'N8WK:FPK\,
M$;\1XLP+(E]>$&E4R"9O1XR+=W7!;AHV,J94CLLI P@9=Q41G5<]J.3\*'-;
M6>C)^R+=SJ6[\#(HJ.NKNF%3#N'6M'%!CD)]GZ)LI1D$K)(JA<1(UVC$]9Z\
MHNV3<_H&V;;;)NP,R\*JAP,"-L#J7IE 6W8"R!N+*2?PP"T9<,\U2R4%U]S9
M-8'G(C7X4O8KD==;Y##FQ!H5KH@3URS;WF-W[)8G"DG#%Z6M&N]]8U8+Z4NN
MEY5ZE[ #QSRN/5./K)!Q6B2YZYKUSN7TI:1QX:O:WKP$^H0T_EWB9+LOK:Y\
M7LI7#5,.EES;.B?$.()S_6VND;-VOA4*D*12]_[XME:/K%WBNZ&Y+D/BVM*:
M_' 7^N<W^[?T^M<O7E:]V>P,4Q\\$T,H$^%3)G7HVK\18T%[J*D<^MISW> ^
M4JBU@[=I.VM>G^Y]<9^V:R?TMQA\-^'TK4;^DH97([B1=.*F6-E;*(>2.B:K
M.(N?#ZB0]"!*M1Z!=/&9BK.(4PTE$$R?@#N:KW $G]U8XGORM;^K,&63:'_E
MMC"43I)AMJ4#GGM=N0G_X2S.3)*R/!:5.;8](6SC&WGUWG>K<A(*R(!O"-*N
MF]N) >7;A%.Q%?%[:3[9QZD$TR>SR)".TH)34QR@^_0!.0,T@QQ P$AZ?,K>
MM8475$LD]X@;EVJ-7;:Z'6<8B15?%'$)IM3X#B,2M@_P1JB[&S@1^#0%KTOO
M55=Z^)))<S]EUU6W$Z;N^AT65E/]4 1%G$8#_/OL"7XN(NYH<D$  X[+W8RW
M3.Y-XF[VLY.59HQXS(06SE94E&XDG(G2@'#?]:B\2N!34]X?2FWE>4:CVF$R
M;E&Y7]%+<Q5\0BK(O_<!!]]W&6.55%%%_9)I[9+J;)?J'D#W>J*6+\7!4G4[
MVVOKB_VEQ2V^:G]12;BXQ$0/_@H!=P^=OR$?OR3W1)NXNH)'-[BK"]S>87K0
M /I+;B[<EGP'H+SO?<89V3?^%DUY$_XTH4B=>,7)5<]&=L"\&GD&RS#6+O(J
MG3-/!]VC&*;N&H2_\4$7($B=RD/!ECS30L^+\I[8RZJ5<^)W*[@M$#J4UXA*
MCM:M=WDW^#M3RG%.L9Y#G,PQ?FERS64?'VR^7^ 6]\?,*%)ZYO_)!FY15_Y7
MX_G5T=,C\3=55H]R0XX[O %C>U.9K2=R4$_T<+XN6=_B #+J/4^&5:9_G6XG
M/8WM3]'ZZ4M3?P_9>Z>O5^VJ(_6BL#>P6&]2&\"U/J%2L@VNU4U/G*\<PH"<
MOIZKUQ,B:WX WY2LB_>7OYZ^=:2\>7=Y^.Z].-D_NSJ]//SE^%>G(J+]>*KB
MRC-WNCY]>W1C5[QC;]KNT$*E^WHF+1#Y-\I*8\S\AFGC'F6=GR4G=\75*,/Z
M^T;V=; KWB*X<=Q^FQ+[-AH7*\NWZ)LG>A_S:X<"J_0;X]VOD*??-/\_4$L#
M!!0    ( *0[:%G985&D8C@  /X1!  *    97@Y.2TQ+FAT;>U];W/:R++W
M>ZKX#G-\DRVG2A#Q'VPG]1#;R?H^CNUC.^><?75JD ;01DBL1K+-?OK;/9)
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M$^F[QG?FB8$E8;C"9*;E"<-G;K\/_3J#\/&!YTK)QIYK"&%*^)'Q,?SU8(T
M:O:$O6F5=0;#L$'T#A6N^$@X)C3GB3OA! *Z@W^YXP,N^Z['@#00U]&8.Y/?
M//E7X!Y*9D#WEL_XP!,"WHXHO1*>(<:^=2>.WI\M3EV>)?5LBLA'P]I!1'8=
MQPT A##_ABM])OD=H$L"/J3O!88?*+ !I@8>'S'?93WAH\;NNT8 7;J @!%T
MI; %;P@^LBU'P/<B5/CPC.48=F!B,YPYH,8 E]7&6^@!U)M:$RR'?2O?E-F]
MZWT'$!J$J!U!5.<M _7B<5B_0%/=@]: J9: !%N4 BG8$% SM@2HP%@=(8PJ
M ([9XZB1$!V$B1QCXBMW^$ M'L4"Z) A:AI<ZAQ8S 0N@09BQ'=-/F'<9^T#
M76>\/"JST]O4Y_V1NV@YRV8[^LZ"U1+;+^GE*CRY?0RD:L#]&4C?ZD]2MN".
MST^[U__NWIY>:V#=GC.TY7X;F5P.#QG\? $Z8-2#-:.MA19OB:%_P):Y!_L7
MW9N3[C\/NE=__.<=ML/V?[--M$.2KQS^YJGOE'*(?I]:+>JO=T )_@@C"/H<
MES'H'\TC7,K&GB5\[DW84-A6,&)CF\L15[K'XZ;E]CWQ5P"PG. O/JQ(L/ )
M8^BXMCN8()N_"Q],*+7DN39\D."Q.,$=#. WL-@.M0C)GO)UT-)#4OI3N]T+
MW1N&!I<%__K*%_HK\H5"^^P&;*N0:S4]9)O& N5!F.J=66OB80R&8;C8LMB&
MZZ//,$&? 9K#I?<$M"PV5RS4*G%[.  K]C/6:Y9%K3;*N07R-D,CFY'#HV\?
MKX6AE.S,2<1)O@RM,9BOWZW!T,;@A3PX>O_MX_9<Q\V,^,>^XVWWT_DI.SX]
M/[_JGIR<77SYL*?OJ;]OKKK'\=\KCS0*-E5T_>W" OMX>04*;Z]7[P(,)A^5
M7,PY:![#NT>W)R\F=[IVO;\]^9A*0VE;#=/I>RF!&\;:K>MS.XK=/_-_L4D+
MJ\Z;2J7<B/UPT+O,%.!4<ZE^K+]5&K6$EG()/R4\IH,YOKR_O<;_A\A..V2^
M: -%+-R\$;1<ZY+TS@E=*]/2V\B\]';-.PRTF:L)\*DCO,%D3HX[Y=J/Q+CY
M6(QAZ7TDOP@%@M5NP.KR].O+EX1JN9J $@;!9EBJ+6*IO)5UH$*K0)97 ;+A
MUB/S0OBKB:N-FRO<]SVK%_B\9PN,?ZN-F2&X_<)3&RYOZN76#P7YC5ZNS'X$
M)[KZ5GL5T283CX1[IX6[:V*C*YMXG\YN3[JAH(>+<OU']AV(<G->E'6299)E
MDN7T9?D8Y'%52>9SN0X_39S@;"BX[0\-[HF2VLN&)_N!8Y((DPB3"*^_'(=I
M1JO)\$N2C]AQ^,#O8)&KQ)6S?VGL_&JZ;3A[,MX97)$FL/B!258?(.;X]B1,
M6Q&*5M_CEHTJQ;\7]ITHC8 +0Q8'FQ;C1]-,JS(\ B2#FN*V/=%6U7,C_F"-
M@E&<8@/=XU:=(V<]A&Z)GE"'N GTIMY(?&,Y:E-/913BK_"AN2(IGI"X10BL
M!;;<<W"53)AR&)V4KF&IG4HU6<@JE7:&\Z>%>[^6E(' 5 ]=TW6=R2'H866"
MA>EOJQ$2YLK!3"5@ ;-@2=>3I,])GY,^7YO,L]'85OIW=;LLD5;XHZS"(?>C
M/2^55@'>U8 [UM\\U)'SF8(J01! L1H9JV8MEMDWD-@PZ6&!&F/(G0'R*K%<
MK4;,/>C@>!W!I(MO6C+YD?4FB33),KM%]>DX 4SNW\I(Q606-I>LV?=<Y*)8
M57\_8JLE&<R0RAXVPV3/Q83B^FP')"0MXD X*)C$P%N-BC$8X#Y_0+9Z [$L
MASGA>,<)@7TW\&!EB5-FX)TPHV4$7%%K-+0J7X)6Z-\!>D 8F!28NHC):6I]
MA14[P#4*(>,"#1X3(!/N1  8A3>R'(4/X)@C^A8N\F>H\<%N $YB@& U0H#/
ML[4:63*U&.9G7J5T0S>&-09N/;8)9#2+/6&[]V@4K$9&@NWSR3VTF-)B2HOI
M"\F\Q@2L%4U<I?N7.4@]EWLFJH@PS@$F+XI\'VW@D4K-D\QT[YUPC1#8\R\J
MQ3"T?Y1*[+,E;/. 7?&!.(0&5*(GOLA*I>AP[M')V;]B,A;$L(EIU#W7 ]-@
M^MTGFX/W48$A2]>V3!345=1%U)KAVC8?2Z D_K2@'QZGO\WTP1(I7WH4<R8+
MR_*=$]W!LPE>Q5PZ9+>3,?3?]7C/,@[9!7AU(2<O7&1?)?G2^_@M_.4QU([>
M Y>7,+P'QMCW4D^ /0)MC]4L)55C,QQZ]CD\S\V?G&65_L06\3O12=88Q$]R
M+LEPG(@0Q7G*XLQYVFT49OKWT++!_ :S]%'\1W(;6HRWDLQ'64+W OX/+'IP
ML-3OTYB) 7U93J .ZTG+ME1&.BAZ[,2TY-B5:D]Z>H@&FAI:QK!8&'A ?N+L
M37RH)G&:AIV[[G=U)&LHN*F("!.^U1,R.J;X5&_1N&"MB>D,$\KC9L!!DT-K
M# Z@C[F3V%3DU73"F$_@6/ZRS')ER<<)_I);)CL&UP"&S[ZXKGEOP9Q<(4-P
M]5 ]'@\MT6>G#\((5.CGLM^W#.&5XY,!9[#6#L&R[PGA #F]0$Y8'SBDPG4A
M!>@4PA/ !0NH"F-7D><Z\Y(B=U5C'K=PHN8V'%1F0'RX4XUH[G2GXDVQ$)^^
M#*<WB@>&,XY\MH5R.G%08_!L #_1G")E8,);X)*$CA: 6J C B\97 Z9%SCW
M>'8&W0$;3?U 38U03!'JN>A(%5 )PQM,RA&+\RMY^58<7[URL1 A>B;JVA2T
MSM3G"R,-W<GX 6CB(W328S?80H=0^CQRG$W A^V.54A:O8(.J6M.5/MN&'21
M$^F+D:;.8MXCIA'>>$*%^X]09KK*KPVCW5Q(^ =6028#8!B>W)%C;@@, P!)
M8;M(''<0@V#?E<"73ARAP1XDAEJ$E* &++ Z!HC%V>D9K5@(;,"G= /'+'$I
M<0_/9+8%VB<40HV-7="6/_C-<OH6OA_^Q>78BC\+&Y22YQHN'P1VZ*FCK/2!
M)'C>D7T0.R#(!;:$YQ.!E%E@R$3.6CC4?X/<!A[(.8898&BAX >]$>Y1L$9%
MW__^3FD4Q7OX#3GW^:3+')=!ORJBQ,/)4_+;C^;1 TTS'\UH*)4!9(RCHS8J
M*G+';0T:"APC7"-BKL<J!RS1(;?[<1LDY*]+_ID#.G\JQK#"H%J/9SU:7A(1
M46C/-4WVN^LYLC?1$FO:OP!]B64/6KA1RR^"^*LZD*9>5U+;$["0A/'6N1"E
MZ/?#[1IFC4;"M%1XK3Q;:GVU[(%>BA?:V0HZ;1C0-E;Z10F+$FG/!6E!!,8#
M1=B/)E&0S 3Z!4;#,*IK8A@,O5-/"!:,\2D,M6GLC/'1U !"*8S.$+.;(0??
M53&;3==PD(.1B[0JGQ:53R23H!QD2 (P:(%EUP)TCP=B@RP["17E]$!J:$+,
MCDE-38BP_VG/4]LLCGJ"LH!>JGHEW$6ST(8 3OV%T5H5^D-=@!2BLD5.37F:
M6TSG7"1O,4S>=]%(4A*"5BV6T%#QXNEF;2\^O:F,7BD&H]C:' BT L?#R4%N
M6;#5(.?SO.\]Y= NA#B?.\!%YSR,S.S%/O)\!/#9Y:=2*K'U. :YTKS=JY =
MCLDV4R5JQISC2YSABP][S;U4R$RU=@(*+*X67Y6S%A)]BCY4YAG\^KA;,L75
M%TUQJO.914Z]/@4[/5>'&,7P14GYBP?@"]W#"IH%LDC%*M(O,/F!-"Q)+6G8
MG,[5%C1L>'J9C/3Y88TQZN$,IKO!E36*:FUT#5FVX_O3G>R7CF-:O2@DOZ9K
M.6!U1LG:<;U%L[J+L[ID-:*I)A5."-A%8:=9W<59?1T5GCTO(]Y P12] V;Y
MT+*Q0;V[?X9[^6X@N6/*=YN(P>1(,IX5^-K@9& NVF8T429C8P26-<%2([ 0
M6)XUM#?AV([584)"#:'F64-[FS)JGFOC$91V#DIDVA!8R+0AL)!I0ZC) FIV
MUK392$3K4)WU&'CJH(SAVJYWP+Q!;[^JU[5JK:U5&XUW:T:]XGM5VV]3O=9U
MX7AD&C,=$?IV0X+U<I(JZ;+N37K,:BQ0MNZ]PAVMVFZG1U[*C$LO)DY0RP#4
MVK4F08V@MGFH[3?JV55J:>P-_3(@2ULLTT=:.16=MLSHW1#\WA+^=D+)59M:
M0V]E5LW1@KI#6*M5M&J&EU3"V@YA;;^NM>J5S&*-S+==,M\JC7(UU_;;UJ*4
M_\8AKAF:3#>H?GGZ-5?9IB\@[NFH?39%=16:U[:!M4JGLZFMJBPRE]":;[36
M=4(KH347:&V08MTD5'^\I?U,BK?%Q50)75N%EE.)0CP[QR!%)J<1=R6%FF.%
MVM)JK8UEXV61N836'*.UJ=5K9 $06O.!UDYM8TGQ660M6:NYL%8K]7)C-\S5
MO";#+G*I6FZL)2JW>"?&!@1X7;JVL=PH&IGI!CU;9&XS<D6*UY;LBE9OIY%\
ML10(^5AT"+.YPVRGE4:V&F&6,+LES.[7VYMP0M-';!II(:\ UA\P)@^6_9JD
MKH_,<BI)2L^Q[3< UTU$HTFYYDNYUFI:N[V)#6DR" BSF\)L2VN2XT68S1-F
M]T'/IG)2@\Q8,F/3-F,K^@[9L=,P=73G=JKWN[V83+K*[268RL+*JYZE>X;H
M*K<4IWAW:DWO& 4[/5=TE5NV52Q=Y4922QHVSW-%5[EE)#Q&]P#A..@>(-);
M&6%?1LG:\5FEJ]Q(A9.P_R+"3K.ZB[-*5[G-;Z#056[;EXQG!;[HOA.ZC" C
M8*'[3@@LS\PDHOM."#4K#VUG[SLA*)%I0V#),EC(M"&PD&E#J"'3)@L1K:U>
MY;8&/TY<^ OH3V-"?Y6ZY1DNC]_26ITT#(%\%'PGJ+TBU-I:LY%*=7R"6B8X
MEF&H[;=3*3=,5WZ\.K,R?^5'IYP*TNC&MFSB+\-*KEK3ZAE6<[2@[A+66EJS
MF49M#\):-CB68:SMU[6J3C>V[03,,F^^T8UM^;VQ[0P#V [W+=?92!5=*MF^
MB<(X&RK97M.:'2K:3FC-"UIKFTO6R")S":UY1FN+[AG<9KTQN@[C.916*MLK
M-4:WMY%*31>\NE:OI@%?TJH$UZW 5:]NHN8HP97@N@&#E4(!9+!FSF"M;2Y5
M@*YO>XF<T/5M+]?<5)$]Z8G2]6V$V=QAEJYO(\SF"K-T?=MVS7JZ]^+YR-RA
M:R]R@U=2KG1]&V'V5\8L7=]&F,T99NGZ-C)C,VO&TO5M2T:S]/JV><+_#*1O
M]2<OIOW9=[KEAORC3Q^/OGV\'5J>62S\,^">+SR&):K8M9"![<NC]]\^'AR]
MA\?R.L2<SY#:O2@6/'$GG$# [Q[SAP+^P]O91B[>'<0$7AO$II7#L6BXFD2-
MF<+P!)?PJ^^R-Y5*N<& #-MRH6/#'8VY!S_=6_X0?JR6]?A'9CFJE[%G07\3
MP3TV!OI<LUPL7"]0TC7ON&- ,Z>.\ 83)L5@)!Q_H>M.N?;#GCOE]L\[9I>G
M7Z=M1]PH%BPGV4FU7/UA)]5R9=I)3+KD(Q&USVPN?=5AF=W"3S'U2-#B"..Y
MN.<2"05<P,P6"R9\!51P9KOW, G\3GA\ )T(Z-09X).&8&Z?#00TPWW7D_BX
M&55J809@!SY[@(6^P 8>_<*"\<#CIE#O*=:/)P_LTA'LV'6D:PO&'1!C/D>\
ME3Q^ 2.VX74@P@$ S@A18Y:S44L&! !K0!]8W+8G\$9?"I_U)M %FS']SK6#
MD1J4A"':HA1 (T.@8FP)0\AB :@RIP-1+<&/*PQHCGI[$LY-W#\.;PDJU+Q$
MDS$E%4A10X\HAI_$@P5$P<0D& ^/VP$N?^QF,AH)WYNPFP"D'DC76 !2%N+F
M&*'E3'[SY%^!>RA!4DL*JE.&@JYP@CXW_,##QG#,,AB/$25\ (*+Y)997*1G
M2OA,9"KZ6P7&D@LH"AM'@+=FDJ*I5N=G-VYG-D&5RM)V:N56L1 U5,ZM:ERJ
MV6$ _RB5V&=+V.8!NP()/(0&_@J$@U9.E95*L2EZ<O:OF(R0_JG-TT2+YZ<5
MMU:ZN/5YU[$N6Z%GN_>+._*^.UYJF,VLP665Q.9N?TWR*N;2(;N=C*'_KL=[
M6'+] K1DR,D+%]E73;[T/GX+?YD9=+$Q=_0>N+R$X3W Y_=23X FAK;':I:B
M28!1J1G(!X?GN7GV]0N[N3[^L"<>.IU2Y;^Z7BG_.1[LL>[Y[8>]/57+/GZG
MJNOCAQF(G^1<DN$X$2&*<R^K^2'_B^=*6,[&GMNW_/6,L-;,S'IDI+2?9X(I
M:EA$3,B0U6A22V13+S?>+I+0;):;;Y^PPI*V$9I?;/"8%CEO&3'N^Y[5"WS>
MLR,+*6F@8$=KV$J&*EPH%2VA38?+_,AZ8#WAWPOA,#< SMR[L9D [ZB1XM=)
MZP'YX%E2K==L""ZZ4*-&M8FD 3$^FN)1![CX#H0+YLMX" 1A?]BJY10+V/ /
MC.*HZV4VV4K=[]B:G1_R+\<(1YBD8D$\C(6#IO*"CZ67FX\<C6<JBL<>6?,Y
MZF#17W%C(MF41F42>Q:8A\J&A[83FB;Y+L +A#8"N"=L[@,YABM1;. U?>9
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MAV#XH>FFH<)-WI.2> $I!Z,:KV@Q)+8'9BG6>3]DZG85PW,%<- =@>F,A_;
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MM^G*:[6MZ:DDG6V&=:FI$P);!L!6KVG-1AIW;6\-;+DR[#><CW[K<5,P;AA
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MLUOD9Z;6W85R/V2)YU'RZEI3ISMA"$-KEHKJ9!]#9(AO+LA/LK8U2XG*)Q.
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MW## UE1?WUO^4"V*Y=P*:,[U"P"G6#A6>)^P(4SZ#"H_4#>/T15C"E^=(NN
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ME<(&II-NU]R$4&_N=DV0ZWH]C<2BS=^NF4;%%8)KSN%:T_36)LH3$EP)KAN
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MSH^NZ6OEK^TROZ840L &)!7'!66CDT6[Q%XAY0"$"8:'_(+KK*F:2:YS%LH
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M@NS.[RW(/I"ZZ+J=;-(?8(:_R*0_W/P?4$L#!!0    ( *0[:%FZ6Q"S?R,
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M\V@XQC09^/)LN]=I;C=KM<?*P!A@@QY(G[F><XLG?$((+D]R^3MA!1F1670
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MN7DE5V2S[1@C_'?/[UN'_P]02P,$%     @ I#MH6?>;@1=&GP  BJ    \
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M!2H,&M:X50/-C.9]+2R?O<J6R>,^4[4#O7@%NUOYT%FG*VCY/I%!B_@RX@F
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M99DSB973S37"63R@.;5T"+)7,Z\SCCFH-VS"%@F38LU_28"CH@1PH[S]^@3
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MM/?XO S;_94<-RR>D\$3,/W;Z$ZW^'FILOQ14<5P ;>:7H*D(G>>G&A21U6
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M"LQND0!]8 G9R$2L2#*6N$&<<0^8C&B&J.I.QH'NA=ASTO"Q'M<"_ITQTB>
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MDC83RITB/ D>KUV3]>-V[P#GWMCRMO@6&_?_X(%DV1ZA9[C_$@(/+2Q#!Y2
M%N2$WS6U@ V(]T7@(DG9J>TB22T]+>#0XH^ LB9?9Q6JZ-YJ,P%.JM#PPB6A
MULRSLC$%X%)#&(\"_TCZB,J)W&&P,K3'N,JE\0[P)?A)75T(L:FL913XM^GB
M8M^SIWT$DSMN EQ6;Q/$^?R.X@&DO>%Z37 ZJ"UB\(@%)2K]]PY #:2A>V*[
M!%_TC1MV5];/)7B9>OJ%W'(!A.%-5I?'QXB%6\$&9U^V<F[+^,+:%>>V95EU
M@Z@](34#T/D4]]L"'/Z1\GU)(5;IZ0G6ZS&WFCY&2-'1#S$]F&,&320RN<_
MSN*0"ZE"?S/P3,-+R-Z1<513?ZS5O;[O<)!R:JG".??T5EAA$1W;3F$*Z,\)
MH [B&$376D^7B5$=EQ(0*Y&T9(XLBH-T3L;Q_@EST*ITGGY?O'<ZIJSNE1(O
MR5$(_;A-0'X<YZ3S=?@.0/AX+1EBI7HPA/?ZT6P;J0KR\LNY=*:F2L\*_;3=
M<@K_1;3MY\-YQN^=*+6V1+/L[+7S[0X-T(IBQE642Z&]U$M]BI[!E:'KS&:*
M)^[_V=<P.]\2&P&9(3IEIL1AE3,\KD#,.^"T?EDO6*N(6^/(9T:V.O)JX'Z*
M_MO>M:K[[L>M*?T1;10GMLJWPSCL[30PC(T_KJ%G\S]D(<4Q+ZJR-Z,,PXX*
M2=MLFGY[W_@KDNVC%BNX!U<6E-\L7D+DWLKXYGVJ8,[)!N_F?U%]D<!.3\??
M*RCWNH=.ZJ=X[<OHSZ\2_\."T@33\Y:II0);\,)3TAD)(_*YW72?"0VK+R?W
M]-XV92[#.0[6T7_#Z>80ZQY/$Z8/# ?$5BL0^DTMX%@_-<<V8Y?? L%VS*%Y
M'7$D)!LOK%E3AGZ5'RX2_X=?!LA5DWNB_&9SY\53,EDRYW>EK(\]]HRG^B6I
M0H1NE9\\49/:2'A"R(;R'U0_TM$JD5/M54/H9.-8?(4]0U(-4LP.'(JQS2IL
M2'9-1*Q.:8V,EDL3(:]7Z[!FB[0R.E%TJT-S%U*2< =PR N!DYS[HBX3NSDQ
MG+TROQHC;AN7W4R:IZJ5JGI>$?IJ<Q"U)7R0_Y1NH#/T OL';8@C$K\1A0CV
M+11V,V-BB[&OT23@+>\[ #D&-#J]W=V:9ORB.2 *EDP,R51@<$[>TA5+^0*I
M&3K!\'SF#9Y6/_C$:HDQ[*9[D"RBR&-^\,!4BM._UYY3BK?UJ2=4INKLYF;C
MPED.I-.9"29EH@'[^>EUA,@;Y8=K='1[_!L4?.="3X=C1I/OO1R4!E%ZD!/;
M,'&&UF@0ZE%E] DEF&:-T'(-BX;91Z8ZW-#2E95QJS7OC%ZHXM"HP=T.Y.53
M5 TQNN2I1X(]42N6@U%DP-9SU-/)R$0<:7#S3LX6:,"GT.E89B(,#E?=+PKP
MR:/L]*O":J)W8KM?8I*1;+.=>A7+SH;UA!XDIF'@].;T9-7*7CE)K9;Z*>3J
M]J,+O_?&]7V7!SA"4Y2)X!,L0S<&5F8DWMV"EGU/:33&]H1[KM>$+\]ZZK&5
M 655<[X/\RW&4SO'7KR#8Y+!$(NXS;@#?*B)@3, -6'[*^*HYHZUFDAAK0R&
MKHL.UW:+NHH>U]]F[+F)Q>;SQBO;8 *\TY^_"_G=7Z:K/2J':N+H48@T9 Z^
M"NHXWHTY/2/?L9D!G&-/]EABUB2HW<34M&08]LD]_LL'-Y+Y S.HLANI5"15
M?^L=@+(5_B@*9E+?;_"S$Y'C,)?S*4A-?\#*FB%)BW@YSH&[2)='9*=IYOQ:
M!P/K^VM!/]+)OA88_-P_4-CH<QM\VNE]&H^W2*9.4;KMGS*%PK4KO3(]1KIA
M_>+;K/ CMO:9\9D)<QC(3/?/9 P.!0H-LR41@EZO7; N&5*5841[&:K.,J[S
M(LXT%="+5.:KCKXMAKI7-E']*6./XWJ%OZ]+CWI0, @E\IIW"0TP/B0*84R6
M\QJ:V#%:Y]+IGTSC.<NWR/)(*0(+I7&W=MM.T$]6%J;,")BNEA7Q_(V34YWI
M,RR+*$V%'3G*))7"I/XUT>M5*>NX56P[+<MD!^6% 06+S50D,I"W+)HY^C5Y
M'XN-_W9+2WDY/U9?]HC4RX7T5(<>+A(X3) 8?G9]\%HO_&_KE7OABT=;!@9T
MCX5E'DK]7*!X?1#G=W[+]6]*>D%$YOEZ02Y-O-1,.)\$(RD#MGOFXUYOGB1_
M,KA$.68+#-8TEZ^Q%>=9YQG/,9G97R_7C0U[SE%D$LVQZ-FEWE18?)5;#EX8
M<O;MBR^I69$>_YRK;>$Q\7SE3(W.78TML'4?L'9,_TON^D;_"T#H"9Z@R=Z>
MS<+DT#E8C?.@Z%95C7TX67W,M+AERB*S@>Q2>4I<-3!>H7?RFI)(3%)H4$P@
MLEQ&E9[.GL0HE.-UWYS0/5< 'ZZ+09]@O,LIGS)S:@]7N%SIWV;760!8I5E#
MU)/)_SM\+?3L0?;&$@HJH\TO=:7"+->=F]9CR?_3RJ[<JI:.R<"H<<.4(@(F
M4Q^TKS:9XA*HX]BAQEF\H\ED)TE.;A\YN%&+LB1QL'+6"P//QK&"A1HT!TI8
MPIO*P C$HE9SS#""SJ6*_X]U<W,(%S)B10A H42BGJ3X]!$QDTX!URXL>XD9
M_[?NFL^@?*-W]:\W>NK"]3%J2NRN^MW#NP7=PY/+";Y+6:E9GBD=?G!1G'W0
MYG67VQ)704PM$5?!E_^OA6>EFUE+;[RP9ZWV^IKMQ[K*[.14P_'H4>Y_.W^_
M* >X2\O= =(T,+"@Y"PHET3>T'XWJD4\>;G)+;WJLUCEK9:>*6HB$JOMVMS-
M]N=LS&Y8>B-3U@4\.WF]0F\ ;,IYT='R78G7E74T[LC691YATG8#"F<A^R3P
M7_<DEA3IK+'H'[CH_%V,7X XRW'#ZE5[RX]/R/0GT>-@U>]U$R/?A$"RH+5*
M2]3[1(I[4RB%PX.H;)!'X!@=H<].@#IHFI&?_W89)J($@=+V;F[^1?LR4=.D
MYPE903YRPV,EA:^XWR_&^IMQ&?:'PN\=T@?<ZC4M]IG*A6L+9L8%>2O;8R$T
M&:A3 ^%=Q__R25QEYA5JI:/03'G!J^I\K*AJ.OWS=HI<TWE8#7GJONM'0T?^
MXI>S2$<KD7;CHT\UA%%],N,9L_M(AYGRBIY3SQM'W335>2G/(O%G"_4='<,9
M%..YKZIU%$41O\MT\X"H5 ^#LO<7KF:)ET(5#)Z>[DY:WML+?SIX!?_\4E_,
M-Q8):P-F!/6'X]5KY/WX"MRH>:,^USSR,FHD4O=18#(U6-87IOJLH,--MW24
M^2M?^6LVP\QM_GU"?%Y>@ 89_VB(8FO9./T] (;;[;:"QL0GL+3+37< #+=6
M[ U5H A&%#E!@Q6; SF0$P<2:<>=0F9Q"\>FRQI&DX'2Z\N6VBBL"5,S;9W#
M]2VBQ;KP:UDA0U$GA?D[Q<'3S_1@G>_;9VC=G\A-9(9..BL]M](_O;X!R3%Z
M1WN;HX"5!=9$ELR/GE=K>^N<(T!S0RW)@Z;,1?!*1Y4OJ-A-AN]K1[+D@XA-
M^^<Y$P ?^=29]J_1!M\HGZ@]:$8-J)+&%T8\%@DQ5I5^V,ER$8\I\T=IK+$@
MM.-,@E.>=/BC.I U<4 ?YX)E\RQ&%Q,HX>[<YU['%MJD1?.N1EK$W&&]F8H+
MV[?*JE??EPBIKOA0JUAFBALE2/VO58CV!<DD5H.YTU=X=20?4C.8N4FC9V["
MOF ZX5,"D=A>P?]P^&<16.S%<%4-^)B+S8OPZKQ/_FB$K921E1#$N)RZ3K1*
M*UX&$L\8=UL(.VX\3)OJ,.E*"!R4'ZDO/W/'#.G'[?\V\,\GU.26M&NSRLY<
M&3(_[TH!-2+Y;&R$!K7N ,@3??8T\RCRE&VQ#X#-=+:OE_K8_&[PQW\URB]B
M<-(9.#*+VVHZ)FB/]'&]" 2.R31DEO^'E4][L[;I]@M ^4096N3VU^LB&FUY
M]/&&"_OJ-K_3&873#K^GDL0"IX7FJC7.#$,H1GEG$JM4L?O-9.2VQ;IDG\^5
M2D/CGG?G:V^+>4N_OWU6*YR):O9+^5T4/<J%O$T]4$X#5:R73I<>2)TJL=./
ML1V>C%;.3%Y6\M$$I6S[<"JD?8[7*^%I\D>=ES41K"S5I^IV)#>FUZ3MN<S]
M:6\) 3*NR[T1/)\@QD"-IY.%R1=\2'FUNMN-%.#I5>(SC?_8Z!.=W#Q.R_/[
MA$CS/ZZM$CJ:0ANPDL@;>GWF&C>8H^]AMBNC3<@ D:>RR,9OYB7R3;U^*,H+
M-%C!$MT-PGBM3?Q-?(/NQ.&C(^.PXHR[P6+HB#*HCS421.7TF>1S_X)O_-I!
MCU6+A\D@_^*O,J<,6N$^LKD%[MG[AUP.K!(?F#AC'6]#SK6),5KK-C';E]IH
MOQAO%TWC%;%%JQ5.E%U.T?+XX[HDXJ7!B)?&WU29W.X 3RODTM2LRVWF%0=F
MBYCT=HP]^X>I8MPC^55EDLNG7:]J.#9SQ^B[Y7H0%$6W)=\G2(KX@(ZZN?S(
MVG_A&R/#%28YLN(<:<G;;AI[MQ&+!7RVULK$*0D_7&G3KJ*(!QG=\=_9Q.2P
MQ_ !W)6! R\:.-S?6,'"UXZ\PCB_^)M<D5\(WC;C'N.6+?$;5^,L'P:^O2Y.
M$Q_-=(O"2I;WWUM=&@QM_WL$Z6 DT+18;"HV #-^&?)O(2!>]GVH37,+"<*H
MX$H%1[1Q!\!C0DMBJ>S75OORHG%T&,N"0+UV]%R_<2"51&(U)E('=5L5QO(W
M,Z'ULF[)R'AE!%@Y*Z^=NOM*.;6>RV #T;=E'/\.82PXXX2L6SI-G"Y7R'Y)
MJ'#4.[TW-2]@Z\Q1F*DI'CRT4?NL%KK@6LC[/L;RZ%D1][*&/:WTM*.\L]CF
M@F/Q2<&M%]5;U0?U:C^1[1OR.8!][4?9N:2\&@S67GC+V?;24@AWX92XN+D1
MEGK\01?MBV^WZ=T/@O^85(<[(@,FXO*( FG1SR][9PT%H?;_C:QW49*:-QX$
MJ:N^R#U[<W'@0'(I%(^@IS?0X&9Y .W1A*\ULCP K>4*VJZ95CT_6%\=-+?Z
MY02^ Y TRIE,J#6B9N-E7>IGL1[KA"-#L)Y G%'=U"?O+FV=-G[![\U)E91+
M>^'#IT!?6SWN'B1GU*!N:KXNQ>5'6C)7/VZYEW1<ZKJ>R>#XZJ5DGF['T+Z/
M+^-K#'3S=8&_/6=U]V%T%=)JA\G:W4-YC:_V'ZJ2)Y,1$.TX'IQ^##9+4#ZT
M\90J>QQEZ/ZIAFGM-/?[!J><LDS"9R]+!'\-EFG@!@PQT00A+)]!/V3Q2R(Y
MRL3<K"L65K%O45NK\^QQ&E2+!SCVWW> 6H%-B")!47>D2L3VZ]S7W"*B4'50
M;<G1.4H01_0 %3*W7M/C MXK;&B+5$</AC1%*27& !^MT[8XFFK,\;'Q'.']
M4KC6*GERHZDU/ZOAKP;6V;/KY,VS:87<NS 3-_*Q$9F_3K]K"#0RLI*U4DM^
M75NX<-P.G#A@ZH]9AT_5RB&?&TITA@9T^Q7T]]6*)U/U4]UH72@-FVL4CU->
MQ;=Q;B.DK.>8LLGP6=G6'B2K]O1#'</B(B<>8\L/5?$?AQ.I];!*X=,_1BDI
MWOMTI)](?(=']G4VY0, R<T9/1L1SA^T5K:*,E.^K\^?<;^#"3'T2&C89\F!
MLA,@>Q$&ODY6Y+>>-48))30^8&B\D.!V=G$LWG<WVQ=UG%4QB)GT;=)O:6^T
MI[R*;Q@=_G?HZQ,;02L XSGUMH_*C#-U2GVU?%R=<FFSZ#1;;]( %QH5FG=]
M7LQ*+:XE7$;TWM-7-SO3W,7'D==T @Q]&V(T+C0_H45&OA'C;*90XBQ/1W*T
M,(\0[0#8N[FL^K$)>+X&JO1!&3#0=<,O6&HT>6]FG$E+!#  :4D&F>I;J%1Z
M9Y(>N9[#,&@V>6+%R_02UEX/_SK3V<CJ.VOP[2DP]J(),U6*&[=LR$/D);3;
MQ3JOQ\+#<_%F VWMD1T';955XOZ-W]\5]Z[_(]C,) [X/O_&@ZG[74<AA:I0
M2>XS7FT*IE<Q1C\,]%,9ZB^2RTM+]T^"?=/;7;V'&ZGQ+010^CDVUYX\KK#/
M4%^1@#RU02^2PG(I.Q9_WUI;MJ,',ZG//N6U_Y201DB7?7W\C9R5_F+B%?S%
M'6#MV_\V,0)1W@.61C<U5@.3M:X=?JW26Q;\'/LFMH>F72MI7;:&<J!L<:3
M=/\.X-;:WC5YMA-B*TE,H&IH79ZL_'#N8#+QQZ+T<DOB._(#DXU:2%P+O=ZC
MF)@$CE"/*NI&D[W;8#LCH#F3[_-<CK"V,@/#V*Z32_*"&-[O^_\GE/ZO5;_V
M],JE'\1G$AQ]<)TR4654BL_8,#C!:2&30#ZU4N ZLB5[WW=*!M\9AZGX/.<A
MSLLJ\FUM'%GL>Z@5*-PF0AIS6F1+Y6 '0L5 HL)UC1]VB+HH+SVDK%9TX5F-
MOO_D-^0+L?WPNI*C*J1;R"KUL2"0$S5X,8A2"3D6^UHVED-];OET[[JZ!!6)
MX :Z\-<+1@NNZJ.R-,(E])QF-8($^):&;JSO /AOH4-)@1RRCY+0-TKL= _9
MB)$3S^PD2(04"WB84$]6WUBFLC3;'_J501)Q!#MW@,?+MYW!=,;F)H%*M[DX
M8JS\GT"O*D<MFHO%GU[.+;065&BF+2)M((X,G=3R=((B.<!9TV*;[L)$PU/E
M&,AO2&CZ502;(11FP2(_YD5"1E399I+_O8]8P3W393!M^.PCS:+9N/S!-!8F
M"XN&#4AAYP12T][E$4?T6W,K-9:O.1ED)C<5C8VP@S7Y7?QF6*^#[A,/'CSO
M>P>H4SF41;NM<V25#99@M=#!:3ZHB;6M4F/-T14@VD8R7=A91X6QXC:O[[/*
M14:T ,<5*XM-2R0D>9W=;2T21[B(A%)#W/ZWI1/!':#7_"/4OA22=1&*(=XP
MY9BV9?DT[9WX#%.\:OHG4-&+J;J^X4#"2[M2D5>)/LVMD@T2!::Z[PG:[2(;
M4W)?Q^9N2Z$?W.93M*9.&N-I^[K)?[_$_'R9H(K4IN\3^UR#.(DZ1*LF<827
M0/14IO@[0<_?I3C-'3USWG::0N#&;G0AH+X\,OC:!GP^]J<%^935GT[NM3PF
M7&\P-0J10C#ZV36T ,+Z4R8XPR8NV.X?W]%'A5&-7_LVGD9U\GFDMB,1(J,C
MD<Z-IY53+];YYI@-,P7<>[;051KDH2XU:\/[55+_!IH7=S+_>.T8#>U@.I\[
M:R^/>%YC/GO[6<SZL&N>%K4 ;2=H*WQCU'G!4,L[0,MD_FTDW/G<9<7H-ALG
MXL:C^@V!PYL=+7SZR_C"=2$K\KL'_2^IFIT,'*ER>V,+AO@&/!C@[^PBB.4G
MC_RIY+Y'E1_;(\)69)V-9]:\O&JO]_2E3LXFB?:9[$W0M[PZVJ- =W>0/4N<
MUJ\.21%H+W$5K0Y\BW'*\WC_ 3O!!U(H 0M*S1+#3IX 7X.QD,ES8SIZ[@"-
M"3"4!$O$"AMJ,.+D;(29UG*&JI]J/Y-]O,BE3*R9X2*NO$Z1\77Y-C0K@.=5
M]P6FFZ9WJS7A\7J,$;;'UKLH^P,[GX8!LXQH<HGTN'L);XNNQ_NNG.RK*F9M
MV#K]#*S_AYR9/..! 2R\C.OC9.Q%E6YUJJ6(Q];LI=."PXGU+=W&M'>S-=VT
M]U!#?&G](KV6AOT6>'SEAQT1;3)] J!MLY]5-_NE@7M=MS4[.R6W"D#(?![4
M80,F&TAML(&R/G]V!PAUP E#+ >Z*='W)RTK\-(>Y,DS!XN7;5-0)#4Z6ZU4
MI6"5_0[P=\4!:\W53$M,_-;N^Q !"=3;]"6\VH'UZ;S):WJC-\Z/I1\YO'K)
MY+]@/!Q"*VO\_8N[FCCJJMDR_2,O<O:1;%&V7FI*JB.B2UQ9?XE=JS!-A;&M
M35VX(;UL68[B3#I84*C_8\6$\# LS8I5N87O19F45AZK3K)[;&-U:N5"TXEK
M">K\#O $IPQ'7=0LK(.R1IXS8:YOB&G (%3+&19_22U0M"/2<S+2]W8;P6TY
MGSC(\I6%".Y@&;'"B=%#^_4LL,1WTJZ/"9RH3WOGN&G5=1JE;].T:*IHY088
MLT\UF<L;QESTZ3<YG%16NVQDKA@L['&BZ^[?B"T%H<")"YMK5'< @KG!<8^4
M4'2B!DNZ*HLN?C"T-=HWU>JG2.FW6E8I"[6/@RN #]:YFD%^4>?EO]<_,3N)
M.TU6D3S7YAJGMJ='!"-$7 0=TA;5#]*7^5+\4!AP.,,/"VN&5,<Q;:HXK^T2
M_+&;=J=C-#Q(SUP;>8,CW9J]]Y]?X"@]MX6:"_58O2XHWM#::O1%E;6/^UR2
MQCT"85*0MXQ]#%D95]U3M)%-8[K$/Q1@2[\.1$4"1SA702@?6I9ZR<.SG]8X
MP<W<R*]KVD_120C(ONP_.=[3*1S!C<@!%&59LY!A7,<1P%9[6W%BGW$2WN(6
MA2-M3-!<^L+IQ7 \;@..3.F66\VW1/D\!R&3H/;=>?\L;9F\[P!)5/U&=X #
MHFN@K@Y:,KR<+>V=EFE8351:V@$XEZ8]1SW#XFQ!36W>8FC>%3*]&(EG_SZR
M@T%J^#>,.D OS/D-0DCK0JW%MOK6-?@^EWJX?K-@./P..41'\^IW>FJE\/SR
M\'8_OM$M_,3YX"LSX8O0"):A"2S5)?(D$N1&CA'T.R)<7XTWL6U)Z)1;2WR*
MA6!:,R6C)GF[Y \#@9A0I%N$Q</&]B:;?P+>R^P^-[PS?YC)?KCSR?\1KQ S
MK;@>O5=M[0T<<_X-P4[2/>PVH?Q._[=]P=O!37?G*\_[NP1#9%GW0IIS6^N=
M=1DCVY$8 6\<ZZHD>[)7V'1;($\S_*M467$0K[]</["'I%SYD6%&LL:\'EJ6
M_G&Z0+A8J6'L5HW&HMWW3'&Y["G=2#E9I7F.PV1GC6OI?OV=GE3[*I[ZSKT1
MC%>J^W=' 8<.;K$MR2H<MV,7O%$P"D3<S8+50FDUH'8&@VG_!.JLN3UUU(3=
M\]2,V CO[?,=]1^D]3\7@D9%37L_6>G)-3:7D0XTSJ+$.Y,&GT;AF.^'4_"^
MM">"GD'7LBV;! ?RHA= @]JDD(JUR'YS_'X<72RR\CD+&J^[P[ZH)/;C7#"S
MI>6!3-@0S,(YF&X*YL)PHJO:LJ(B/NU;IT(2RP3ZK<>G1*;#F,[N7DWV0 L?
M2,'Z*"DQIU[(*=6D.5'\P'C12<9[;J^+K2'A>KEZ(_D)5(3S*]-H,0TE(47&
M)<1E^&&*90[2*WN"].O &NJX$M6Z#T:\]\Q1UVWRG5'CB2EAR^Z>MM7L8/=-
M5IE:]\QN[Y8EM_#>TZT)K1A3*'Q5-E:B+'SAB'BO&].0K"72X-==18*F:2N$
M."O.8A6K5]\4.WQ^DE)Z\'FVR'NX^=HUH\AXHM1R=7R4_BTX??;?4K=!<SE3
M16(Z?)POD Q3=#^IT-M\^%HQM$DY(;-I(+(73H"96_<+S4?,3&]. 5]?V_>"
M'I@H+_ZQ.$7FA34M:ZU/2@A2;WV++PY;[J^'&M^CCZ7;0AG(+@_#69/8V,6H
M'\#R/#!PAJ^;""-<5<SORW\^PJ^HCTXH+Q]&!^62$^V:=#)NZ1!K![C1I8RV
M)T('+5&O8^'SVA<VMZ&5)\%L@5X86N0J2_!O!ES-!I06 S7%9"%Y2>TU4$A#
M%#RL4[;R[XJSL)D1=$#66J"$(_M5#+_LC2[76QYD""Z\E]HC4+3/'TYI^]>R
MT@Y3WFI6PO-?Z7#Y5KRZCRCWO$)1JOMY;I5X4-<6(W:50J\HQP[#E-ZE]4Z,
M:PX![IR,5Z'3U\].0_HK>$\7M&7DS$:VW8=/*[Q)$BM(_E=1 Z-9Z33I]%SP
M]@=64;)O:*TS: X-H07?*+>ASB4:\)U)>=62M4D7U=\3T*K'+"A,OC6_ RA#
MUTHC02AMRX7-C9- "G22-!TGCOWFBHEB+V%9&N%\I7B?7Y98#93EX<O[V:C%
MS-W(.EA(H4ZB@A]B@^> >JC5G_=5=2+*!:B!#(@7U9]9'+P#/,)6')']NT"<
M&DT='5NC:$H"@/$!%['+;ZKI'Q\/7G?</_,_/!:4MML"4I)F'B6)^'#LQ4KB
MV// CRV#+32#DV]>>MQY8IVO7NJYU#!:3*#V1]6G#I%\B!0GB>8G/&,O99U$
M/EC4Q?X89WF[UNXJQV"E"LEZ6?E4%; [@1-/9C(Y=;M,;V"RL[ Q\+>CI$,%
M6X87VAE'JD5_FPYRJ+P#L R:JDB=R^/]9OLY)/5^2NI1RA<8Y^.\_329O(([
M  _NWE.O3:^I'-;=O!5^3(ZQ\(U-)F"$(Q^BMO53?H<0L%:_V0BUG'GJ8W;\
MPKWS@HYI\XSNUT',/ZD]*,(ZV[&B?/$\,/'\L(L,1QEC3&964-DFIG[D<HH=
M<BB.T/OUP6,N:7!N,L>2?VNNQ;+U^GU!#!?@_VJE9B0I<UMNKLH;B:Y=03Q.
MUB_9OJD /46$E,GQ0\_$<BY61.*FNY@8+ -\KP[R1341(\$.H'8U>)LY-G%;
M]MX=9 K?4 9RN^P380,GGQV_E'?#* ,5-DG[75])ZVJG4M7%?C%@JKFO/N\L
M(Y_38.ZE_;'?;88\#69".]0(E=%O.6^MC7*+\C[XOI%+?]8%U9P1NTGW3OIB
MS-_]NV%Q.-R5_[@@PLC80F3D6@TMN9;1"X^[ELN(E.?'RJ(X^U?)C)QTG"YP
M+.A[L?;6IG.H<W+O_Q!SS2QJT=A=%['UPOXKVU/A!$D._N2PI,]N>!C:WCL
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M3=!:2M9_)>W_Q$"U1YH5M#28.@\20@"8O'HXI3?)N@!T@Q9/@(H6MS^@]G<
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M4FD<AU)D0]*64"V'FC>L$!:31C1+R'TG0/.7O2:WT7;ULYUR*.C/:W")XTL
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M$@IT]FM^?;.:/T/H8>9DXKYF3XO^Z7FY2-F1+O_P8'EL!UG2LHY%'N(@V9;
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M>LU2.?;8I4ZY TP]/<]6;GU!^>V\#WF+B8DLM)G\B&FN?G9R48>]++)[/Z#
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MG;K+/,_3J0 5%R_P,/%L)*]M4BK]*B2_-CQK:6)?VO/TM/ET#8:B7@=&D:Q
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MJ7>5P1[LRS4O$MKF5PP%;/F.Y_X/4$L! A0#%     @ I#MH68$N%,LL P
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M+FAT;5!+ 0(4 Q0    ( *0[:%FA+NZ0PYT   \:!  *              "
M ?4W  !E>#$P+3(N:'1M4$L! A0#%     @ I#MH64MLV3:O0P  I-,!  D
M             ( !X-4  &5X-"TQ+FAT;5!+ 0(4 Q0    ( *0[:%D$80XU
MQQ   '!>   )              "  ;89 0!E>#4M,2YH=&U02P$"% ,4
M" "D.VA9V6%1I&(X  #^$00 "@              @ &D*@$ 97@Y.2TQ+FAT
M;5!+ 0(4 Q0    ( *0[:%D_JC)K7PT  +\Y   *              "  2YC
M 0!E>#DY+3(N:'1M4$L! A0#%     @ I#MH6;I;$+-_(P  G18!  L
M         ( !M7 ! &9O<FTX+6LN:'1M4$L! A0#%     @ I#MH6?>;@1=&
MGP  BJ    \              ( !790! &9O<FTX+6M?,# Q+FIP9U!+!08
1    "P + (D"  #0,P(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="apyx-20241104.xsd" xlink:type="simple"/>
    <context id="AsOf2024-11-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000719135</identifier>
        </entity>
        <period>
            <startDate>2024-11-04</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-11-04" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-11-04" id="Fact000004">0000719135</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-11-04" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-11-04" id="Fact000010">2024-11-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-11-04" id="Fact000011">APYX MEDICAL CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-11-04" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-11-04" id="Fact000013">001-31885</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-11-04" id="Fact000014">11-2644611</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-11-04" id="Fact000015">5115 Ulmerton Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-11-04" id="Fact000016">Clearwater</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-11-04" id="Fact000017">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-11-04" id="Fact000018">33760</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-11-04" id="Fact000019">(727)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-11-04" id="Fact000020">384-2323</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-11-04" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-11-04" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-11-04" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-11-04" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-11-04" id="Fact000025">Class     A common stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-11-04" id="Fact000026">APYX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-11-04" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-11-04" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
